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Abstract:
Sex determination in the mammalian embryo is initiated when the bipotential 
gonad becomes committed to either the testicular or ovarian fate, depending on 
the presence or absence of the sex determining gene Sry. In the presence of Sry 
the gonad forms a testis. Sry is expressed in the supporting cells of the gonad and 
results in the differentiation of Sertoli cells. This process instigates a cascade of 
gene expression leading to testis cord development and masculinisation of the 
embryo. Many steps are required for this process. Little is known about these 
steps or how they are co-ordinated after the expression of Sry. In the absence of 
Sry the gonad develops into an ovary. Again little is known about ovarian 
development as the majority of research in this field has focused on the 
development of the testis. The aim of this project was therefore to find new 
genes, in new functional classes involved in the development of male and female 
gonads.
The starting point of this project was the use of wholemount in situ hybridisation 
analyses to validate the expression of candidate sexual development genes. 
These had been shown to be expressed in a sexually dimorphic manner in the 
developing gonad using microarrays. Two genes, Gatal and Vanin-1, were 
chosen for further study. Gatal is expressed in the germ cells of the developing 
ovary and is currently the only gene whose expression is found to be female- 
specific during gonadogenesis. Vanin-1 is a GPI-anchored cell surface molecule 
thought to be involved in the migration of bone marrow cells to the thymus. Cell 
migration is an important feature of testis cord development, therefore Vanin-1 
could play similar role in this process. It is expressed in the developing male 
gonad prior to overt testis cord formation and in the Sertoli cells once they form. 
Organ culture studies with an anti-Vanin-1 monoclonal antibody showed that 
cord formation in XY gonads could be blocked in vitro. However, studies of the 
Vanin-1 -/- mouse revealed no overt abnormalities in testis development.
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Chapter 1: Introduction
1.1 Mammalian sex determination and sexual development
The anatomical basis of sexual development in mammalian embryos is the 
bipotential gonad, which in the mouse arises as a thickening of the 
mesonephros at about 10.5 days post coitum (dpc). The developmental fate of 
this indifferent gonad depends on the genetic sex of the individual. Genetic 
sex is established at fertilisation with the inheritance of either an X or a Y 
chromosome from the father. Depending on whether a Y chromosome is 
present this bipotential gonad will either become a testis or an ovary. If a Y 
chromosome is present a testis develops through the action of the sex 
determining gene Sry (Gubbay et al., 1990). The process by which Sry 
commits the bipotential gonad to the testicular fate is known as sex 
determination. Once the testes begin to differentiate they secrete factors, for 
example anti-Müllerian hormone (AMH, otherwise known as Müllerian- 
inhibiting substance, or MIS) and testosterone, which promote 
masculinisation of the rest of the embryo. There are many steps in this 
process that, if adversely affected by mutation (Vilain, 2002) or 
environmental insult (Sharpe, 2001), will give rise to different degrees of sex 
reversal, gonadal dysgenesis and infertility.
Human sex reversal occurs at an estimated frequency of 1 in every 20 000 
births and results in XY females, XX males, or XX or XY true hermaphrodites 
(McElreavey et al., 1993). According to current knowledge only 10-15% of 
XY females result from SRY open reading frame mutations, 10-15% from
SjRY deletions while the remaining 70-80% are unaccounted for by mutations 
in any of the known sex determining genes. In addition, only 80-90% of XX 
males are SRY positive while the remaining 10-20% are unexplained (Scherer 
et al., 1998). Only a small percentage of XX hermaphrodites have been 
shown to be SRY positive, the great majority are still unexplained. A small 
number of genes have been isolated as a consequence of their ability to cause 
sex reversal in the human population when mutated, for example, S0X9 
(Wagner et al., 1994) and DAXl (Guo et al., 1995), WTl (Pelletier et al., 1991) 
and SFl (Ingraham et al., 1994). Clearly, there must be many more genes 
with important roles in sex determination and development than have so far 
been identified. The search for these genes has generated much interest in 
the processes of sex determination and sexual differentiation.
Mammalian sexual development is a unique example of organogenesis 
because the gonad arises as a bipotential primordium in the male and female 
embryo and undergoes development into one of two distinct organs due to 
the action of SRY. This binary system of development provides the 
opportunity to study how genes control cell fate in organogenesis. Also, an 
important feature of this developmental process is that the gonad is not 
essential for viability. Hence, adult carriers of mutations in key genes 
involved in sexual development often survive and are easily identified due 
to their infertility or because they exhibit gonadal dysgenesis or sex-reversal. 
It is also possible to study mutations that lead to a complete absence of the
gonad, without loss of the embryo. Hence, the genetics and biology of gonad 
development permits the use of powerful functional techniques such as the 
generation of null mutations by gene targeting. This makes mammalian 
sexual development a useful system to study organogenesis and cell fate 
determination during development.
In this introduction the processes of mammalian sex determination and 
differentiation of both the testis and the ovary will be described, along with 
our current knowledge of the molecular genetic mechanisms underlying 
these processes. Gaps in our knowledge will also be described and an 
overview of the various screens for new genes which may help to fill these 
gaps. Two genes described in this thesis, Vanin-1 and Gatal, have been 
identified as part of an expression-based screen and their expression profiles 
suggest they may play a part in the development of the gonads.
1.2 Sexual development in the mouse
The mouse has been used as the primary model in the study of mammalian 
sexual development because of the similarity of mouse development and the 
mouse genome to that of the human, together with the growing power of 
mouse genetics and genomics.
1.2.1 Origin and development of the gonads
The genital ridge, comprising the indifferent gonad together with the 
mesonephros, develops in the mouse from intermediate mesoderm from 
around 9.5 dpc. The pronephros, which is vestigial in mammals, forms at the 
anterior end of the body cavity. The mesonephros develops centrally and 
gives rise to the gonads and adrenal gland. The metanephros develops more 
posteriorly and develops into the kidney. The gonad begins to develop along 
the ventromedial side of the mesonephros at about 10.0 dpc and consists of 
somatic cells and primordial germ cells (PGCs) (Figure 1.1). The somatic cells 
originate form the mesonephros and the coelomic epithelium. This is a single 
layer of epithelial cells which line the coelomic cavity (Karl and Capel, 1998). 
PGCs first form in both sexes at the base of the allantois at 7.5 dpc, and then 
migrate through the gut mesentery and reach the genital ridge at 9.5 dpc. 
These then enter the gonads at 10.0 dpc as they are forming (Ginsburg et al., 
1990). Until 11.5 dpc the gonads from both sexes are morphologically 
identical and are able to form either testes or ovaries. They consist of four 
different cell lineages, each lineage having a bipotential cell fate which is 
determined by the sex of the organ in which they are located (Figure 1.2).
1. The supporting cells. These cells differentiate into Sertoli cells in the 
testis and follicle cells in the ovary. The primary role of both these cell 
types is to nurture germ cells during their development. Sertoli cells 
arise from the coelomic epithelium (Karl and Capel, 1998) and play a
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different cell lineages, each lineage having a bipotential cell fate which is 
determined by the sex of the organ in which they are located (Figure 1.2).
1. The supporting cells. These cells differentiate into Sertoli cells in the 
testis and follicle cells in the ovary. The primary role of both these cell 
types is to nurture germ cells during their development. Sertoli cells 
arise from the coelomic epithelium (Karl and Capel, 1998) and play a
central role in testis development, since it is the pre-Sertoli cells that 
express Sry (Koopman et al., 1990).
2. The steroidogenic cells. These cells are responsible for the production 
of sex hormones that determine the secondary sexual characteristics 
of the embryo. In male gonads, these cells differentiate into Leydig 
cells and secrete testosterone and probably originate from the anterior 
mesonephros and/or the adrenal primordium before 11.5 dpc. In 
female gonads, the cells develop as theca cells and produce oestrogen.
3. The primordial germ cells (PGCs). The developmental fate of PGCs 
depends on the environment in which they develop and they play no 
role in determining the sex of the gonad (McLaren, 1995). In males, 
PGCs enter mitotic arrest at 12.5 dpc whereas germ cells in an ovary 
enter arrest in meiosis a day later (McLaren and Southee, 1997).
4. Other cells can be found in the gonad. These are also somatic and 
consist of peritubular myoid cells (PMCs), endothelial cells and 
perivascular mesenchyme cells. PMCs are only found in the testis, no 
homologous lineage exists in the ovary. They are thought to originate 
in the mesonephros, migrate into the gonad and probably co operate 
with Sertoli cells in the formation of testis cords (Tung et al., 1984). 
Endothelial cells are found in the gonads of both sexes and form its
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Figure 1.1 Position and structure of the urogenital system within the 
mouse embryo at 10.5 dpc
Epithelial structures are shown in red, mesenchymal structures are shown in 
blue, and the striped region denotes the genital ridge (GR). (WD) Wolffian 
duct; (MT) mesonephric tubules; (MD) Müllerian duct; (UB) ureteric bud; 
(CE) coelomic epithelium. From Swain and Lovell-Badge (1999).
Figure 1.2 Different gonadal cell lineages have bipotential fates that are 
determined by the sex of the organ in which they are located
Indifferent gonads form in both sexes at mid-gestation (top), and can 
develop as either testes or ovaries depending on the genetic sex (bottom). 
Each of the cell types in the gonad must differentiate accordingly. Germ cells 
(yellow) give rise to oocytes in the female or mitotic spermatogonia in the 
male. Supporting cells (dark pink), become either Sertoli cells of the testis or 
granulosa cells in the ovary. Steroidogenic cells (pink) become Leydig cells 
in the male or theca ceils in the female. In the male, Sry induces migration of 
cells from the mesonephros (green) which include precursors of the 
peritubular myoid cells and other interstitial cell types. From Loffler and 
Koopman (2002).
vasculature. By 12.5 dpc this is most noticeable in the male with the 
formation of the large coelomic vessel.
1.2.2 Sex determination
The sex determination process is set in motion with the expression of the 
male-determining gene Sry in the developing male gonad. The expression of 
this putative transcription factor occurs in a narrow time window between
10.5 and 12.0 dpc (Hacker et al., 1995b; Jeske et al., 1995). The expression of 
Sry has a profound effect on the male gonad resulting in an increase in size 
compared to the female gonad and to the formation of testis cords. These 
cords can be seen at 12.5 dpc under a light microscope and represent the first 
morphologically visible difference between male and female gonads. Testis 
cords are formed by three cell types: primordial germ cells aggregate and are 
surrounded by Sertoli cells, which are surrounded, in turn, by peritubular 
myoid cells. Sertoli cells act co-operatively with PMCs to lay down a 
basement membrane that defines the testis cord (Tung et al., 1984) (Figure
1.3 A and B). Little is known about the cellular and molecular processes 
involved in testis cord formation. Migration of cells from the mesonephros is 
required, however, germ cells are not required as testis cords form in mutant 
mice lacking PGCs (Buehr et al., 1993b). In the absence of Sry expression an 
ovary develops. This process will be described in section 1.4.
1.2.3 Sexually dimorphic development of the 
mesonephros
Like the gonad, the mesonephros has a bipotential fate, developing into one 
of the sex-specific reproductive tracts depending on the gonadal sex of the 
embryo. In male embryos, the Wolffian duct develops into the vas deferens, 
epididymis and seminal vesicle. In females, the Müllerian duct forms the 
oviducts, uterus and upper vagina. The fate of the mesonephros is dictated 
by the sex of the neighbouring gonad, and is characterized by the sex- 
specific regression of either the Wolffian or Müllerian duct. The testis 
secretes anti-Müllerian hormone (AMH) and testosterone. Together, these 
hormones cause Müllerian duct regression and the persistence of the 
Wolffian duct. In the absence of these hormones (i.e. in a female embryo), the 
Wolffian duct regresses and the Müllerian duct persists (Behringer et al., 
1994).
1.2.4 The importance of the supporting cell lineage in 
male sexual development
Sertoli cell precursors are thought to act as the organizing centre for the 
developing testis by directing all other cell types into their respective 
lineages. The Sertoli cell is the only cell type which has a strong bias for a Y 
chromosome in XX<->XY mosaic mice (Palmer and Burgoyne, 1991). 
Therefore, Sry-expressing pre-Sertoli cells are thought to start the
differentiation process in other cell types via cell-cell contacts or the 
production of signalling molecules. In the embryonic gonads of XX<->XY 
chimaeras as few as 25% of the pre-Sertoli cells require a XY chromosomal 
constitution in order for normal testis development to ensue. This suggests 
that Sertoli cells, once specified by Sry, are able to recruit other cells to the 
male pathway, irrespective of their chromosomal content and that no 
genuinely cell-autonomous step exists in mammalian sex determination. 
Sertoli cells also play a key role in testis cord formation by interacting with 
PMCs. They also signal to other cell types in the gonad and mesonephros. 
For example, Sertoli cell signals are necessary to stimulate the production of 
testosterone by Leydig cells (Koopman et al., 2001). This hormone (along 
with AMH) leads to the masculinisation of the mesonephros as described in 
section 1.2.3. Sertoli cells are also thought to induce mitotic arrest in PGCs 
(McLaren, 1995). When germ cells differentiate in ectopic tissues, such as the 
adrenal, they enter into meiotic arrest (McLaren, 1995), suggesting that these 
cells are programmed to arrest in meiosis and that the role of the embryonic 
testis is to produce a factor which will prevent this and cause them to enter 
mitotic arrest, and hence produce sperm in the adult. Hence, Sertoli cells 
have a central role in sex determination and testis development.
One of the important early products of Sertoli cells is anti-Müllerian 
hormone. This hormone is expressed from 12.0 dpc and is secreted from 
Sertoli cells. Its role is to initiate regression of the Müllerian duct by
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Figure 1.3 Structure of the testis cords from 12.5 dpc
(A) Testis cords begin to form in the male gonad Between 11.5 and 12.5 
dpc. From (Capel, 2000).
(B) Cords consist of mitotic germ cells with large round nuclei. These are 
surrounded by Sertoli (supporting) cells. Peritubular myoid cells migrate into 
the gonad from the mesonephros. They interact with Sertoli cells in order to 
form a basement membrane between them, thus forming the testis cord.
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binding to its receptor (AmhllR), which is present on the cell membrane of 
Müllerian duct mesenchymal cells (Münsterberg and Lovell-Badge, 1991). 
Hence, the expression of Amh links gonad development to mesonephric 
development. Various genes expressed in Sertoli cells have been implicated 
in the regulation of Amh, for example, Sfl, Sox9, and Wtl.
AmhllR is also expressed in Sertoli cells (di Clemente et al., 1994), and 
Leydig cells (Racine et al., 1998) of the developing testis.
1.2.5 The importance of mesonephric cell migration in 
male sexual development
Many studies have demonstrated that cell migration from the mesonephros 
and the coelomic epithelium is required for the development of the gonads. 
Early organ culture studies showed that XY gonads would not form testis 
cords without an adjoining mesonephros. Neither will they form if a 
membrane is placed between the two and cells cannot migrate (Buehr et al., 
1993a; Merchant-Larios et al., 1993). It has also been shown that this 
migration is male-specific and directly depends on the expression of Sry 
(Capel et al., 1999; Martineau et al., 1997). At least three cell lineages have 
been demonstrated to migrate into the gonad from the mesonephros: PMCs, 
endothelial cells and perivascular cells. PMCs co-operate with Sertoli cells in 
vitro to form a basement membrane (Tung et al., 1984). Therefore, it is 
thought that migration of PMC precursors from the mesonephros is required
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for interaction with Sertoli cells and formation of the testis cords (Tilmann 
and Capel, 1999b).
Mesonephric cell migration into the XX gonad does not occur during ovary 
development after 11.5 dpc (Martineau et al., 1997). However, mesonephric 
cell migration into XX gonads can be induced when the gonad is cultured 
between an XY gonad and a mesonephros of either sex or when a protein 
extract from XY gonads is cultured next to an XX gonad. This migration 
leads to the formation of testis cords in the XX gonad, indicating that 
precursor cells capable of differentiating into Sertoli cells are present in the 
female gonad at 11.5 dpc (Tilmann and Capel, 1999b). These experiments 
also demonstrate that the signal for cell migration is a chemoattractant 
protein signal capable of acting over a distance of 100pm (Martineau et al., 
1997). Cell migration and testis cord formation is also seen in XX gonads 
carrying an Sry transgene (Capel et al., 1999). This demonstrates that the 
chemoattractant signal is a direct consequence of Sry expression and that Sry 
expression is necessary and sufficient to induce mesonephric cell migration 
and testis formation.
1.3 Molecular genetics of male gonad development
1.3.1 Early acting genes
Many of the genes involved in sexual development have been identified by 
analysis of mutations in humans and mice (spontaneous or engineered) that
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lead to sex reversal or abnormal development of the reproductive organs. 
Such mutation studies in the mouse have identified several genes essential 
for early gonad development, including Sfl W tl, Liml, Lhx9 and Emx2. All 
these genes are expressed early in both sexes.
Sfl encodes a nuclear hormone receptor and is expressed as soon as the 
gonads form at 10.0 dpc (Ikeda et al., 1994). In males this expression can be 
seen in Leydig and Sertoli cell precursors up to 12.5 dpc. This expression 
continues in Leydig cells and Sertoli cells. In females expression is observed 
in somatic cells until 13.0 dpc (Ikeda et al., 1996). In Sfl -/- mice the gonad 
begins to form, however, by 12.5 dpc in both sexes apoptosis causes it to 
regress (Luo et al., 1994).
WTl is the gene mutated in Wilm's tumour, an embryonic kidney tumour 
affecting 1 in 10000 children. As well as this role in tumour suppression WTl 
also plays a role in development. In mice homozygous for a null allele of 
W tl neither the gonads or kidneys form (Kreidberg et al., 1993). Point 
mutations in WTl are associated with two syndromes, Denys-Drash and 
Fraiser, both of which are characterized by urogenital abnormalities ranging 
from gonadal dysgenesis to sex reversal (Barbaux et al., 1997; Pelletier et al.,
1991). WTl is characterized by complex post transcriptional modifications 
with up to 24 different isoforms. Two of these lead to the omission or 
addition of three amino acids (KTS) which differ in their ability to activate or 
repress transcription (Menke et al., 1998). Transgenic studies have
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demonstrated that these two isoforms possess distinct functions in vivo. Mice 
lacking only the KTS-negative isoform (-KTS-/-) exhibit an increase in 
apoptosis at 11.5 dpc consistent with the phenotype of mice lacking both 
isoforms. However, mice lacking just the +KTS isoform (+KTS-/-) show no 
increase in apoptosis and XX mice develop normally, but XY mice show 
male to female sex reversal (Guo et al., 2002; Hammes et al., 2001). Sry 
expression is decreased in +KTS -/-  mice (Guo et al., 2002) indicating that 
W tl may be a regulator of Sry expression.
Mice carrying null mutations for Liml, Lhx9, and Emx2 also do not form 
gonads, though the precise roles of these genes in gonad development 
remains unclear.
1.3.2 Sry and Sox9
Up to approximately 12.0 dpc the gonads in both sexes are morphologically 
indistinguishable. The pathway leading to sexual dimorphism is initiated at
10.5 dpc when Sry begins to be expressed in the male gonad. Initially it was 
thought to be expressed in a wave starting at the anterior end of the gonad, 
with each cell only exhibiting expression for a few hours (Hacker et al., 
1995b; Swain et al., 1998). More recently this expression is thought to 
originate from the centre of the gonad and emanate towards the poles 
(BuUejos and Koopman, 2001). As mentioned previously, using XX<->XY 
mosaic mice it has been shown that the vast majority of Sertoli cells are XY
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whereas other cells exhibit no bias. Thus, Sry is thought to act on supporting 
cells to promote Sertoli cell differentiation. Sertoli cells then go on to trigger 
further testis differentiation in other cell types. How Sry mediates these 
changes is unclear, as is whether it acts on only one or more downstream 
targets.
Sry was identified from the minimal region of the Y chromosome required to 
induce male development in mice (Gubbay et al., 1990). XX mice carrying 
this region as a transgene develop as infertile males (Koopman et al., 1991) 
and XY individuals with deletions of the region containing Sry develop as 
females (Gubbay et al., 1992). These findings demonstrate that Sry is 
necessary and sufficient for male sexual development.
The exact function of the Sry protein is unclear. Sry is a putative 
transcription factor with an HMG-box (High Mobility Group) DNA binding 
domain that is thought to induce a bend in DNA by binding in the minor 
groove (Giese et al., 1992). This DNA bending is critical to the sex 
determining function of Sry , as demonstrated by sex reversal mutations that 
alter the degree of DNA bending (Pontiggia et al., 1994). Like other HMG- 
box containing proteins, Sry is thought to act as an architectural 
transcription factor, bringing about changes in gene expression by inducing 
local changes in chromatin configuration (Giese et al., 1994). It is not clear 
whether it acts to repress or activate transcription.
16
One possible direct target of Sry is Sox9. Sox9 is a member of the SOX gene 
family, which encodes a HMG-box DNA-binding domain similar to that of 
Sry. Sox9 is expressed in the gonads of both sexes at 10.5 dpc at low levels, 
but at 11.5 dpc it becomes down-regulated in females. Furthermore, as Sox9 
acquires this sexually dimorphic pattern of expression its protein 
localization changes from cytoplasmic to nuclear in pre-Sertoli cells (da Silva 
et al., 1996). It is also expressed in the developing chondrocytes, heart, 
pancreas and central nervous system. Humans with SOX9 mutations exhibit 
degrees of XY sex reversal along with the dwarfism syndrome Campomelic 
dysplasia. Transgenic studies have shown that Sox9 is sufficient to induce 
testis formation (Vidal et al., 2001), and it has been proposed that Sty directly 
regulates Sox9 (Canning and Lovell-Badge, 2002).
Study of the Odd Sex (Ods) mouse (ocular degeneration with sex reversal) 
initially suggested that in XX gonads there may exist a negative regulator of 
Sox9 (Bishop et al., 2000). Ods is a transgenic line carrying a tyrosinase 
minigene driven by a dopachrome tautomerase (Dot) promoter integrated 
upstream of the Sox9 promoter, also associated with a deletion of 134kb in 
this region. Ods results in ectopic expression of Sox9 in the gonad causing 
female to male sex reversal in XX Ods/+ mice, along with eye defects. It was 
thought that the 134kb deletion removed a site required for a negative 
regulator of Sox 9 expression and hence Sox9 could maintain a male-specific 
pattern of development in these mutant gonads. However, this deletion
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alone is not responsible for the observed sex reversal (Qin et al., 2004). 
Therefore, it has been proposed that the Ods sex reversal is caused by the Dct 
promoter activating an enhancer element that is sufficient to activate Sox9 
expression in XX gonads and induce female to male sex reversal.
Sox8, a homologue of Sox9, can also activate the Amh promoter. Studies of 
mice doubly homozygous for null mutations in both Sox8 and Sox9 also 
suggests it can re-enforce the action of Sox9 (Schepers et al., 2003).
1.3.3 Other key genes
Once Sertoli cell fate is triggered by Sry, genes involved in Sertoli cell 
function become activated. One of these genes is Amh. Amh was first 
characterized as the factor in serum that induces masculinisation of the 
female twin in freemartin cattle (Jost et al., 1973). It is a member of the 
transforming growth factor beta (TGFp) family and is expressed in the 
Sertoli cells from 11.5 dpc onwards (Münsterberg and Lovell-Badge, 1991). It 
is responsible for the regression of the Müllerian duct, which develops into 
the female reproductive tract. Mis-expression of AMH in XX gonads leads to 
the regression of this duct, while in AMH -/- males both Müllerian and 
Wolffian ducts develop (Behringer et al., 1994). However, testis development 
and spermatogenesis occurs normally in these animals, with infertility being 
caused by the presence of the female duct.
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Studies have demonstrated that Sox9 and Sfl can interact and bind to the 
Amh promoter in vitro (De Santa Barbara et al., 1998) and in vivo (Arango et 
al., 1999), though other targets of Sox9 probably exist.
Another gene expressed in a sexually dimorphic manner, specifically in 
Sertoli cells at 12.5 dpc, is Desert Hedgehog (Dhh). In Dhh -/- mice, females 
develop normally whereas males are infertile owing to the complete absence 
of mature sperm (Bitgood et al., 1996). Patched-1 (Ptc-1), a likely target of 
Dhh shows down regulation in Dhh -/- mice. It is expressed in Leydig cells 
and PMCs (Clark et al., 2000). Both these cell types are located in the 
interstitium, with PMCs surrounding the cords, separated from the Sertoli 
cells by a basement membrane. Mature Leydig cells are absent in these null 
mice, therefore Ptcl is required for the formation of mature Leydig cells. 
DHH/PTCl signalling is thought to trigger Leydig cell differentiation by 
upregulating Sfl and See (P450 side chain cleavage enzyme, an early marker 
of Leydig cells) expression in Pfcl-expressing precursors located outside the 
testis (Yao et al., 2002). Moreover, PMCs in the adult do exhibit defects that 
could account for their sterility. During embryogenesis, defects in Dhh -/- 
mice begin to occur at 13.5 dpc when the basement membrane, that de-limits 
the testis cord, is disrupted. Also, some germ cells are observed outside the 
cords (Pierucci-Alves et al., 2001). Sterility of these mice could therefore be 
caused by a lack of PMC maturation due to absence of Dhh signaling.
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A critical feature of XY gonad development is the migration of cells from the 
mesonephros into the gonad. One gene which plays a role in this process is 
Fibroblast growth factor 9 (Fgf9) (Colvin et al., 2001). During development 
Fgf9 -/- gonads show disrupted cord formation and Sertoli cell differentiation 
and aberrant testicular differentiation. A role in migration of cells from the 
mesonephros was suggested by the addition of Fgf9 to gonads in organ 
culture. Addition of this protein was able to induce mesonephric migration 
into XX gonads. Fgf9 could also act to stimulate mesenchymal (interstitial) 
proliferation. This was demonstrated by BrdU labelling whereby a severe 
reduction in labeled cells was observed in Fgf9-/~ XY gonads. During 
development Fgf9 -/- gonads show disrupted cord formation and Sertoli cell 
') differentiation and aberrant testicular differentiation. Fgf9 -/- mouse
phenotypes range from testicular hypoplasia to complete male-female sex 
reversal. Fgf9 could function to stimulate cell proliferation in order to 
facilitate the production of pre-Sertoli cells. Therefore any reduction in this 
process would result in a loss of Sertoli and interstitial cells. Fgf9 signaling is 
thought to be mediated through Fibroblast growth factor receptor 2 (Fgfr2) 
(Schmahl et al., 2004). Fgfr2 is located on the cell membrane in proliferating 
coelomic epithelial cells which give rise to Sertoli cells. Furthermore, it is 
also found in the nucleus of cells that show nuclear localisation of Sry and 
Sox9. This could imply differing roles for Fgf signaling between proliferating
cells and cells differentiating under the influence of Sry. Nuclear localization
'1
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} of Sox9 and Fgfr2 are lost in mice lacking Fgf9, though it is unknown
whether Sox9 expression is upstream or downstream of Fgjrl.
The family of Platelet-derived growth factor receptors and ligands has an 
established role in migration, proliferation and differentiation of cells in 
various organ culture systems. Recently it has been demonstrated that Pdgfr- 
a  plays an important role in promoting testis cord organization and fetal 
Leydig cell development (Brennan et al., 2003). XY Pdgfr-a - /-  gonads 
display disruptions in the organization of the vasculature and in the 
partitioning of interstitial and testis cord compartments. Defects in cell 
proliferation and migration also occur in these mice. Pdgfr-J3 -/- mice 
exhibited no overt defects in gonads between 11.5 and 13.5 dpc. Therefore a 
 ^ role for this receptor in gonad development was ruled out. The gene
encoding its ligand, Pdgf-B, was also shown to be expressed a low levels in 
endothelial cells in the developing gonads of both sexes. However, it has 
also been reported that the B-ligand is expressed at higher levels in the male 
(Puglianiello et al., 2004). Furthermore, addition of this ligand to a serum- 
free culture system will allow male gonads to form testis cords. This 
indicates that the B receptor and ligand do play a role in testis cord 
development.
One gene which is expressed later in development in a sexually dimorphic 
manner is Dmrtl. This gene was identified via homology to the genes 
\  doublesex {dsx) in Drosphilia and mab-3 in C. elegans, all of which contain a
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DM-DNA binding motif. Dsx and mab-3 play a role in sex determination and 
male-specific differentiation in flies and worms. Dmrtl is expressed in the 
gonads of both sexes early in development and then becomes specific to the 
testis between 13.5 dpc and 14.5 dpc (Raymond et al., 1999). Studies of mice 
lacking Dmrtl reveal a role for this gene later in testis development with 
Dmrtl required for postnatal testis development (Raymond et al., 2000).
1.4 Ovarian development
In comparison to testis development the molecular and cellular details of 
ovary development remain elusive for a variety of reasons. These include the 
failure to identify a large number of genes which play a role in its 
development, the lack of cell markers with which to study the differentiation 
of ovarian cell lineages and the absence of any clear morphological 
compartmentalization before birth. In contrast, it is the characteristic 
architecture of the testis that allows examples of disruption of male gonad 
development and their cellular basis to be identified with relative ease.
Up to 11.5 dpc the gonad is morphologically indistinguishable between the 
sexes. The four gonadal cell lineages present each have a bipotential fate, as 
described in section 1.2.1. Cellular changes do occur in the ovary at the same 
time as testis cords are forming in the male. Loose cord-like structures begin 
to form at 12.0 dpc, known as ovigerous cords (Konishi et al., 1986; Odor and 
Blandau, 1969), although they are not observable under the light microscope.
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Isolation of Caveolin-1 and studies of its expression have also revealed a 
complex vascular network in the developing ovary (Bullejos et al., 2002). 
PGCs cluster at the centre of these ovigerous cords surrounded by somatic 
cells. Unlike the male, the presence of germ cells is essential for the proper 
development of the ovary. Mutants which contain no germ cells, for example 
WyW homozygotes, exhibit ovarian dysgenesis (Buehr et al., 1993b). Meiotic 
germ cells exert important regulatory functions over the surrounding 
somatic cells and when ovaries become depleted of germ cells cord-like 
structures form (Behringer et al., 1990). The presence of meiotic germ cells 
also inhibits mesonephric cell migration into gonads in vitro (Yao et al.,
2003).
1.4.1 Molecular genetics of ovarian development
Early experiments (Jost, 1947) showed that removal of gonads from fetal 
rabbits led to the development of female secondary sex characteristics, 
whether the animal was XX or XY. Male secondary sex characteristics 
depend on the presence of a testis and this led to the hypothesis that female 
development is the "default" state because no gonads are required to specify 
female characteristics.
To date, two genes have been reported to play a role in ovarian 
development, Daxl and Wnt4. Both are expressed in the XX gonad from 11.5 
dpc.
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DAXl is an X-linked gene that was identified from a region on human 
chromosome Xp21 linked with Dosage Sensitive Sex reversal (DSS) (Bardoni 
et al., 1994). Duplication of the genomic region containing DAXl causes the 
development of XY females, which suggests that a dosage-sensitive step 
exists in mammalian sexual development (Bardoni et al., 1994).
Daxl is expressed in the gonads of both sexes until 11.5 dpc when its 
expression becomes down-regulated in males and up-regulated in female 
gonads (da Silva et al., 1996). This expression pattern is reciprocal to that of 
Sry and Sox9. Daxl is expressed in the somatic compartment of male gonads 
at 11.5 dpc, and so is in a position to antagonise Sry action, thereby 
potentially explaining the DSS phenomenon.
Such an antagonistic effect of Daxl on Sry is seen in transgenic mice 
expressing Sry and Daxl under the control of the Daxl promoter region. 
Female development ensues in transgenes with higher expression of a 
DaxliDaxl transgene than of a DaxliSry transgene. Conversely, XY males 
develop when the expression of the DaxliSry transgene is higher than the 
DaxliDaxl transgene. This suggests a direct antagonistic interaction of the 
two transcription factors in these animals (Carulli et al., 1998). Importantly, 
whether such gain-of-function studies reflect the normal role of Daxl during 
gonadogenesis is unclear. Ironically, mice lacking Daxl exhibit defective 
spermatogenesis and Leydig cell hypoplasia, whilst female development is 
unaffected (Ito et al., 1998).
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Wnté exhibits a similar expression pattern to Daxl with transcripts present in 
both sexes until 11.5 dpc followed by down-regulation in XY gonads. Wnt4 - 
/- XX mice fail to form the Müllerian duct whereas the Wolffian duct 
differentiates as normal. These mice also exhibit ectopic Leydig cell 
development. XY null mice were reported to have no testis defects (Vainio et 
al., 1999). Wnt4 has been demonstrated to repress mesonephric, endothelial 
and steroidogenic cell migration and hence repress formation of the male- 
specific vasculature and Leydig cell differentiation in XX gonads (Jeays- 
Ward et al., 2003). Wnt4 also appears to activate the expression of Daxl in 
vitro (Mizusaki et al., 2003). Another target of Wnt4 is Follistatin (Fst). Fst 
encodes a TGFB binding protein which is thought to regulate vascular 
boundaries and maintain germ cell survival in the ovary (Yao et al., 2004). 
Figure 1.4 summarizes the genes known to be involved in male and female 
pathways of testis and ovary development.
1.5 Unanswered questions
The process of mammalian sexual development involves several complex 
processes and coordination of these processes is vital. The majority, though 
not all, of the genes so far identified in this process are transcription factors 
that orchestrate the earliest molecular processes involved in sexual 
development. As the differentiation of the gonad, especially testis formation, 
involves a great deal of architectural changes, thfese cellular processes are
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thought to include cell migration, cell signalling, cell adhesion, 
vascularisation, cell proliferation and extracellular matrix (ECM) 
deposition/remodelling. However, very few genes involved directly in these 
processes have been identified.
The vast majority of the research in this field has focused on the 
development of the testis. The lack of understanding of the structural 
changes in the ovary during the period of sex determination makes it a 
difficult organ to study. Clearly, ovarian tissue is differentiating from an 
early stage, because there are changes in the expression of genes such as 
Daxl. The discovery of new markers for the cell types present in the ovary 
will allow further studies to be performed on ovarian development.
Many other questions remain unanswered, for example,
1. Why does the gonad form on the ventromedial aspect of the 
mesonephros?
2. What is the male-specific signal for cell migration into the gonad?
3. How are XY pre-Sertoli cells able to recruit XX pre-Sertoli cells and 
other cell types to the male developmental pathway?
4. What is the molecular basis of the interaction between Sertoli cells and 
PMCs, which leads to deposition of the basement membrane and 
characteristic cord structure? What is the molecular basis of the 
nurturing interaction between Sertoli cells and PGCs? What is the
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signal for PGCs to develop as spermatogonia or oocytes and how is the 
mitotic arrest of PGCs in male gonads achieved?
5. What are the regulatory relations between the different genes 
implicated in sexual development?
1.6 The search for new genes involved in sexual
development
1.6.1 Criteria for screening for new genes
Many of the genes so far identified as playing a role in sexual development 
have been found from the analysis of known sex reversal loci in humans and 
by fortuitous observations of sexual abnormalities in null mutations 
generated in mice. One exception to this was the discovery of Dmrtl which 
was found by homology searching. These genes subsequently have been 
shown to display a sexually dimorphic expression pattern in the developing 
gonads. This raises the possibility that new genes involved in sexual 
development may be identified by screening for genes that are expressed in 
a sexually dimorphic manner in the developing gonad. Such expression 
screens will provide candidates whose role in sexual development can then 
be examined by functional analysis such as the generation of null mutations 
in mice or analysis in organ culture systems.
Clearly the Sertoli cells play a vital role in the development of the testis, 
acting as the organizing centre for the recruitment of cells in the formation of
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testis cords. Thus, identifying novel gene expressed in this lineage is another 
important element in an expression-based screen.
A third important property to analyse in such a screen is the timing of gene 
expression. For example, in order to identify genes that regulate testis cord 
formation it is necessary to examine expression both prior to and during this 
time period (12.0-13.0 dpc).
1.6.2 DNA microarray technology can be used for rapid 
high through-put screening
DNA microarrays have recently been used for the study of transcriptional 
regulation in various developmental systems (Smith and Greenfield, 2003). 
Microarrays provide a rapid method for expression screening of large 
numbers of genes.
Briefly, DNA elements (cDNA clones, PGR products or oligonucleotides -  all 
called "probes") are immobilised in arrays on glass slides treated with 
various chemicals to assist DNA adhesion. These arrays are hybridised with 
fluorescently labelled "targets" derived from two samples. These samples 
can be different tissues or the same tissue at different developmental time 
points.
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Figure 1.4
F ig u r e  1 .4  P a t h w a y s  o f  t e s t i s  a n d  o v a r y  d e v e l o p m e n t
From 9.5 to 11.5 dpc gonads of both sexes are morphologically 
indistinguishable. However, once the sex-determining gene Sry is expressed 
the fate of XX and XY gonads diverges. In XY gonads, under the influence of 
Sry, various male-specific genes are activated whereas in XX gonads a 
female-specific gene expression pathway ensues. Only a subset of genes 
thought to be involved is shown.
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Each target is produced from RNA that is labelled by incorporation of a 
fluorescently tagged nucleotide (Cy3 and Cy5 are most commonly used). 
Recently, the advent of RNA amplification technologies has allowed smaller 
starting materials to be used and has increased sensitivity (Smith, 2003). 
Labelled target RNAs are co-hybridised to the slide. For each probe on the 
array, the relative expression ratio between the two samples can then be 
determined by measuring the relative fluoresence of Cy3/Cy5 hybridising. 
This measurement is achieved by scanning the hybridised slide with lasers 
to detect the fluorescence of each dye independently.
Microarray analysis is readily applicable to the identification of genes 
involved in sexual development. RNA extracted from male and female 
gonads may be amplified, and labelled (e.g. male with Cy5 -  red, female 
with Cy3 -  green). Following hybridisation to the array, male-enhanced 
elements would be identified by more Cy5 signal (red) and female-enhanced 
elements would be identified by more Cy3 signal (green). The elements that 
are up-regulated in one sex over the other could then be studied by other 
techniques, such as wholemount in situ hybridisation (WMISH), to 
determine which cell types the gene is expressed in. This is potentially a 
powerful way to identify new genes involved in sexual development.
In addition to their use in expression screens, microarrays have other 
advantages, as they allow semi-quantitative analyses of gene expression and 
facilitate multi-point analyses (analysis of expression at several time points).
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This allows microarrays to be used for expression profiling, which shows the 
relative expression of all the genes on the array during the time course of a 
developmental process. This is achieved by comparing the relative 
expression of all genes on the array at each time point to a reference sample 
that remains constant in all hybridisations. As the reference is constant, it 
allows the indirect comparison of expression in samples over a range of time 
points. Alternatively, samples from different wild-type and mutant tissues 
could be compared to the reference sample, so allowing direct comparison of 
expression profiles for a known set of genes in many different mutant 
organs.
1.6.3 Organ culture studies can be used in further
analysis
The use of in vitro organ culture systems has long been established in the 
study of gonad development, and has given great insight into how gonads 
develop as three dimensional structures. Many early experiments 
established the importance of mesonephric cell migration in order for testis 
cords to form, and showed that these cells were destined for the interstitium 
(Buehr et al., 1993a). Also, they established that cell migration into the 
developing gonad was male specific (Martineau et al., 1997) and depends on 
the expression of Sry (Capel et al., 1999). The origin of Sertoli cells was also 
found to be in the coelomic epithelium using organ culture (Karl and Capel,
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1998). This was performed by injecting Dil into early gonads and following 
the fate of injected cells in culture.
More recent experiments have given a greater understanding into how the 
two pathways of testis and ovarian pathways operate. Organ culture has 
been used to demonstrate the importance of the presence of meiotic germ 
cells. Indeed the presence of the germ cells can initiate ovarian development 
and block testis development. Sry opposes this pathway by initiating testis 
cord formation prior to meiosis which sequesters germ cells inside the testis 
cords and arrests them in mitosis (Yao et al., 2003).
How various processes that are required for the development of testis cords 
are related and interact with each other have also been studied using organ 
culture techniques. Testis cord development was investigated by treating 
cultures with two hedgehog signaling inhibitors cyclopamine and forskolin 
(Yao and Capel, 2002). These inhibitors caused varying effects on gonad 
development in culture. Cyclopamine inhibits Smoothened, the first 
downstream signaling molecule after binding of Dhh to its receptor Ptc-1. 
When XY gonads are treated with cyclopamine in culture PGCs do not enter 
meiosis, and mesonephric cell migration is also unaffected. However, Leydig 
cell differentiation is disrupted. In contrast, Forskolin activates protein 
kinase A (PKA), which blocks hedgehog signaling downstream of 
Smoothened. When cultured gonads are treated with this inhibitor meiosis is 
induced in XY gonads and mesonephric cell migration is inhibited.
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However, no effect on Leydig cell differentiation is observed. In vivo these 
processes normally take place in a tightly regulated sequence. However, 
organ culture studies have demonstrated that they can occur separately.
The use of organ culture can also be useful when the generation of null 
alleles results in lethality. Homozygous Sox9 null mice die at 11.5 dpc as a 
result of cardiac failure which prohibits the in vivo analysis of the fate of XY 
gonads in these embryos at later stages. These gonads can be cultured and 
and testis cord formation studied at these later stages (Chaboissier et al.,
2004).
Organ culture can also be used to study how potentially new genes play a 
role in the development of the testis by knocking down expression of these 
genes. One way to do this is to use antisense morpholino oligonucleotides 
(morpholinos). Morpholinos can be designed to inhibit the translation of 
mRNA from a target gene and are designed to be complementary, and 
therefore bind to, the mRNA AUG translational start site and the 22 bases 3' 
to that site. Translation is inhibited solely by a steric block mechanism. These 
compounds can be used in organ culture systems to block the function of a 
gene as opposed to producing mice carrying a null allele, and have the 
advantage of swiftness in assessing the role of a gene in gonad development. 
However organ culture approaches do have their limitations. For example, 
XY gonads when cultured do not increase in size at the same rate as in vivo;
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and; the number of cords which form in the testis is fewer than observed in 
vivo.
1.7 Aim of this project
The aim of this project is to identify and analyse genes involved in murine 
sexual development. We chose to characterise genes whose expression met 
certain criteria as described in section 1.6.1. In males the focus of this project 
is to identify genes expressed in a male-specific manner in the supporting 
cell lineage prior to overt differentiation. Germ cells are not required for the 
development of the testis; however, they are required for the development of 
the ovary. Therefore in females, the aim of this project is to find genes 
expressed in a female-specific manner in any ovarian cell lineage.
Finally, one objective of this research is to identify genes acting in the sexual 
development pathway that belong to new functional categories, beyond 
transcription and growth factors.
The starting point of this project was to analyse by wholemount in situ 
hybridisation candidate genes which were found to be expressed in the 
mouse gonad in a sexually dimorphic fashion at 13.5 dpc using DNA 
microarrays.
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Chapter 2: Materials and Methods
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2.1 Standard solutions
All standard solutions were prepared according to Sambrook et al. 
(Sambrook et al., 1989). All chemicals were obtained from Sigma/Aldrich 
unless stated. All restriction endonucleases were obtained from New 
England Biolabs unless stated.
2.2 NMUR cDNA library
A Normalised Mouse Urogenital Ridge (NMUR) cDNA library was 
prepared from urogenital ridges (gonad and mesonephros) dissected from
11.5 and 12.5 dpc embryos (Grimmond et al., 2000). Briefly, approximately 
150 pairs of 11.5 dpc UGRs were collected and sexed by amnion staining (see 
section 2.5.2). Poly (A)  ^ RNA was extracted from the sexed pools of tissue 
and equal amounts of male and female RNA were combined. This RNA was 
mixed with that from 12.5 dpc UGR dissections in a 3:1 ratio. A second 
round of poly (A) ^ purification was performed and the library was 
constructed and normalised according to previously published procedures 
(Bonaldo et al,1996).
2.3 Isolation of plasmid DNA
2.3.1 Plasmid mini preps
10 ml of LB broth containing ampicillin (50 pgml^) was inoculated from
glycerol stocks and incubated at 37 ”C with shaking (200 rpm) overnight. The 
culture was centrifuged at 6000 x g for 10 min at 4 “C and plasmid DNA was
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isolated from the pelleted cells using the High Pure Plasmid Isolation Kit 
(Roche), according to the manufacturer's protocol.
2.3.2 Plasmid midi preps
40 ml of LB broth containing ampicillin (50 pgml'^) was inoculated from 
glycerol stocks and incubated at 37 °C with shaking (200 rpm) overnight. The 
culture was centrifuged at 6000 x g for 10 min at 4 °C and plasmid DNA 
isolated from the pelleted cells using the Qiafilter Plasmid Midi Kit (Qiagen) 
according to manufacturer's instructions.
2.4 DNA Sample Sequencing
Plasmid DNA (350 ng) was mixed with 3.2 pmoles of sequencing primer ( 
either T7 orT3, see appendix A) and 2 pi of ABI Prism Bigdye Cycle 
Sequence Ready Reaction Mix (PE Biosystems) in a total reaction volume of 
8 pi. Samples were incubated in a Tetrad thermocycler (MJ Research) using 
the following program:
35 cycles of: 96 °C 1.0 minutes (min)
step down to 50 °C at 1 ° decrease per cycle 
50 "C 5.0 min
step up to 60 °C 1 ‘‘increase per cycle 
60 "C 4.0 min
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Sequencing products were recovered by ethanol precipitation (Sambrook et 
al., 1989), washed in 70% ethanol, re-centrifuged and resuspended in 2 pi of 
sterile water (Analar water, BDH). Sequencing samples were then submitted 
to the Genotyping, Arraying and Sequencing core facility at MRC Harwell, 
where sequencing fragments were resolved using an ABI 377 DNA 
sequencer ( PE Biosystems).
2.5
2.5.1
Embryonic tissue collection 
Collection for wholemount in situ hybridisation
Timed matings of female and male breeding pairs were used to generate 
staged mouse embryos. Pairs were set up at approximately 3pm and females 
were checked for the presence of vaginal plugs on the following morning. 
Noon on the day of the plug was counted as 0.5 dpc. Embryos were 
accurately staged by counting tail somites posterior to the hindlimb bud, as 
follows:
Tail
somites
13-16 17-21 22-24 24-26 26-28 29-37
Age; dpc 10.5-10.75 11.0-11.25 11.5-11.75 12.0-12.25 12.5-12.75 13.5
Table 2.1 Embryonic staging using tail somite numbers
Table 2.1 shows the tail somite number and corresponding age of embryos 
in days post coitum (dpc).
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The following strains and crosses were used:
Female strain Male strain Embryos generated
C3H/HeH lOlH 3H1
Vanin-1 -/-  (BALB/c) Vanin-1 - /  - (BALB/ c) Vanin-1 -/-
BALB/c BALB/c BALB/c
C3H/HeH Vanin-1 -/- (BALB/c) Vanin-1 backcross
CrmVO C3H/HeH XO
Table 2.2 Crosses used to generate embryos for study
Table 2.2 shows the various crosses used in order to generate specific 
embryos used in this study.
Embryos and urogenital ridges were dissected into sterile phosphate 
buffered saline (PBS) containing 0.2% bovine serum albumin (BSA) and fixed 
in 4% paraformaldehyde/ PBS overnight at 4 °C. Tissues were dehydrated 
using a methanol/PBS series and stored at -20 °C. As follows, all washes are 
at room temperature unless otherwise stated:
PBS 5 min 4 °C x 2 
25% methanol/PBS 5 min 
50% methanol/PBS 5 min 
75% methanol/PBS 5 min 
100% methanol 5 min 
100% methanol. Store at -20 “C.
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2.5.2 Amnion staining for embryonic sexing
Embryonic urogenital ridges collected after 12.5 dpc were sexed by the 
presence or absence of testis cords. Prior to 12.5 dpc, embryonic tissue was 
sexed by staining the amnion for the presence of Barr Bodies in XX 
individuals, according to Palmer and Burgoyne, 1991. Amniotic membranes 
were collected in 1 ml freshly made fixative (3:1 methanol: glacial acetic 
acid). Fixative was aspirated, 3 drops of 60% acetic acid were added and the 
sample was gently vortexed for 10 seconds. 1 ml of fixative was added and 
amniotic cells collected by centrifugation (2000 x g for 2 minutes). The 
supernatant was removed and the amniotic cells resuspended in a minimal 
volume of solution by gentle vortexing. 25 pi of the cell suspension was 
pipetted onto a clean glass slide and air dried. 1 drop of 1% toluidine blue 
was added to a clean coverslip and applied to the slide. XX females were 
identified by the presence of Barr Bodies in the nuclei of cell spreads.
2.5.3 Tissue collection for RNA extraction
Tissues were collected as described in section 2.5.1 and quickly frozen on dry 
ice. Samples were stored at -70 °C.
2.6 Wholemount in situ hybridisation
2.6.1 Riboprobe preparation
NMUR or IMAGE clones were linearised by restriction enzyme digestion as 
follows:
40
30.0 pi mini prep plasmid DNA (approximately 3 pg)
4.0 pi lOx reaction buffer
1.0 pi restriction enzyme (20 U)
5.0 pi AnalaR water
Samples were incubated for 2 hours at 37 °C. Linearised template was 
purified by ethanol precipitation and resuspended in 6pl AnalaR water. 
Antisense digoxygenin-labelled riboprobes were synthesised as follows:
2.0 pi linearised DNA template
1.0 pi lOx RNA Polymerase Reaction Buffer (Roche)
1.0 pi lOx Digoxygenin-UTP Labelling Mix (Roche)
1.0 pi RNA polymerase (Roche)
0.5 pi RNAguard (Pharmacia)
4.5 pi Analar water
Samples were incubated for 2 hours at 37 °C, template DNA was removed by 
the addition of 2 pi DNasel (Roche). After 20 minutes at 37 “ C the reaction 
was stopped by the addition of 2 pi 250 mM EDTA (BDH). Riboprobes were 
purified by ethanol precipitation and resuspended in 50 pi Analar water.
2.6.2 Wholemount in situ hybridisation (WMISH)
All steps were performed at room temperature for 5 minutes, unless 
otherwise stated.
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Tissues which had previously been dehydrated (see section 2.5.1) were 
rehydrated using a methanol series (100%, 75%, 50%, 25% methanol/PBS) 
and washed twice in PBT (0.1% Tween-20 in PBS). Samples were bleached in 
6% hydrogen peroxide /PBT for 1 hour and washed 3 times in PBT. 
Proteinase K digestion was performed using 10 pgml^ Proteinase K (Roche) 
in PBT for 12 minutes for gonads between 10.5 and 13.5 dpc and 15 minutes 
for gonads between 14.5 and 15.5 dpc, and was halted with 2 washes of 2 
pgml'^ glycine in PBT. Samples were re-fixed in 0.2% glutaraldehyde /4% 
paraformaldehyde/ PBT for 20 minutes and washed twice in PBT. Pre­
hybridisation was performed in 50% formamide (Fluka)/5x SSC pH 
4.5/0.1% Tween 20/ 50 pgml'^ heparin at 70 °C for at least 60 minutes. 
Hybridisation was performed in 50% formamide/ 5x SSC pH 4.5/0.1% 
Tween 20/ 50 pgml^ heparin/ 100 pgml'^ salmon sperm DNA /lOO pgml^ 
yeast tRNA. Antisense DIG labelled riboprobes was added to each sample at 
a dilution of 1:200 and samples were incubated at 70 °C overnight .
Next day, samples were washed twice in Solution 1 (50% formamide/ 4x 
SSC/ 1% SDS) for 30 minutes. Then three washes in Solution 2 (0.5 M 
NaCl/lOmM Tris-HCl pH 7.5/ 0.1% Tween 20). Unhybridised RNA was 
removed by digestion with 100 pgml'^ RNase in Solution 2 for 1 hour at 37°C. 
Samples were then washed twice for 30 minutes in Solution 3 ( 50% 
formamide/ 2x SSC pH 4.5) at 65 °C. Samples were then washed in Ix BST 
(140mM NaCl/ 2.7mM KCl/ 25mM MgCl^/ 0.1% Tween 20) and pre­
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blocked in 10% Heat-Inactivated Sheep Serum (HISS)/ Ix TEST for 3 hours. 
Samples were hybridised with Anti-Digoxygenin Alkaline Phosphatase 
fragments (Roche) (0.5 pi per ml in 1% HISS/ Ix TBST), overnight at 4 °C. 
Following antibody hybridisation, samples were washed 5 times in Ix TBST 
for at least 1 hour, and further incubated in Ix TBST overnight at 4 °C. 
Samples were then rinsed in NTMT (O.IM NaCl/ 0.05M Tris-HCl pH 9.5/ 
0.05M MgCiy 0.1% Tween 20) and then transferred to the staining solution 
(4.5 pgml'^ NBT/3.5 pgml'^ BCIP Roche/ NTMT). Samples were kept in the 
dark during colour development, after which they were fixed in 4% 
paraformaldehyde/  PBS.
2.6.3 Photography and sectioning
Following WMISH, tissues were photographed on 0.5% agarose/PBS using a 
photomicroscope (Nikon) with Fuji 64T film. They were then frozen in OCT 
compound (BDH) and sections were cut at 16 microns thickness on a 
cryostat (Leica). Bright-field photographs were taken using an Axiophot 
(Zeiss) with a digital camera.
2.7 In situ  hybridisation to frozen sections
2.7.1 Single probe in situs
This protocol was adapted from Strahle et.al (Strahle et al., 1994). Freshly 
dissected gonads were fixed overnight in 4% PFA/PBS at 4 °C. Next day
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they were embedded in 1.5% agarose/ 5% sucrose/ PBS. These blocks were 
trimmed and re-embedded in 30% sucrose and frozen on dry ice. 10 pm
sections were cut on a cryostat, transferred to clean slides, air-dried for 30
minutes, and stored at -20 “C until required.
The riboprobe (or mixture of probes see section 2.7.2) was diluted 1:200 in 
hybridisation buffer (see section 2.7.3), denatured at 70 ”C for 5 mins and 100 
pi added to each defrosted slide. These were hybridised overnight at 65"C in 
a humidified container.
Next day, sections were washed as follows:
1 X 15 mins 65 “C Solution A (see section 2.7.3)
1 X 30 mins 65 "C Solution A
2 X 30 mins 1 x TBST room temp
1 X 60 mins 10% HISS/ 1 x TBST room temp.
Anti-Digoxygenin Alkaline Phosphatase fragments were diluted 1:2000 in 
0.5 ml 10% HISS/ 1 X TBST and added to the slides, which were incubated 
overnight at 4 °C.
Next day slides were washed as follows:
4 X 20 min 1 x TBST
2 X 10 min NTMT
Sections were stained in the dark in 4.5 pi NBT + 3.5 pi BCIP/ml NTMT.
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After colour development had sufficiently proceeded, the reaction was 
stopped by washing the slides twice in distilled water, and post fixed in 4% 
paraformaldehyde.
Sections which were treated with a single riboprobe were then mounted 
under coverslips using Aquamount (BDH) and photographed using an 
Axiophot with a digital camera.
2.7.2 Section in situ hybridisation with two probes
In sections where the expression of two different genes was to be analysed, 
one probe was labelled with digoxygenin and the other with fluoroscein. 
Labeling with fluoroscein was performed in the same manner as for 
digoxygenin (see section 2.6.1).
Sections were treated as for digoxygenin labelled single probes, then fixed in 
4% paraformaldehyde for 20 minutes. They were then washed in 1 x TBST, 
pre-blocked in 10% HISS/ Ix TBST for at least one hour at room 
temperature. Sections were then treated with a 1:8000 dilution of anti- 
fluoroscein alkaline phosphatase fragments in 10% HISS/lx TBST 
overnight at 4 °C.
Next day slides were rinsed five times in 1 x TBST for 20 minutes, followed 
by 2 X 10 minute washes in NTMT pH 8.0. One tablet Fast Red/m l NTMT 
was used for the colour development, which was done at room temperature 
in the dark. The reaction was stopped by rinsing in water, and the sections
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mounted under coverslips in Aquamount and again photographed using an 
Axiophot with a digital camera.
2.7.3 Solutions
10 X Salt per litre: NaCl 114 g
Tris HCL 14.04 g
Tris base 1.34 g
NaH,PO,.Hp 7.8 g
Na,HPO, 7.1 g
0.5M EDTA 100 ml
Hybridisation buffer: 1 x Salt 50% formamide, 10% dexran sulphate, 1 
mgml \  Ix Denhardts.
Solution A: Ix SSC, 50% formamide, 0.1% Tween-20.
2.8 Genomic DNA extraction
2.8.1 Using PhenoiiChloroform
Embryo carcasses were incubated overnight at 55°C in 700 pi of PK Buffer 
(50 mM Tris-HCl pH 8 /  100 mM EDTA /  0.5% SDS) with 35 pi of 10 mgml ' 
proteinase K (Roche). Following digestion, 700 pi of phenol:chloroform 
(50:50 v/v) was added and samples were mixed by rotation at room 
temperature for 10 minutes. After centrifugation (5 minutes at 21000 x g at 
room temperature), the upper (aqueous) phase was removed and subjected 
to a second phenol:chloroform extraction followed by a chloroform
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extraction (performed as detailed above). Genomic DNA was precipitated by 
the addition of 600 pi isopropanol to the aqueous phase and was collected by 
brief centrifugation at 21000 x g at room temperature. The DNA precipitate 
was washed with 70% ethanol and resuspended in 200 pi AnalaR water. 
Aliquots of the genomic DNA solution were used for genotyping PGR or 
Southern analysis (see Sections 2.17.2 and 2.9).
2.9 Southern blotting
Genomic DNA was digested as follows:
20 pg genomic DNA 
10 pi relevant lOx Reaction Buffer 
7 pi relevant restriction endonuclease 
AnalaR water to 100 pi 
Incubate overnight at 37 °C
Restriction fragments were ethanol precipitated and resuspended in 18 pi of 
water. Following the addition of 2 pi of loading dye the restriction fragments 
were resolved by gel electrophoresis in a 0.8% agarose /  Ix TAB gel run 
overnight at 30 V. Loading dye consisted of 40% sucrose, 0.03% 
bromophenol blue, 0.3% xylene cyanol FF and was used in order to keep the 
samples in the wells and to track the DNA as it migrated through the 
agarose.
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The gel was photographed, then depurinated by washing with agitation in 
0.25 M HCl (BDH) for 30 minutes at room temperature. DNA in the gel was 
then denatured by washing in 0.4 M NaOH (BDH) for 30 minutes at room 
temperature. DNA fragments in the gel were transferred to a nylon 
membrane (Hybond^^-N+ - (Amersham)) by capillary blotting using 0.4 M 
NaOH, as described in the manufacturer's instructions. After blotting 
overnight, the nylon membrane was rinsed in 2x SSC. Membranes were 
stored at -20°C until required for hybridisation.
2.10 Radioactive hybridisations
2.10.1 Radioactive probe preparation
Probes were labelled by incorporation of ^^Pa-dCTP (Amersham) using the 
Megaprime DNA labelling system (Amersham) according to the 
manufacturer's instructions. Unincorporated radionuclides were removed 
using a Microspin S-400 HR column (Amersham), according to the 
manufacturer's instructions.
2.10.2 Membrane hybridisation
Prior to hybridisation, each nylon membrane was prehybridised for at least 1 
hour at the relevant temperature in 10 ml of ExpressHyb solution (Clontech). 
Radio-labelled DNA probe was denatured at 95 °C for 5 minutes, chilled on 
ice for 3 minutes and added to 10 ml of ExpressHyb solution (Clontech). The
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prehybridisation solution was replaced with the hybridisation solution, 
containing the labelled probe, and hybridisation was performed for 1 hour at 
60 °C. All membranes were washed according to the ExpressHyb user 
protocol. After washing, membranes were wrapped in Clingfilm and placed 
on autoradiographic film (Kodak) at -70 °C overnight or until sufficiently 
exposed. Autoradiographs were developed using an X-ograph developer. 
Following hybridisation and signal development, membranes were stripped 
of the radioactive probe by heating in 0.1% SDS at 94°C for 10 minutes and 
were stored at -20 °C.
2.11 Total RNA isolation
Total RNA was isolated using the Qiagen RNeasy Mini Kit in conjunction 
with the QiaShredder Homogenisation Column (Qiagen) according to the 
manufacturer's protocols. Total RNA was eluted in a final volume of 30 pi 
RNase-free water (Qiagen) and was stored at -70 °C until required.
2.12 Polymerase Chain Reaction (PGR)
PCR reactions were set up as follows:
3 pi lOx PCR Reaction Buffer including final MgCl^ concentration of 1.5 
mM
1.5 pi 4 mM dNTP mix (ABgene)
1.0 pi Forward amplification primer (10 pM)
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1.0 pi Reverse amplification primer (10 pM)
1.0 pi Template DNA (approx. 1-5 ng)
0.2 pi Taq DNA polymerase (ABgene)
Reaction volumes were adjusted to 30 pi with sterile water and samples 
were incubated in a Tetrad thermocycler (MJ Research) according to the 
following regime:
30 cycles of 94 °C 3.0 minutes
55 °C 2.0 minutes
72 °C 3.0 minutes
Final step 72 °C 1.0 minute
Typically, a 55 °C annealing temperature was used; however, certain primer 
pairs required higher annealing temperatures (see Appendix A- for details).
2.13 Reverse Transcription PCR (RT-PCR)
First strand cDNA was synthesised using the Superscript II Reverse 
Transcriptase Kit (Invitrogen) according to the manufacturer's instructions. 
Subsequent PCR reactions were set up as follows:
5.0 pi lOx PCR reaction buffer including a final MgCl^ concentration of 1.5 
mM
2.5 pi 4 mM dNTP mix (ABGene)
1.0 pi amplification primer 1 (10 pM)
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1.0 Ipl amplification primer 2 (10 pM)
1.0 pi Taq DNA polymerase (5 U -  ABGene)
2.0 pi cDNA (from first strand reaction)
37.5 Ipl Analar water
PCR was performed in a Tetrad thermocycler (MJ Research) according to the 
protocol detailed in the previous section.
2.14 Analysis of PI-derived Artificial Chromosome
(PAC) clones
2.14.1 Isolation of PAC DNA
400 ml of LB broth containing 250 pi chloramphenicol (25 mgml’) was 
inoculated from a single colony of the PAC clone. The culture was grown for 
20 hours at 37°C with shaking at 200 rpm. Bacterial cells were collected by 
centrifugation at 15000 x g for 10 minutes. The cells were resuspended in 20 
ml of 10 mM EDTA and kept at room temperature for 5 minutes. 40 ml of 0.2 
M NaOH /  1% SDS was added, the solution mixed by inversion and kept at 
room temperature for 5 minutes. 30 ml of Solution 3 (1.875 M KG Ac, 11.5% 
Acetic acid (v/v)) was added and the mixture incubated on ice for 10 
minutes. Cellular debris was collected by centrifugation at 15000 x g for 20 
minutes at 4 °C. The supernatant was filtered through sterile gauze and 
DNA was precipitated by addition of 45 ml isopropanol.
Precipitated DNA was collected by centrifugation at 15000 x g for 20 minutes 
at 4 °C. The precipitate was resuspended in 9 ml Ix TE pH 8 and 4.5 ml 7.5 M
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KOAc was added. The sample was stored at -70 °C for 30 minutes, thawed 
and centrifuged at 5000 x g for 10 minutes at 4 “C. 27 ml of absolute ethanol 
was added to the supernatant and the sample kept on ice for 10 minutes. 
Precipitated DNA was collected by centrifugation at 5000 x g for 10 minutes 
and resuspended in 700 pi Ix TE pH 8.
RNA in the sample was removed by digestion with 10 pi of RNase A (10 
mgml'^) at 37 °C for 30 minutes. 700 pi of phenokchloroform (50:50 v /v ) was 
added and the sample inverted gently for 2 minutes at room temperature. 
Phases were separated by centrifugation at 21000 x g for 2 minutes at room 
temperature. The aqueous phase was reserved and an equal volume of 
chloroform was added. This mixture was again inverted for 2 minutes at 
room temperature and centrifuged at 21000 x g for 2 minutes. The aqueous 
phase was removed to a fresh tube and an equal volume of isopropanol was 
added. The sample was mixed by inversion and precipitated DNA was 
collected by centrifugation at 21000 x g for 5 minutes at 4 °C. The precipitate 
was washed with 700 pi ethanol and centrifuged at 21000 x g for 2 minutes. 
Finally, the DNA precipitate was resuspended in 100 pi AnalaR water.
2.14.2 Digestion of PAC DNA
PAC DNA was digested as follows:
6.0 pi PAC DNA
3.0 pi relevant lOx reaction buffer
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3.0 pi BSA (where necessary, according to manufacturer's notes)
1.0 pi relevant restriction endonuclease
The volume of each sample was adjusted to 30 pi with sterile water and 
samples were incubated at 37 °C for 2 hours. DNA fragments were resolved 
by gel electrophoresis in a 0.8% agarose /  Ix TAE gel run at 10 Volts cm \  
DNA fragments containing the gene of interest were identified by Southern 
hybridisation (see Section 2.9).
2.15 Plasmid digests and DNA ligations
2.15.1 Plasmid DNA digestions
Mini-prep plasmid DNA digestions were set up as below:
10.0 pi Plasmid DNA (approx. 1.0 pg)
3.0 pi relevant lOx Reaction Buffer
3.0 pi lOx BSA (if required)
1.0 pi relevant restriction endonuclease (20 U pl' )^
Sample volumes were adjusted to 30 pi with Analar water and samples were 
incubated at the relevant incubation temperature for 2 hours. DNA 
fragments were resolved by agarose gel electrophoresis following standard 
techniques (Sambrook et al., 1989).
2.15.2 PCR product ligation
PCR products were ligated into a cloning vector using the pGEM-T-Easy kit 
(Promega) following the manufacturer's instructions.
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2.15.3 Isolation and purification of DNA fragments
The DNA fragment of interest was generated by restriction digestion as 
detailed previously (Section 2.14). The fragment was resolved by agarose gel 
electrophoresis and the relevant band was excised in a minimum of agarose. 
DNA from this gel slice was isolated using the QiaQuick Gel Extraction kit 
(Qiagen) following manufacturer's instructions.
Where necessary, fragment cohesive ends were blunted using the Klenow 
fragment of DNA polymerase I in the following reaction:
10.0 pi DNA fragment of interest
2.0 pi lOx EcoPol reaction buffer (New England Biolabs)
0.3 pi 2 mM dNTP mix
1.0 pi Klenow DNA polymerase fragment (New England Biolabs)
The reaction volume was adjusted to 20 pi with AnalaR water (BDH) and 
samples were incubated at room temperature for 15 minutes. After this time, 
the reaction was quenched by the addition of 2 pi of EDTA (250 mM) and 
heating to 65 °C for 10 minutes.
2.15.4 Preparation of cloning vector
The cloning vector (typically pBluescript -  Stratagene) was digested with the 
relevant restriction enzyme and the cut vector was purified by gel extraction 
as detailed above (Section 2.14). The purified vector was then treated with
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shrimp alkaline phosphatase (SAP - Amersham) to remove 5' phosphate 
groups and prevent vector re-ligation:
5.0 pi purified, cut vector
0.2 pi Shrimp alkaline phosphatase
2.0 pi lOx SAP reaction buffer
Reaction volumes were adjusted to 20 pi with AnalaR water and samples 
were incubated at 37 °C for 1 hour. The enzyme was inactivated by the 
addition of 2 pi EDTA (250 mM) and incubation at 65 °C for 15 minutes.
2.15.5 Ligation reactions
For each experimental ligation, positive and negative controls were 
performed. Positive controls contained vector (and insert) that had not been 
SAP treated, negative controls contained SAP treated vector but no insert. 
All DNA ligations were performed with an insert: vector ratio of 3:1, 
estimated from visualisation on agarose electrophoresis. Experimental 
ligations were prepared as below:
2.0 pi SAP-treated vector
1.0 pi lOx T4 DNA ligase reaction buffer (New England Biolabs)
0.5 pi T4 DNA ligase (New England Biolabs)
3.0-6.0 pi purified insert DNA (depending on concentration)
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Ligation volumes were adjusted to 10 pi with AnalaR water and samples 
were incubated at 15 °C overnight. Following this, the ligase was inactivated 
by incubation at 65 °C for 15 minutes.
2.16 Transformation of E.co//with ligated plasmids
2.16.1 Heat-shock transformation:
CaClj competent cells (30 pi, E. coli strain DH5o', Invitrogen) were mixed 
with 10 pi of the ligation reaction and kept on ice for 30 minutes. Cells were 
then heat-shocked by incubation at 42 °C for 90 seconds. The cells were 
minutes and 350 pi of SOC medium (Sambrook et al..
1989) was added. The sample was incubated at 37 °C with shaking (180 rpm) 
for 1 hour to allow expression of the ampicillin resistance gene. 10 pi and 50 
pi aliquots of the transformation sample were then spread on LB-Agar plates 
containing 50 pgml^ ampicillin. Plates were incubated overnight at 37 °C.
2.16.2 Electroporation transformation:
Ligated DNA was precipitated by the addition of 1 pi 3M NaOAc pH 4.8 and 
25 pi absolute ethanol to the ligation reaction and was chilled to -70 °C for 30 
minutes. Precipitated DNA was collected by centrifugation at 21000 x g for 
20 minutes at 4 °C. The precipitate was washed with 500 pi 70% ethanol and 
resuspended in 4 pi sterile water. 2 pi of the resuspended DNA was placed 
in a chilled electrocuvette (Biorad) on ice. 15 pi of electro-competent cells (£.
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coli strain DH5a) were added and the cuvette was kept on ice for a further 
minute. The cuvette was transferred to an electroporator (Biorad) and pulsed 
at 1.8 kV. 300 pi of ice-cold SOC medium was added and the sample 
incubated at 37 °C with shaking (180 rpm) for 1 hour. Aliquots of each 
sample (10 and 50 pi) were then spread on LB-Agar plates containing 50 
pgml'^ ampicillin and incubated at 37 °C overnight.
2.17 LacZ reporter construct analysis
2.17.1 Transgenic mouse generation
A LacZ reporter construct containing the DNA sequence of interest placed 
upstream was generated by standard ■clQning-lecbnjquas-(detai]edJn-Sectioru
2.15). The reporter construct was liberated from vector DNA by digestion 
with the relevant restriction endonucleases (see Chapter 5). The construct 
was purified by gel extraction using the Qiagen Gel Extraction kit, following 
the manufacturer's protocol. Final elution was performed with 30 pi of 10 
mM Tris-HCl, pH 8.5. DNA concentration was estimated by visual 
inspection following gel electrophoresis. 0.5 M EDTA was added and the 
construct eluate was diluted to give a final concentration of 5.0 ngpl'^ in 10 
mM Tris-HCl /  0.1 mM EDTA. The construct was submitted to the 
Transgenic Facility at MRC Harwell, where it was injected into pronuclei 
derived from FI matings (strain CBA x C57BL/6). Injected pronuclei were 
transferred to pseudopregnant recipient females (strain CBA x C57BL/6). At
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3 weeks of age, tail biopsies were taken from the progeny. Genomic DNA 
was isolated and used in genotyping PCR reactions as detailed previously.
2.17.2 Genotyping transgenic mice
Genomic DNA was isolated from transgenic tail tips as described above 
(Section 2.8). Genotyping was performed by PCR as follows:
2.0 pi lOx PCR reaction buffer including final Mg^  ^ concentration of 1.5 
mM
1.0 pi 4 mM dNTP mix
1.0 pi forward genotyping primer (15 pM)
1.0 pi reverse genotyping primer (15 pM)
1.0 pi genomic DNA (1:1000 dilution)
0.5 pi Taq DNA polymerase (ABgene)
Sample volumes were adjusted to 20 pi by addition of sterile water and 
samples were incubated in a Tetrad thermocycler (MJ Research) according to 
the following protocol:
35 cycles of: 94 °C 30 seconds 
55 °C 1.0 minute 
72 °C 1.0 minute 
Final step 72 °C 2.0 minutes
The genotyping primers used are listed in Appendix A. PCR products were 
resolved by gel electrophoresis at 10 Vcm ^  in a 1% agarose /  Ix TAE gel.
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2.17.3 X-Gal staining of transgenic embryos
Embryonic tissue was collected as previously detailed. Part of the embryo 
was stored at -70 °C for genotyping purposes. The remainder was rinsed in 
Ix PBS. The sample was then fixed in Fix solution (0.2% glutaraldehyde /  2 
mM MgClj (BDH) /  5 mM EGTA in 0.1 M sodium phosphate buffer pH 7.3) 
for 30 minutes at 4 °C. Samples were then washed three times for 2 minutes 
each at room temperature in Wash solution (2 mM MgCl^ /  0.1% sodium 
deoxycholate /  0.02% Nonidet P40 (BDH) /  0.05% (w/v) bovine serum 
albumin in 0.1 M sodium phosphate buffer pH 7.3).
The wash solution was then replaced with 1 ml of Stain solution (41 mg 
potassium ferricyanide, 52.5 mg potassium ferrocyanide (both BDH) in 24 ml 
of Wash solution with 1 ml of 25 mgml ^  X-Gal (5-bromo-4-chloro-3-indolyl 
yg-D-galactopyranoside) in dimethyl sulphoxide). Samples were then 
incubated at 37 °C in the dark. Once sufficient staining had developed, 
samples were washed twice in Wash solution and stored in Fix solution at 4 
°C in the dark. Samples were photographed on agarose as detailed above 
(Section 2.6.3).
2.18 Organ Culture
Timed matings of female and male breeding pairs were used to generate 
staged mouse embryos. Three different mating pairs were used, female
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(C3H/HeH) and male (101), female and male BALB/c, and female and male 
mice homozygous for the Vanin-1 null allele, henceforth known as the Vanin- 
1 null. Pairs were set up as described in section 2.5.1. For organ culture 
urogenital ridges comprising the gonad and attached mesonephros were 
dissected into PBS at the 17-20 tail somite stage corresponding to 11.0-11.25 
dpc (see table 1), prior to testis cord formation in males. The sex of each 
embryo was determined by staining the amnion for the presence of Barr 
bodies as in section 2.5.2. Organ culture was performed as essentially 
described in Martineau et al (1997). Briefly, dissected urogenital ridges were 
stored in Dulbecco's Minimal Eagle's Medium (DMEM)/ 10% fetal calf 
serum (ECS)/ 50 pgml^ ampicillin/ 200mM L-glutamine, for a short time in 
individual dishes whilst the embryonic sex was determined. Single male 
urogenital ridges (comprising one gonad-mesonephros pair) were then 
placed into grooves on 1.5% agar blocks incubated in 35mm culture dishes 
containing 0.4 ml DMEM/FCS/ 50 pgml^ ampicillin/ 200 mM L-glutamine. 
Organs were cultured at the air/medium interface at 3TC in 5% CO .^ 
Culture medium was changed after 24 hours. Experimental cultures 
contained 50 pgml^ anti-Vanin-1 mAh 407 dissolved in the culture medium. 
One gonad-mesonephros pair from each embryo was also treated as a 
control and cultured in the absence of mAb 407 or, in some experiments, in 
the presence of a distinct mAh contained in the control culture medium. 
After 48 hours urogenital ridges were scored for the presence or absence of
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testis cords and then either fixed in 4% paraformaldehyde for subsequent 
WMISH or freshly frozen in OCT for immunohistochemical analysis.
2.19 Immunohistochemistiy
2.19.1 Sample preparation
Tissues were freshly frozen in OCT compound and cryosections cut at 10 
pm, air dried and fixed for 15 minutes in ice-cold acetone. Sections could 
then be used directly, or stored at -20 '’C until required.
2.19.2 Laminin, mAb 407, and mAb 31.9 detection
Sections were rinsed in PBCT (0.5% gelatine/0.05% Tween 20 in PBS) for 3 x 
5 minutes, and then incubated with 10 pgml ^  mAh 407, mAh 31.9 (P.Naquet) 
or rat anti-mouse laminin A chain (Chemicon), in PBCT for 45 minutes at 
room temperature. They were then washed 3 x 5  minutes in PBCT, and 
incubated in rabbit anti-mouse FITC IgC (Chemicon) at a 1:100 dilution in 
PBCTN (PBCT + 5% HISS) for 45 minutes at room temperature. After rinsing 
in PBCT, sections were mounted under coverslips in Vecta Shield (Vecta 
Laboratories Inc) and photographed under ultraviolet light using an 
Axiophot microscope.
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2.19.3 p75NTR Detection
This was performed essentially as described by Russo et al (1999). Slides 
were thawed for 20 minutes and pre-blocked in 10%FCS/PBS for 30 minutes 
at room temperature. They were then incubated in rabbit anti-mouse p75 
receptor polyclonal antibody (Chemicon) at a 1:200 dilution in 
0.1%/BSA/PBS for 30 minutes again at room temperature. After 3 x 5  
minute PBS washes, slides were incubated in goat anti-rabbit IgC FITC at a 
1:100 dilution in 0.1% BSA/PBS for 45 minutes at room temperature. Slides 
were then rinsed in PBS and mounted under coverslips in Vecta Shield and 
photographed as in section 2.18.2.
2.19.4 Alkaline phosphatase staining
In order to verify that immunostaining was being performed on sections 
containing testis cords, alternate sections were taken and stained for the 
presence of germ cells using alkaline phosphatase staining. Sections were 
washed 3 x in NTMT pH 9.5, and then incubated in the dark in 4.5 pi NBT +
3.5 pi BCIP/ml NTMT for 10 minutes. They were then rinsed in NTMT and 
PBS and mounted under coverslips in Aquamount.
2.19.5 PECAM staining
Purified rat anti-mouse CD31 (PFCAM-1) (BD Pharmingen) monoclonal 
antibody was used in order to detect migratory endothelial cells. Conads
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were embedded on OCT and cryosections cut at 10 pm thickness. After a ten 
minute acetone fixation sections were incubated in 3% hydrogen peroxide in 
isopropanol, then in 10% rabbit serum (DakoCytomation). Sections were 
then incubated in PECAM-1 mAb (1:10) for one hour in 10% rabbit serum. 
Visualisation was performed via a three-step staining procedure initially 
using biotinylated rabbit anti-rat polyclonal antibody incubation (1:400) for 
30 minutes as a secondary antibody (BD Pharmingen). A streptavidin -HRP 
tertiary antibody was then used in conjunction with the ChemMate detection 
kit Peroxidase/DAB Rabbit/Mouse (DAKO). Slides were then 
counterstained with Haematoxylin and mounted under coverlips with 
Aquamount.
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Chapter 3: Expression analysis of candidate
genes using wholemount in situ hybridisation
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3.1 Introduction
In the mammalian testis development pathway, the supporting (Sertoli) cell 
lineage plays a critical role. Studies of XX<->XY chimeras (Burgoyne et al., 
1988; Palmer and Burgoyne, 1991) suggest that they are the initial site of the 
Y-linked sex determining signal. Pre-Sertoli cells express the Y-linked sex 
determining gene Sry around 10.5 dpc (Hacker et al., 1995a). The presence of 
Sry is thought to initiate the expression of other testis-determining genes. 
Over the next 48 hours the testis develops a distinctive morphology under 
the control of Sry, due to the promotion of various cellular processes, for 
example, cell signalling, migration, and proliferation, tissue remodelling and 
vascularisation. Most genes found thus far to play a role in testis 
development have encoded transcription factors: Sox9 (da Silva et al., 1996; 
Kent et al., 1996) (Swain et al., 1996), Sfl (Shen et al., 1994), Dmrtl (Raymond 
et al., 1999)), or signalling molecules (Amh (Behringer et al., 1994), Dhh 
(Bitgood et al., 1996) Fgf9 (Colvin et al., 2001). One major feature of all these 
genes is that they are thought to display a sexually dimorphic expression 
pattern in the developing testis and are expressed in the Sertoli cell lineage. 
Clearly, the above list is restricted to two broad functional groups; given the 
diversity of cellular processes involved in gonad development other genes 
must be functioning which have not yet been identified. Additionally, no 
known target genes of these transcription factors have been identified so far, 
though new candidate genes continue to be discovered (McClive et al., 2003).
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In the developing ovary at equivalent stages, using light microscopy, the 
morphological organisation is less well defined than in the testis. For this 
reason it is more difficult to determine the cell type expressing any 
particular gene. Few ovarian determining genes are known, although using 
various tools, for example gain/loss of function studies, two genes, Daxl 
and Wnf4, have been shown to be important (Mizusaki et al., 2003; Swain et 
al., 1998). In contrast to the testis, primordial germ cells (PGCs) are required 
for ovarian development. PGCs are required for the differentiation of follicle 
cells; in the absence of PGCs follicles never form (Bedell et al., 1995; Huang 
et al., 1993). In contrast, Sertoli cell differentiation and testis cord formation 
are not dependent upon the presence of PGCs.
The aim of this chapter is to analyse in detail the expression of candidate 
genes which have arisen from a DNA microarray-based screen for sexually 
dimorphic transcripts at 13.5 dpc. This validation is performed by 
wholemount in situ hybridisation (WMISH). The objective with respect to 
male developement is to identify sexually dimorphic transcripts specifically 
in the pre-Sertoli cell lineage, before overt differentiation of the testis, in 
order to attempt to expand the list of functional classes known to be 
important in male sexual development. In females, given the paucity of 
known ovarian determining genes, a lesser knowledge of the morphology of 
the developing ovary, and the fact that PGCs are known to play a role in
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ovarian development, any gene observed to exhibit an ovarian-specific 
expression pattern is of interest.
3.2 Objectives
• To validate the sexually dimorphic expression of candidate genes 
arising from DNA microarray experiments.
• To identify cell type specificity of expression, and in males, to identify 
potential Sertoli cell expression using the Sertoli cell marker Sox9 for 
comparison.
• To choose potential genes which may expand the list of functional 
classes known to be important in sexual development.
3.3 DNA Microarrays
A key feature of genes previously shown to be involved in sex determination 
is that they were found to exhibit sexually dimorphic expression during 
gonadogenesis (for reviews see: Capel, 2000; Greenfield and Koopman, 1996; 
Swain and Lovell-Badge, 1999). DNA microarray technology provides a 
rapid means of screening large numbers of genes for differences in gene 
expression between two tissues. This technique was therefore exploited in 
order to identify additional genes exhibiting sexually dimorphic expression. 
Three different probe sources were used, either from the NMUR cDNA 
library (Grimmond et al., 2000), from the Ko developmental gene collection 
(Ko et al., 2000) or from the Mouse Known Gene SGC Oligo Set Array 2
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fwww.hgmp.mrc.ac.uk). This last array uses a commercial oligonucleotide 
library designed by Compugen. These microarrays also contained genes 
which are known to be expressed in gonad development in a sexually 
dimorphic manner, and therefore could be used as useful internal controls 
for the hybridisations.
These microarrays were hybridised to fluorescently-labelled cDNA targets 
made from 12.5 and 13.5 dpc dissected gonads, as the transcripts of most 
early onset sexually dimorphically expressed genes are still detectable at 
these stages. Microarray hybridisations and data analyses were performed 
by Sean Grimmond (Grimmond et al., 2000) and Lee Smith (Smith, 2003).
3.4
3.4.1
Results 
Candidate clones
Seven clones were obtained for further study because they exhibited 
significant sexually dimorphic expression on DNA microarrays in replicate 
experiments (Table 3.1).
Gene Accession
Number
Microarray Expression
Adh 4 NM_011996 NMUR MALE
ENHANCED
Mod-1 NM_008615 KO-SET MALE
ENHANCED
Hey2 NM_013904 NIA/OLIGO MALE
ENHANCED
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NM_019626 NIA/OLIGO MALE
ENHANCED
SlclOal NM_015747 NIA/OLIGO MALE
ENHANCED
Gatal NM_008090 NMUR FEMALE
ENHANCED
Vanin-1 NM_011704 NMUR MALE
ENHANCED
Table 3.1 Candidate clones
Table 3.1 shows candidate clones chosen for further analysis after initial 
microarray data suggests they exhibit sexually dimorphic expression and 
hence may play a role in gonad development. Each candidate is listed along 
with its accession number, library and initial expression data.
For each candidate clone, riboprobes were synthesised according to the 
vector used in each library (Table 3.2).
Library Vector Linearise Antisense
Riboprobe
NMUR pT7T3 ECORI T3RNA
Polymerase
KO SET pSPORT SALI SP6RNA
polymerase
NIA/OLIGO pSPORT SALI SP6RNA
polymerase
Table 3.2 Riboprobe svnthesis
Table 3.2 shows how each riboprobe was synthesised according to its 
original library.
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Wholemount in situ hybridisation (WMISH) was performed with each 
probe. Initially, male and female gonads were dissected at 12.5 and 13.5 dpc, 
because at these stages the testis cords in the male are clearly visible 
facilitating the identification of the cell-type expressing each gene. As stated 
previously, the identification of ovarian cell-types expressing a given gene is 
more difficult.
3.4.2 Alcohol Dehydrogenase Class IV, (Adh 4) 
expression is enhanced in the developing male gonad
Alcohol dehydrogenase has been shown to be an enzyme that metabolises 
retinoids to produce their active forms (Duester, 2000). WMISH performed 
on male and female gonads at 12.5 dpc and 13.5 dpc confirmed initial 
microarray data, indicating an enhancement of expression in the developing 
male gonad (Figure. 3.1A, 3.1B).
Upon longitudinal sectioning of these gonads, it can be seen that expression 
of Adh4 exhibits a similar pattern to that of Sox9, namely it is confined to the 
periphery of the testis cords in the vicinity of Sertoli cells (Figure. 3.1C and 
D).
3.4.3 Malic Enzyme-1 (Mod~1) shows male-enhanced 
expression in the developing gonad
Mod-1 encodes a metabolic enzyme which catalyses the reversible oxidative 
decarboxylation of malate, and is a link between the glycolytic pathway and
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the citric acid cycle. It is cytosolic, and has previously been shown to be 
expressed in the liver (Johnson et al., 1981). WMISH using a Mod-1 riboprobe 
at 12.5 dpc and 13.5 dpc again reveals male-enhanced expression 
(Figure.3.2A and B). This expression is again located around the edges of the 
testis cord in a similar pattern to that of Sox9 at 13.5 dpc (Figure.3.2C ).
3,4.4 Hairy/enhancer of split-related protein with YRPW 
motif 2 (Hey2) expression is enhanced in the male gonad at
13.5 dpc
Hey2 is a member of a novel subfamily of hairy/Enhancer of split (E(spl))- 
related genes. Whereas hairy/E(spl) proteins are characterized by an 
invariant proline residue in the basic domain and a carboxyterminal 
groucho-binding WRPW motif. Hey genes encode a carboxyterminal YRPW 
sequence. Hey2 is expressed in the developing somites, heart, craniofacial 
region and the nervous system in the mouse embryo (Leimeister et al., 1999). 
At 13.5 dpc Hey2 expression is confirmed as sexually dimorphic with up- 
regulation in the male. Transcripts are located in the interstitial area of the 
testis, the site of Ley dig, endothelial and peritubular myoid cells. Expression 
is not observed in the Sertoli cells. (Figure 3.3 A and B).
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Figure 3.1
F ig u r e  3 . 1  Adh4  i s  e x p r e s s e d  in  t h e  d e v e l o p i n g  m a le  g o n a d
Representative images of wholemount in situ hybridisation (WMISH) of 
gonad explants with an Adh4 riboprobe are shown. Expression is observed 
along the length of the testis at 12.5 dpc. Expression in the ovary is 
negligible in comparison (A). At 13.5 dpc transcripts are primarily confined to 
the testis cords in the male. Low level expression is still observed along the 
length of the ovary (B). Longitudinal sections of 13.5 dpc males revealed 
expression concentrated towards the periphery of the testis cord (arrows C) 
in a similar fashion to Sox 9 expression (D).
O ovary, T testis, TC testis cords.
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Figure 3.2
Figure 3.2 Mod-1 shows male-enhanced expression in the developing 
gonad
Representative images of WMISH of gonad expiants with a Mod-1 riboprobe 
are shown. Mod-1 expression is enhanced in the developing testis cords at 
12.5 dpc (A arrow). Expression is seen in the testis cords at 13.5 dpc (B). 
Low level expression is seen in the ovary at both stages. Low levels of 
expression are also observed in the Müllerian duct mesenchyme of both 
sexes at 13.5 dpc. Sagittal sections of 13.5 dpc male gonads (C); revealed 
expression concentrated towards the periphery of the cord (arrows) in a 
similar fashion to Sox9 expression.
M, Müllerian duct mesenchyme, TC, testis cords.
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3.4.5 Cerebellin 1 precursor protein {Cbln1) Is 
expressed in the interstitium of male gonads at 13.5 dpc
Precerebellin 1 (Cblnl) is the precursor of cerebellin, a brain-specific 
neuropeptide. In addition to neuropeptide properties, Cblnl also has 
structural features similar to circulating atypical collagens, and it forms 
heterodimeric complexes with CblnS (Pang et al., 2000).
WMISH of 13.5 dpc male and female gonads supported the original sexually 
dimorphic expression profile observed in the microarray data. However, as 
with the results of Hey2, expression is seen between the testis cords. This was 
confirmed upon sectioning (Figure 3.4A and B). The cell-type specificity of 
expression is unclear but it appears to be distinct to that of Hey2.
3.4.6 Solute carrier family 20, member 1 (Slc20a1) Is 
expressed In the developing testis from 12.5 dpc
Slc20al encodes the Pitl phosphate transporter (Palmer et al., 2000). At 13.5 
dpc WMISH revealed that Pitl is expressed in the testis cords of the male 
gonad. Sectioning also showed expression corresponding to Sox9-positive 
cells. Expression was absent from females (Figure. 3.5).
3.4.7 GATA binding protein 2 (Gatal) expression Is 
restricted to the ovary
Gata2 is a member of the GATA family of zinc finger transcription factors. 
WMISH performed on male and female gonads at 12.5 and 13.5 dpc reveals
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expression exclusively in the developing ovary. This confirms the initial 
findings of the microarray data. Sectioning of the 13.5 dpc explants after 
hybridization reveals a punctate pattern of expression throughout the ovary 
(Figure 3.6). A detailed examination of cell-type specificity will be presented 
in Chapter 4.
3.4.8 Vanin-1 (Vnn1) is expressed in the developing 
male gonad
Vanin-l encodes a GPT(glycosylphosphatidylinositol) anchored cell surface 
molecule, whose putative function has been postulated to be involved in the 
homing of bone marrow precursor cells to the thymus under physiologic 
conditions. As expected from the microarray data, expression is prominent 
in the testis at 13.5 dpc, with no expression seen in the ovary at this stage. 
This sexual dimorphism is also observed at 12.5 dpc. Sections of the testis 
revealed a concentration of signal towards the periphery of the testis cords, 
in a similar fashion to Sox9 expression. This region corresponds to the Sertoli 
cells (Figure 3.7).
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Figure 3.3 Hev2 expression is male-specific in gonads at 13.5 dpc
Representative images of WMISH of gonad expiants with a Hey2 riboprobe 
are shown. Sexually dimorphic expression can be observed, with expression 
in the male concentrated in the interstitium. Low levels of expression can be 
seen in the ovary (A). In cross-section this is confirmed (B). Expression can 
be seen in the same area of the gonad as the Leydig cell marker 3Hhsd (C), 
though expression is more extensive in the case of Hey2.
Figure 3.4 Cblnl is expressed between the testis cords in male gonads 
at 13.5 dpc
Figureure 3.4 shows representative images of WMISH of gonad explants 
with a Cblnl riboprobe. Expression is seen around the testis cords in the 
male and is absent from the female (A). Longitudinal cross-section reveals 
widespread expression in the interstitium of the testis (B).
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3.4.9 Negative candidate clones
Six additional candidate clones from initial microarray data were also 
examined. However, WMISH revealed little or no expression, or expression 
was not confirmed to be sexually dimorphic. The following table 
summarises the result for each gene, showing accession number and from 
which library each was located, initial expression data (from microarray 
results) and WMISH verification results (Table 3.3).
Gene Accession Library Microarray
expression
WMISH
expression
Cfi NM_007686 NIA/OLIGO MALE
ENHANCED
NO EXPRESSION
Pcml AB029291 NIA/OLIGO MALE
ENHANCED
NO EXPRESSION
Manlhl NM_010764 NIA/OLIGO MALE
ENHANCED
NO EXPRESSION
Prlr NM_011164 NIA/OLIGO MALE
ENHANCED
LOW LEVEL
NOVEL BG072209 NIA/OLIGO MALE
ENHANCED
GERM CELL 
BOTH SEXES
Ig-Heptal NM_007429 NMUR FEMALE
ENHANCED
VERY SLIGHT
FEMALE
UPREGULATION
Table 3.3 Negative candidate clones
Table 3.3 shows the results of WMISH studies which failed to verify initial 
microarray data, which initially suggested a sexual dimorphic expression 
pattern.
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Figure 3.5
F ig u r e  3 .5  Pit1 i s  e x p r e s s e d  in  t h e  d e v e l o p i n g  t e s t i s  fr o m  1 2 .5  d p c
Representative images of WMISH of gonad expiants with Pit1 riboprobe are 
shown. Pit1 is expressed in the male gonad at 12.5 dpc (Arrow, A). No 
transcripts are observed in the ovary (A). Expression becomes more intense 
at 13.5 dpc with transcripts present in the testis cords (B). Longitudinal 
sections reveal an expression pattern where transcripts are located towards 
the periphery of the testis cords in a similar pattern to that of Sox9 (C).
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Figure 3.6
Figure 3.6 Gata2 transcription is restricted to the female gonad
Figure 3.6 shows representative images of WMISH of gonad explants with a 
Gata2 riboprobe. At 12.5 dpc Gata2 is expressed in the ovary and not the 
testis (A). Expression is seen in the mesonephros in both sexes. This pattern 
of expression is observed at 13.5 dpc (B). Upon sectioning, expression can 
be seen to be dispersed throughout the ovary (C) and is absent from the 
testis (D).
M, mesonephros; T, testis; O, ovary.
79
3.5 Discussion
Many genes with a role in sexual development have been shown to be 
transcribed in a sexually dimorphic fashion during gonadogenesis. One way 
therefore to identify new genes in this process, in either sex, is to screen for 
additional genes with this property.
Clones which initial microarray data indicated were expressed at higher 
levels in either the developing male or female gonads were further analysed 
by WMISH. This technique can not only confirm the sexually dimorphic 
expression, but can also reveal the site of expression, particularly in the 
developing testis.
Genes exhibiting enhanced expression in the male gonad 
Adh4
Vitamin A (retinol) and provitamin A (beta-carotene) are metabolized to 
produce specific retinoid derivatives that function in either vision or growth 
and development. Investigation of retinoid metabolic pathways has resulted 
in the identification of numerous retinoid dehydrogenases that potentially 
contribute to metabolism of various retinoid isomers to produce active 
forms. These enzymes fall into three major families. Dehydrogenases 
catalyzing the reversible oxidation/reduction of retinol and retinal are 
members of either the alcohol dehydrogenase (ADH) or short-chain 
dehydrogenase/reductase (SDR) enzyme families, whereas dehydrogenases
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Figure 3.7
Figure 3.7 Vanin-1 is expressed in the testis of the developing male 
gonad
Representative images of WMISH of gonad expiants with a Vanin-1 
riboprobe are shown. Vanin-1 is expressed in the male gonad at 12.5 dpc 
(arrow) and is absent from the ovary (A). Expression is located in the testis 
cords at 13.5 dpc (B). Expression is observed in a similar pattern to that of 
Sox9 when sectioned longitudinally with transcripts located at the periphery 
of the cord (arrow C). Expression is absent from the ovary at all stages 
examined.
TC, testis cords.
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catalyzing the oxidation of retinal to retinoic acid are members of the 
aldehyde dehydrogenase (ALDH) family (Duester, 2000).
Retinol is known to play an essential role in spermatogenesis and 
maintenance of the reproductive tract by its active form (retinoic acid) acting 
as a ligand for nuclear retinoic acid receptors. Adh4 catalyses retinol 
oxidation, the rate-limiting step in the conversion of retinol to retinoic acid, 
and is expressed in adult mouse testis and epididymis (Deltour et al., 1997). 
Previously, transgenic mice have been used to examine the expression of 
class Adh4 in vivo (Deltour et al., 1997). Expression was highly localized in 
the brain and craniofacial region at stages during neurulation, 
corresponding to the otic vesicles and migrating neural crest cells. This 
indicates that Adh4 may function in retinoic acid synthesis required for 
brain and neural crest development, and that it participates in the 
mechanism of ethanol-induced brain and craniofacial birth defects.
Adh4 exhibits sexually dimorphic expression during gonadogenesis. It is 
restricted to the region containing Sertoli cells in the testis cords and it 
encodes an enzyme primarily involved in the metabolism of retinoic acid. 
This molecule has importance in the maintenance of the adult reproductive 
tract, and in the development of other embryonic organs, namely the brain 
and neural crest. However, it was not chosen for further study because we 
learnt that another research group was examining its possible role in gonad 
development.
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Modi
Development of the testis is associated with increased cellular activity, 
requiring a corresponding increase in metabolic energy. M odi is a metabolic 
enzyme, which, although fulfilling the criteria for this screen, was not chosen 
for further study because its up-regulation in the testis probably corresponds 
to this metabolic requirement, and may not reflect a direct role in regulating 
testis differentiation.
Hev2 and Cblnl
Both these genes exhibited male enhanced expression. However, WMISH 
revealed this expression to be restricted to the interstitium of the developing 
male gonad. Therefore, they did not meet the criteria for this screen and 
were not studied further.
Slc20a1
SlclOal encodes the Pitl phosphate transporter, which belongs to the type 111 
sodium-dependent phosphate transporter/retrovirus receptor family. Type 
111 transporters are expressed in a wide variety of tissues and play a role in 
phosphate uptake in many cell types. Pitl is also probably involved in 
regulated phosphate handling in bone forming cells (Palmer et al., 2000). 
SlclOal is expressed in the Sertoli cells of the developing testis whereas 
transcripts are absent from the developing ovary. However, it was not 
chosen to be studied further due to time and resource constraints.
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Vanin-1
During development haematopoietic precursor (pro-T) cells migrate to the 
thymus where they differentiate into mature T lymphocytes. Vanin-1 
(vascular noninflammatory molecule 1) is a GPI-anchored cell surface 
molecule thought to be involved in this thymic homing of bone marrow cells 
to the thymus. It is expressed by perivascular thymic stromal cells, and 
antibodies against Vanin-1 were able to block thymus colonization by these 
precursor cells in both short- and long- term assays. This antibody also 
blocks lymphostromal cell adhesion, and Vanin-1 is thought to regulate late 
adhesion steps of thymus homing under noninflammatory conditions 
(Aurrand-Lions et al., 1996).
Vanin-1 has been shown in this screen to be prominently expressed in the 
Sertoli cells in the developing testis. Various studies have shown that the 
development of the characteristic architecture of the testis is dependent on 
the male-specific migration of precursor cells from the mesonephros into the 
gonad (Albrecht et al., 2000; Capel et al., 1999; Mart ineau et al., 1997; 
Tilmann and Capel, 1999a; Yao et al., 2003). Given its role in the migration of 
bone marrow progenitor cells and the importance of cell migration in gonad 
development, Vanin-1 was chosen to be studied further.
Gata2- a gene up-requlated in the developing ovary
Gata2 is a member of the GATA family of zinc finger transcription factors.
This family has been implicated in a wide variety of developmental
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processes (Simon, 1995). Gata2 is known to be essential for the development 
of primitive haematopoietic cells. Mouse embryos homozygous for a Gatal 
null allele display marked anaemia and die by 11.5 dpc (Tsai et al., 1994). 
Partial rescue of this mutation reveals a distinct role for Gata2 in urogenital 
ridge development. Neonates die from hydroureternephrosis, with 
malformed kidneys and ureters (Zhou et al., 1998). There are also 
malformations in Müllerian and Wolffian duct derivatives, though 
embryonic testes appear normal at 13.5 dpc.
In contrast to the testis, few ovarian determining genes are known, with the 
exception of Wnt4 and Daxl. Also, in contrast to the testis, germ cells in the 
female are important for the development of the ovary. They are required for 
the initial organisation of ovarian cells into follicles and for the maintenance 
of the follicles. Therefore, the sexually dimorphic expression of genes was 
used as the sole criterion when selecting genes expressed in the developing 
ovary: genes expressed solely in the germs cells of the testis would not have 
been pursued.
As stated previously Gata2 is required for the development of primitive 
haematopoietic cells. Partial rescue of the mutant homozygotes reveals a role 
for Gata2 in urogenital development. These mutants exhibit malformations 
of mesonephros derivatives in the male: this phenotype corresponds with 
the strong expression seen by WMISH. However, no reports have been made
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of the expression in the developing ovary, as seen in this screen. Therefore, a 
more extensive study of its expression in the ovary is relevant.
3.6 Summary
• cDNA clones were obtained for potential candidate genes involved in 
gonad development based on their sexually dimorphic profile on 
DNA microarrays. These were further analysed by WMISH; in order 
to validate these preliminary data, and to examine the spatial pattern 
of expression during embryogenesis.
• One gene (Vanin-1) with male-specific expression was selected for 
further study on the basis of its potential role in downstream 
processes in gonad development, and its presence in the Sertoli cell 
lineage.
• One female specific gene (Gatal) was selected for further study on the 
basis of its sexually dimorphic expression alone.
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Chapter 4: Detailed characterisation of Gata2 
expression during gonadogenesis
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4.1 Introduction
Members of the Gata family of transcription factors, which contain zinc 
fingers in their DNA binding domain, have emerged as candidate regulators 
of gene expression in haematopoietic cells (Tsai et a l, 1994). Gatal is 
essential for normal primitive and definitive erythropoiesis and is expressed 
at high levels in erythroid cells, mast cells, and megakaryocytes. Gata3 
expression is restricted to T-lymphoid cells and some non-haematopoietic 
cell-types, including embryonic stem cells.
Gata2 is expressed in haematopoietic progenitors, including early erythroid 
cells, mast cells, and megakaryocytes, and also in non-haematopoietic 
embryonic stem cells, and may play a role in regulating genes controlling 
growth factor responsiveness or the proliferative capacity of early 
haematopoietic cells (Tsai et al., 1994).
Mouse embryos homozygous for a Gatal null allele display marked anaemia 
and die by 11.5 dpc (Tsai et al., 1994). Partial rescue of this mutation reveals 
a distinct role for Gatal in urogenital development. Neonates die from 
hydroureternephrosis, with malformed kidneys and ureters (Zhou et al., 
1998). There are also malformations in the Müllerian and Wolffian duct 
derivatives, although the embryonic testis appears normal at 13.5 dpc.
This gene was chosen for further investigation for two main reasons. Firstly, 
despite this extensive study of the effects of this mutation on urogenital 
development, no data concerning ovarian morphology of rescued mutants
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have been reported. Secondly, the previous chapter showed that Gatal is 
expressed in a sexually dimorphic manner during gonadogenesis, with 
transcripts restricted to the developing ovary. In contrast to testis 
development, few genes have been shown to exhibit this female-specific 
expression pattern during ovarian development. In fact only three genes 
have been shown to exhibit elevated levels of transcription in the developing 
ovary: Daxl (Swain et al., 1996), Wnt4 (Vainio et al., 1999), and Psx2 
(Takasaki et al., 2000). Each of these is initially expressed in both XX and XY 
embryonic gonads.
A detailed study of the expression of Gatal in the developing ovary, 
including determining the cell type(s) expressing this gene would therefore 
be useful in gaining insight into its possible role in ovarian development. 
The aim of this chapter therefore is to perform a detailed expression analysis 
of Gatal in ovarian development, and to ascertain the cell-type expressing 
this gene.
4.2 Objectives
• To analyse the complete spatio-temporal expression of Gatal during 
gonad development.
• To determine the cell-type expressing Gatal.
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4.3 Strategy
• To determine the onset of Gatal expression in the developing gonads 
and to compare expression between the development of the testis and 
ovary by WMISH.
• Two strategies can be used in order to determine the cell-type 
expressing Gatal in the ovary. Firstly, Gatal expression can be studied 
in embryos homozygous for the extreme allele of white dominant 
spotting (W /W) whose gonads lack primordial germ cells (Buehr et 
al., 1993b). Secondly, expression of Gatal can be compared to the 
expression of Oct4, a marker of germ cells in the gonad (Scholer et al., 
1990), by in situ hybridisation to sections of embryonic ovary.
4.4 Results
4.4.1 Expression studies of Gata2
4.4.1.1 Onset of expression
Expression of Gatal was first observed in the developing ovary at 11.5 dpc. 
Expression was examined earlier, at 10.5 dpc, but at this stage only 
mesonephric signal was observed. This mesonephric expression was 
observed in both sexes, though relatively greater expression was observed in 
the female mesonephros (Figure.4.1A and B). This mesonephric expression 
illustrated that the Gatal riboprobe synthesised was indeed working and 
therefore served as a useful internal control for the WMISH efficiency. No
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expression was observed in the male gonad at this stage or subsequent 
stages.
4.4.1.2 Expression from 12.0 dpc to 14.5 dpc
The sexual dimorphism of expression is apparent at 12.0-12.5 dpc when 
Gatal expression in the ovary is prominent but absent from the testis. This 
pattern of expression continues from this stage until 14.5 dpc (Figure 4.2).
4.4.1.3 Expression at 15.5 dpc
Gatal transcripts are no longer observed at 15.5 dpc in the ovary, though 
expression in the male and female mesonephroi is observed at all stages 
(Figure 4.2).
4.4.2 Determination of cell type expressing Gata2
To determine the cell type specificity of Gatal expression in the ovary, two 
complementary approaches were taken. Firstly, Gatal expression was 
examined in W /V f homozygous embryos. Secondly, expression was 
compared directly to that of the PGC marker Oct4.
4.4.2.1 Gata2 expression in l/l/Vl/l/® homozygous embryos
Towards the end of gastrulation of the mouse embryo, the germ cells are 
distributed along the hind gut, from which they migrate into the genital
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Figure 4.1
Figure 4.1 Gata2 is first expressed at 11.5 dpc
WMISH using a Gata2 riboprobe reveals no expression at 10.5 dpc in the 
testis or ovary (A). However, transcripts are observed in the mesonephroi in 
both sexes, though there is a greater intensity of expression in the female. 
Expression is first observed in the female gonad at 11.5 dpc (arrow), but is 
absent from the male (B). Expression in the mesonephros again shows a 
greater intensity in the female compared with the male (B).
M, mesonephros; G, gonad (area surrounded by dotted line).
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Figure 4.2
Figure 4.2 Gata 2 exhibits continued sexually dimorphic expression 
from 12.0 dpc to 14.5 dpc and is absent by 15.5 dpc
High levels of Gata2 transcript are observed exclusively in the female gonad 
at 12.0 dpc (A), 12.5 dpc (B), and 13.5 dpc (C). No expression is seen in the 
testis at these stages. Longitudinal sections through the 13.5 dpc ovary and 
testis confirm expression of Gata2 in the ovary and absence of expression in 
the testis (D). Expression is still observed in the ovary at 14.5 dpc and is 
absent from the testis (E). Minimal expression can be seen in the ovary and 
female mesonephros at 15.5 dpc. Diffuse staining can be seen in the testis 
at 15.5 dpc, however sectioning confirmed this as probe trapping (data not 
shown). Probe trapping occurs when WMISH is performed on larger hollow 
tissues. Subsequent washing after probe treatment is insufficient to remove 
any probe trapped in internal structures, in this case the testis cords at 15.5 
dpc (F).
T, testis; M, mesonephros; O, ovary.
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') ridge. Throughout this period they rely on the c-kit/stem cell factor signal
transduction pathway for their continued proliferation. Therefore, embryos 
homozygous for mutations in genes coding for either the receptor (W) or the 
ligand (Steel) are deficient in germ cells.
Germ cell migration studies in embryos homozygous for the extreme allele 
of dominant white spotting (W  (Buehr, 1993) found that germ cells did 
survive after 8.5 dpc, but their numbers did not increase and migration was 
defective. Very few germ cells reach the genital ridge. Ovaries were therefore 
collected from 13.5 dpc embryos homozygous for the extreme allele (W) of c- 
kit. Expression was then examined to see if ovarian Gatal is dependent on 
the presence of germ cells.
) Homozygous mutants and wild-type littermates were identified by
genotyping using Southern blotting and Gatal expression was analysed by 
WMISH. Figure 4.3 shows that Gatal transcripts are present in the wild-type 
ovary and mesonephros. They are also present in the W7W mesonephros, 
but, expression is absent in the W7W ovary. These data demonstrate that 
ovarian expression of Gatal is dependent on the presence of germ cells.
4.4.2.2 Gata2 expression is limited to the germ cell 
lineage of the ovary
In order to distinguish between germ cell induced somatic expression of 
Gatal and germ cell restricted expression, a comparative in situ hybridisation 
analysis was performed on sections with the germ cell marker Oct4
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Figure 4.3 Ovaries from embryos homozvous for the V f  allele do not 
express Gafa2
WMISH on gonads at 13.5dpc using a Gaia2 riboprobe reveals Gata2 
expression in the developing ovary and mesonephros of wild-type 
littermates, and in the mesonephros of mutants (A). However it is not 
expressed in the mutant ovary. Longitudinal sections confirm these WMISH 
data (B).
O, ovary; M, mesonephros.
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(Scholer et al., 1990). Ovaries were examined at 13.5 dpc since this represents 
the latest stage at which both Oct4 and Gatal display high levels of 
expression (Nichols et al., 1998).
Gatal expression is visible in the ovary and mesonephric mesenchyme 
(Figure 4.4A), whilst Oct4 is restricted to the germ cells of the ovary (Figure 
4.54B).
Simultaneous hybridisation of differentially labelled Oct4 and Gatal probes 
to the same sections indicates that ovarian expression of Gatal overlaps that 
of Oct4 as evidenced by a mix of the blue and red probes revealing a purple 
signal (Figure 4.4C).
In the mesonephric mesenchyme the signal is blue due to expression of 
Gatal but absence of Oct4. These data strongly suggests that Gatal 
transcripts are restricted to the germ cell lineage at this stage.
4.4.3 Gata2 expression in XO embryonic gonads
In female embryos, all epiblast-derived cell lineages, including the germ cell 
lineage, initially show random X- inactivation (McMahon, 1981). Therefore, 
as germ cells are migrating towards the genital ridge, dosage compensation 
for X-linked genes is achieved. When germ cells enter the genital ridge, their 
silent X chromosome becomes reactivated (Monk, 1981). Therefore, both X 
chromosomes are expressed throughout oogenesis. It is noticeable that the
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Gatal expression profile described here coincides with the timing of this 
reactivation of the silent X chromosome in females.
To address this possible association, expression of Gatal was examined in 
13.5 dpc female gonads which do not undergo X inactivation, due to the 
presence of only one X chromosome (XO) and hence no reactivation of the 
silent X occurs. In order to identify XO embryos we used a colony of mice 
segregating for the Cream (Crm) mutation. Adult X ^  /O females were 
distinguished from heterozygous carriers (X /+) by their variegated 
fluorescence under UV light. Once identified, XO females were crossed with 
C3H/HeH males. XO embryos were then identified by an absence of both a 
Barr body and a PGR product when assayed for the Y chromosome-linked 
gene Ubely. Using this cross XO embryos were generated at a greater 
frequency than in normal wild-type crosses with 50% of females carrying 
only one X chromosome.
A down-regulation of Gatal transcription in these mice might suggest a 
direct role for Gata2 in the reactivation process. However, Gatal 
transcription is unaffected in XO embryonic gonads when compared to XX 
and XY littermates (Figure 4.5).
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F ig u r e  4 .4  Gata2 e x p r e s s i o n  i s  r e s t r ic t e d  t o  g e r m  c e l l s  o f  t h e  o v a r y
Figure 4.4 shows representative images of section in situ hybridisations 
using two riboprobes, either Gata2, Oct4 or a combination of both on female 
gonads at 13.5 dpc. Gata2 expression (blue) is observed in a subset of cells 
in the ovary and mesonephros (A). The primordial germ cell marker Oct 4 
(red) is restricted to the germ cells in the ovary (B). In situ hybridisation using 
both Oct 4 and Gata2 probes simultaneously reveals co-expression (purple 
signal) (C) in all ovarian cells exhibiting expression (for example the cell 
indicated by the white arrow), demonstrating that Gata 2 is expressed in 
germ cells. In the mesonephric mesenchyme the signal is blue due to 
expression of Gata2 but absence of Oct 4 (black arrow) (C).
O, ovary; M, mesonephros.
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4.5 Discussion
Gatal was shown to exhibit a sexually dimorphic expression pattern in initial 
microarray experiments, with transcripts detected at higher levels in the 
female gonad. Because of the rarity of known genes which show this 
expression pattern, this gene was studied further.
The ovarian expression of Gatal was confirmed and the onset of expression 
found to be at 11.5 dpc. No testicular expression was observed at any stage; 
however, expression was seen in the mesonephric mesenchyme of both 
sexes. Expression in the ovary was eventually down-regulated at 15.5 dpc.
In contrast to the testis, the ovary exhibits a less well defined gross structure 
as it develops and at the stages examined it is difficult to deduce the cell 
type(s) containing Gatal transcripts. Ovigerous cords develop between 12.5 
and 13.5 dpc (Odor and Blandau, 1969), (Konishi et al., 1986). These cords 
are not defined by basal laminae as are seen in testicular development, and 
are not observable at the level of the dissecting light microscope. One cell- 
type present in the ovary at this stage is the primordial germ cell, and to 
determine if Gatal is expressed here, expression was examined in embryonic 
gonads lacking germ cells. Gatal was found not to be expressed in these 
gonads.
However, germ cells may be required to induce Gatal expression in other 
(somatic) cell-types. Using Gatal in conjunction with Oct4, a marker of germ
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cells, it was shown that these two transcripts were present in the same 
ovarian cells.
Only 3 genes to date have been shown to exhibit an ovary-specific pattern of 
expression in the developing embryo: Daxl, Wnt4, and Psx2. All of these are 
initially expressed in both sexes and down-regulated in the developing 
testis. StraS has been reported to be expressed in this manner (Oulad- 
Abdelghani et al., 1996) but also expressed specifically in the female (Menke 
et al., 2003). However, S expression was observed later in development 
than Gatal, from 12.5 dpc to 14.5 dpc. Gatal still shows the earliest 
expression of a female-specific gene.
This Gatal expression, from 11.5 dpc to 14.5 dpc, could point to a role for 
Gata2 in the reactivation of the silent X chromosome in the germ cells of the 
developing ovary. A down-regulation of expression in XO ovaries might 
further support a direct role for Gata2 in this process, as cells containing 
only one X chromosome do not undergo X inactivation or reactivation. 
However, Gatal expression is unaffected in these gonads. Nevertheless, this 
result does not rule out a potential role for Gata2 in this process.
The role of Gata2 in the developing ovary remains unclear. Given that the 
possible function of Gata2 in the developing haematopoietic system is to 
regulate genes controlling growth factor responsiveness or the proliferative 
capacity of early haematopoietic cells, it could function in a similar fashion 
in the developing ovary.
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LFigure 4.5
F ig u r e  4 .5  Gata2 e x p r e s s i o n  in  X O  e m b r y o n ic  g o n a d s
Gata2 expression is not down-regulated in XO ovaries when compared to 
XX littermates. Gonadal expression is not observed in male (XY) littermates 
at 13.5 dpc. Transcripts are seen in the mesonephric mesenchyme in XX, 
XY and XO gonads. Londitudinal sections confirmed this expression pattern. 
XO embryos were identified by the absence of a Barr body and by the 
absence of a PCR product when assayed for the Y chromosome-linked gene 
Ube1y.
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Germ cells are known to be important for the construction and/or 
maintenance of the ovary, and Gata2 may therefore play a part in this 
somatic cell regulation. The use of conditional gene targeting, restricting the 
loss of Gatal to the developing ovary, would allow this hypothesis to be 
tested.
4.6 Summary
• Gatal is expressed in the developing ovary between 11.5 dpc and 15.5 
dpc, and is absent from the testis.
• Expression is restricted to the germ cell lineage.
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Chapter 5: Detailed characterisation of Vanin-1 
expression during gonadogenesis
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5.1 Introduction
Vanin-l was first identified as part of a screen for molecules involved 
specifically in the homing of bone marrow cells to the thymus (Aurrand- 
Lions et al., 1996). During fetal development, T cell progenitors are 
synthesised in the liver and migrate to the thymus. This occurs in several 
waves at set times during development. After birth this homing of bone 
marrow cells continues at a low level. These cells must first adhere to the 
thymic vascular endothelium before entering the thymus, after which they 
interact with other epithelial cells which support their maturation. Each step 
in this process depends on interaction with several adhesion molecules. 
Firstly, cells arrest on contact with endothelial cells. Secondly, there is 
chemokine induced activation and integrin-dependent reinforcement of cell 
adhesion. CD31, an endothelial-specific cell marker, contributes to the 
activation of integrins and participates in the transmigration of cells. These 
sequential interactions allow the tethering, rolling and activation of pro T 
cells and their binding to the endothelial cell wall. Therefore, various 
combinations of adhesion molecules are needed for the homing process to 
occur. GPI-anchored proteins are also thought to play a role in targeting 
molecules to the apical membrane. It has been demonstrated in other 
homing systems that some molecules are required for the specificity of 
homing, for example, homing to the gut is dependent on the expression by
104
leukocytes of the a4fi7 integrin that binds to the gut endothelial mucin 
MadCAM-1.
Few molecules have been found to be involved in thymic homing, and to 
identify more which are expressed by thymic endothelial cells and or 
perivascular epithelial cells, Aurrand-Lions et al. developed a panel of cell 
lines representing different subtypes of thymic stromal cells. Monoclonal 
antibodies recognising membrane molecules expressed by the lines were 
screened for their ability to stain perivascular cells in immunocytochemical 
tests on thymic sections and to block cell adhesion in vitro. One specific 
monoclonal antibody, 407, (mAb 407) was shown to block intrathymic 
homing. This antibody identifies a novel glycosylphosphatidylinositol (GPI)- 
anchored molecule, Vanin-1. Subsequently, mAb 407 was shown to inhibit 
thymic regeneration in whole body irradiation tests and to block cell 
adhesion, though it did not inhibit thymocyte differentiation in organ 
culture. The molecule recognised by mAb 407 identified a perivascular 
molecule involved in the regulation of thymic homing under 
noninflammatory conditions and was therefore named Vanin-1 (vascular 
noninflammatory molecule-1) (Aurrand-Lions et al., 1996).
Vanin-1 is a GPI anchored 70KDa protein, encoded by a 2.3kb mRNA. This 
transcript encodes a protein of 55KDa which is subsequently glycosylated. It 
also exhibits 40% homology to the human biotinidase gene. This gene 
encodes an enzyme produced by liver cells which catalyses the release of
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biotin from its precursor biocytin. However, Aurrand-Lions et al. concluded 
that it was not the murine equivalent of human biotinidase because of 
differing sites and cell types of expression and the fact that whereas 
biotinidase is a secreted molecule, Vanin-1 is not.
Three related human genes, VNNl, YNN2 and VNN3, were identified by 
database homology searches (Galland et al., 1998; Granjeaud et al., 1999). All 
are located on the long arm of human chromosome 6, a region involved in 
the invasivity of metastasis in human cancer (Galland et al., 1998). Vanin-1 is 
localised on the syntenic region of mouse chromosome 10.
A second mouse gene, Vanin-3, was also identified (Granjeaud et al., 1999), 
though to date no murine equivalent of Vanin-2 has been identified. Human 
VNNl and murine Vanin-1 are GPI-anchored, encoding isoforms of 
pantetheinase ectoenzymes. VNN2 lacks a leader peptide, whereas both 
VNN3 and Vanin-3 lack this anchoring, and are secreted. However, they 
both also encode proteins with a pantetheinase activity (Martin et al., 2001). 
Pantetheinases recycle vitamin B5 to produce cysteamine, a potent anti­
oxidant.
In addition to these, a rat Vanin-1 orthologue and a putative Drosophilia 
homologue were identified (Granjeaud et al., 1999). All human, rat and 
mouse Vanin sequences present a 60% homology at the amino acid level, 
along with a 40% homology to the Biotinidase sequence.
106
Vanin-1 is thought to be involved in the homing of bone marrow precursors 
to the thymus, because a specific antibody to it blocks thymus colonisation 
after sub lethal irradiation, and also interferes with lymphostromal cell 
adhesion.
It is believed that Vanin-1, which is expressed in thymic epithelial cells, 
regulates late adhesion steps of thymic homing under physiologic 
noninflammatory conditions.
5.2 Aim of this chapter
Chapter three described the sexually dimorphic expression of Vanin -1 in the 
gonad at 13.5 dpc. Initial expression studies suggested that expression was 
located in the Sertoli cells of the developing testis. Therefore, given its role in 
the migration and homing of pro T cells, it is hypothesised that a similar role 
might exist for Vanin-1 in the developing testis. The aim of this chapter is 
therefore to ascertain the precise onset of Vanin-1 expression in gonad 
development and to determine the cell-type expressing it. Furthermore, the 
male-specific expression of Vanin-1 highlights it as a possible candidate for 
regulation by male-specific transcription factors. Hence, an assay was 
performed for Vanin-1 regulatory sequences required for gonadal expression 
in transgenic embryos.
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5.3 Strategy
• To determine the onset of expression of Vanin-1 in the developing 
male gonad by WMISH and to determine the cell type expressing 
Vanin-1 by examining expression in W /W  homozygotes (Buehr et aL, 
1993b) using RT-PCR.
• To identify sequences required for gonadal expression of Vanin-1 by 
isolating part of the Vanin-1 promoter (and upstream genomic 
regions) and using this to generate a lacZ reporter construct. This 
construct can then be used to generate transgenic mice and lacZ 
expression analysed in the embryonic gonads of these mice. If 
gonadal expression is observed this genomic fragment would then be 
further studied in order to isolate the minimal sequences (enhancers) 
needed for gonad specific Vanin-1 expression.
5.4 Results
5.4.1 Expression at 10.0-11.5 dpc
A range of embryonic gonad stages were examined in order to determine the 
onset of Vanin-1 expression. No expression is observed at 10.5 dpc (data not 
shown) and 11.0 dpc (Figure 5.1 A) or 11.5 dpc (Figure 5.1B). In each case 
Sox9 was used as a positive control for the WMISH.
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5.4.2 Onset of expression
Vanin-l is first observed in the developing male gonad at 12.0-12.25 dpc, 
immediately prior to overt testis differentiation (Figure 5.2). At no time is 
expression observed in the developing ovary.
5.4.3 Expression from 12.5 dpc
Vanin-l continues to be expressed in the developing testis cords at 12.5 dpc 
and at 13.5 dpc. Longitudinal sections reveal that expression is concentrated 
around the periphery of the cord in the region of the Sertoli cells and is 
generally absent from the centre of the cord where the primordial germ cells 
are located (Figure 5.3 A, B). This sexually dimorphic expression continues 
through 14.5 dpc and 15.5 dpc, (Figure 5.3 C, D).
5.4.4 Expression of Vanin-1 is not dependent on the
presence of primordial germ cells
Longitudinal sectioning of gonads revealed expression located towards the 
periphery of the testis cord, in the region of the Sertoli cells. To verify this 
germ cell-independent expression, the presence of Vanin-1 transcripts was 
examined in gonads homozygous for the extreme allele of dominant 
spotting (W /W). As described in the previous chapter, these mutants lack 
primordial germ cells. Vanin-1 transcripts are present in this mutant, in 
contrast to those from the germ cell marker Oct4 (Figure 5.4). These data
109
\
f  ?
"L
9  / d" '
9 c?
Sox 9
%
% f
B
Sox 9
Figure 5.1
F ig u r e  5 .1  Vanin-1 i s  n o t  e x p r e s s e d  b e t w e e n  1 1 .0  a n d  1 1 .5  d p c
WMISH to detect Vanin-1 expression was performed on a range of 
embryonic gonads from 11.0 to 15.5 dpc. The Sertoli cell marker Sox9 was 
used as a comparison for expression. No expression of Vanin-1 is seen at 
ll.Odpc (arrows) (A), when compared to Sox9. Expression was still not 
detected at 11.5 dpc (arrows) (B).
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Figure 5.2
F ig u r e  5 .2  O n s e t  o f  Vanin-1 e x p r e s s i o n  i s  b e t w e e n  1 2 .0  a n d  1 2 .2 5  d p c
Expression of Vanin-1 is initially observed along the length of the testis (T, 
white arrow) at 12.0 dpc prior to the formation of testis cords. In contrast, 
expression is absent from the ovary (O, black arrow).
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Figure 5.3
F ig u r e  5 .3  E x p r e s s io n  o f  Vanin-1 b e t w e e n  1 2 .5  a n d  1 5 .5  d p c
Using WMISH Vanin-1 expression is observed in the developing testis cords 
(arrow) at 12.5 dpc (A). Expression is observed in the testis cords at 13.5 
dpc and is located towards the periphery of the cord (arrow B), this is more 
clearly visible at higher magnification (Box, B). Continued expression is seen 
in the testis cords at 14.5 and 15.5 dpc (arrows) (0, D). No expression is 
observed in the ovary at these stages.
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Figure 5.4
F ig u r e  5 .4  E x p r e s s io n  o f  Vanin-1 in  g o n a d s  fr o m  W^/W^ h o m o z y g o t e s
RT-PCR analysis of Vanin-1 and the primordial germ cell-specific marker 
Oct4 in gonads dissected from wild-type (+/+) 12.5 dpc embryonic gonads 
give products for each gene (upper gel image). Oct4 is not expressed in 
gonads dissected from 12.5 dpc embryos homozygous for the extreme allele 
of dominant spotting (1/1/®/!/!/®) (lower gel image) due to the absence of germ 
cells. However, these germ-free gonads still express Vanin-1 indicating that 
expression in the testis cords at 12.5 dpc is not germ cell-dependent. RT+, 
PCR template is reverse transcribed gonadal RNA; RT-, template is RNA 
incubated without reverse transcriptase; nt, no template; gDNA, template is 
genomic DNA.
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support the WMISH results and indicate that Vanin-1 is expressed in the 
somatic cells of the testis cords, i.e. the Sertoli cells.
5.5 Isolation and analysis of a Vanin-1 genomic
fragment in transgenic mice
5.5.1 Isolation of a genomic fragment
To isolate sequences which may drive gonadal expression of Vanin-1 a 
genomic fragment containing the first exon of Vanin-1, along with sequence 
5' to it was isolated. A PAC library (available from the HGMP Resource 
Centre, Hinxton) was screened using a PCR-amplified probe from Vanin-1 
exon 1 labelled with ^ ^Pa-dCTP (see appendix A for primer sequences).
Eight PAC clones were identified as positive for this first exon (data not 
shown). To isolate fragments of sub-clonable size containing this exon, these 
PACs were digested with a range of restriction enzymes and again probed 
with the ^^Pa-dCTP-labelled Vanin-1 first exon. A Sad fragment of 
approximately 6Kb, detected in PAC 38 and PAC 562 was chosen to be 
studied further because it was large, but not too large to cause difficulties 
when cloning (Figure 5.5).
This -6Kb Sad fragment was isolated from PAC 562 and cloned into the Sad 
restriction site of the pBluescript plasmid (Stratagene). The inserts from the 
resulting clones were liberated by digestion with Sad and hybridised to a 
radioactively labelled exon one PCR product to ensure the correct fragment
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Figure 5.5
Figure 5.5 Vanin-1 exon one probe detects a 6kb PAC genomic 
fragment
Figure 5.5 shows an autoradiograph of a PAC Southern blot radioactively 
probed with Vanin-1 exon one. This probe detected a Sad fragment (blue 
circle) from 2 PAC clones. This Sad fragment was chosen for ease of 
cloning into pBluescript.
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Figure 5.6 6kb fragment cloned into pBluescript and sequenced
The ~6kb PAC fragment was cloned into the plasmid pBluescript.Ten 
colonies were chosen (Lanes 1-10).
(A) shows an ethidium bromide-stained electrophoresis gel of the 6kb insert 
liberated from the plasmid when digested with Sad. This gel was blotted and 
probed with the radioactively labeled probe of Vanin-1 exon one to confirm 
that this was the correct fragment. One clone (blue circle) was picked for 
further analysis (B).
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had been cloned. Six clones were found to contain the correct insert and one 
of these was chosen for subsequent study (Figure 5.6).
This clone was sequenced using the vector primers T3 and T7 and also the 
first exon primers VnnlF and VnnlR. These latter primers were used to 
verify the presence of exon one in this clone. The Ensembl database 
(Hubbard et al., 2002) was used in order to locate its genomic position which 
revealed it to be 5'of Vanin-1.
The position of exon one within this 6Kb fragment was also determined by 
PCR using the VnnlF or the VnnlR primers together with the vector primers 
(T7 or T3). A product of -1.8Kb was obtained with the combination of 
VnnFl and T7 and one of -4Kb when VnnRl and T3 were used. Hence exon 
one is positioned towards the 3' end of this fragment, with approximately 
4Kb extending upstream of it (5') (Figure 5.7A).
5.5.2 Production of a LacZ reporter construct
The genomic fragment was liberated from pBluescript by Sad  digestion and 
cloned into a Spel restriction site of the LacZ reporter construct pl229 (a gift 
from Dr M. Maconochie, MRC Harwell) using blunt ligation (Materials and 
Methods) (Figure 5.7B). Sad could not be used for cloning as this site 
appears in the LacZ coding region of the construct.
The resulting construct was again cut with various restriction enzymes and 
probed with a ^^Pa-dCTP labelled exon one PCR product to confirm the
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presence of this exon (Figure 5.8). The orientation of this insert in the vector 
was also examined by PCR and confirmed to have exon one immediately 5' 
to the fi globin minimal promoter (data not shown).
This construct was then digested with a combination of Xhol and Xbal to 
liberate the -9  Kb fragment containing the 4Kb and exon one ligated to the 
LacZ reporter gene. The construct was purified and then submitted to the 
Transgenic Facility at MRC Harwell. Four rounds of pronuclear injection 
were performed to generate transgenic mice.
5.5.3 Transgenic mice
Genomic DNA was isolated from tail biopsies of potentially transgenic 
founder mice at 3 weeks of age. This DNA was screened for the presence of 
the Vnn-l:lacZ reporter construct by PCR, using primers /flcZN2F/R (see 
appendix A) which amplify a 5' region of the lacZ gene, to give a 400bp 
product (Figure 5.9A). PCR using primers to amplify a 3'region to test that 
the construct had inserted intact was unsuccessful (data not shown).
In addition to this, the integrity of the genomic DNA was tested by PCR 
using the Vanin-1 exon one primers in order to test for the presence of 
endogenous Vanin-1. In total 101 potential mice were produced, resulting in 
the identification of the following four founders (Table 5.1). These four mice 
were further bred to C57BL/6 wild-type mice, all of which were able to
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Figure 5.7 Orientation of Vanin~1 first exon in the genomic fragment
(A) shows the gel image and schematic localization of exon one in the 
pBluescript subclone. PCR using the primer combinations of T3A/nn1R and 
T7A/nn1 F demonstrated that the first exon is 1.8Kb from the T7 primer, with 
4 Kb 3’ to it. (B) shows a schematic diagram of the reporter construct P1229. 
This fragment was cloned into the Spe I restriction site of this reporter 
construct.
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Figure 5.8 Cloning of genomic fragment into p1229
(A) shows a schematic diagram of the position of the fragment cloned into 
the reporter construct P1229. This genomic fragment was blunt ligated into 
the Spel site of P1229. The resulting construct was cut with various 
restriction enzymes and probed with Vanin-1 first exon PCR product. (B) 
shows the gel photograph and corresponding autoradiograph. One copy was 
located in each digest (except Kp/?1 which did not digest to completion).
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transmit the transgene (Table 5.1). All genotyping and breeding data can be 
found in Appendix C.
Injection round Number of 
progeny
Number 
containing 
transgene by 
PCR
Number passing 
transgene to 
progeny
First 29 l(male) 1
Second/Third 62 0
Fourth 10 3 (2 male, 1 
female)
3
Table 5.1 Transgenic founder mice
Table 5.1 shows a summary of the numbers of injection rounds along with 
the corresponding progeny founders produced, and the numbers of founders 
which were able to pass the transgene to subsequent progeny.
The 3 transgenic founder males and the transgene positive sons of the 
founder female were timed mated to C57BL/6 wild type females to produce 
staged embryos for the detection of lacZ in urogenital ridges. These were 
explanted from the embryos at 13.5dpc. In addition, the remainder of the 
embryo was collected to analyse the expression of the reporter construct in 
tissues outside of the urogenital ridge and to confirm the presence of the lacZ 
gene (Figure 5.9B).
No lacZ expression was observed in embryonic gonads at 13.5 dpc for any of 
the progeny of the founder mice (Table5.2, Figure 5.9C). In all cases embryos 
were positive for the presence of LacZ by PCR (Figure 5.9B).
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Figure 5.9 PCR genotyping potential transgenic mice and LacZ analysis 
of gonads
(A) shows a gel of the PCR results using LacZ primers to detect a 400bp 
fragment of the 3’ region of the gene potentially inserted. Four mice were 
typed as founders: 17, 102, 106 and 107.
(B) shows a gel image of the genotyping results from timed matings, of 
which gonads were taken for LacZ staining. The same lacZ primers were 
used for this. This PCR confirmed the presence of the transgene in this litter 
(embryos 1-7). Primers corresponding to Vanin-1 exon one were used to 
verify the integrity of the DNA used and produced a 200bp PCR product.
(C) shows an example of embryonic gonads stained for the presence of 
LacZ. No gonads at 13.5 dpc were found to express the trangene. DNA and 
tissue from the LacZ expressing mouse ROSA 26 were used as positive 
controls in PCR and X-Gal staining (data not shown). DNA from a 3H1 FI 
hybrid mouse was used as a source of negative control DNA (A).
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Founder X 
C57/BL6
Litters Total number 
male embryos
Total number 
female
X-Gal positive
P17 2 2 13 0
P107 3 9 15 0
PI 06 1 3 7 0
P117(from
female
founder P I02)
2 5 8 0
Table 5.2 LacZ expression in transgenic embryos at 13.5 dpc
Table 5.2 shows a summary of all litters obtained for the study of expression 
of the transgene in male gonads at 13.5 dpc. No gonads exhibited any 
positive expression.
5.6 Discussion
Microarray experiments originally indicated that Vanin-1 expression was 
enhanced in the developing male gonad at 13.5 dpc. This was confirmed by 
WMISH. Detailed expression analysis has revealed that expression is 
initiated immediately prior to overt cord formation at 12.0-12.25 dpc. This 
observation is at slight variance with other published data (Bowles et al., 
2000), where expression was first observed at 11.5 dpc. This difference could 
be due to differences in the strain of mice used or differences in probe and 
hybridisation conditions.
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Expression was also limited to the Sertoli cells of the testis cord, as 
confirmed by the study of sections of WMISH-treated gonads and 
expression analysis in gonads from W /W  homozygote.
As previously stated, Vanin-1 is a GPI-anchored cell-surface molecule 
expressed in thymic epithelial cells and is thought to be involved in the 
homing of bone marrow cells to the thymus. This chapter describes the 
expression of Vanin-1 in an epithelial cell type of the developing testis, the 
Sertoli cell. A role in the regulation of cell migration might exist for Vanin-1 
in this developmental context. It is known that several somatic gonadal cell 
types have their origin in either the mesonephros or ceolomic epithelium 
(Karl and Capel, 1998; Martineau et al., 1997). In the case of three cell types 
(peritubular myoid cell, vascular endothelial cell, and myoepithelial cells) 
migration from the mesonephros occurs before 11.5 dpc in a male-specific 
fashion as an indirect consequence of Sry expression (Martineau et al., 1997). 
It has been suggested that migrating peritubular myoid cell precursors 
might drive testis cord formation via interaction with cells within the gonad 
(Tilmann and Capel, 1999b). The close physical association between 
peritubular myoid cells and Sertoli cells suggests that it is likely that some 
interaction between these two cell types is required for normal cord 
formation. Given the expression of Vanin-1 in the Sertoli cell lineage just 
prior to cord formation and its role in regulating cell homing in other 
contexts, it is possible that Vanin-1 regulates Sertoli cell association with and
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adhesion to migrating myoid cells, either prior to or after migration of 
peritubular myoid cell precursors.
The expression profile of Vanin-1 in the developing testis suggests that it is 
possible that Vanin-1 expression could be regulated by a known sex- 
determining gene product. Hence, isolating any Vanin-1 gonadal enhancer 
elements would be useful in the investigation of the role Vanin-1 might play 
in gonadogenesis. To this end, a genomic fragment containing the first exon 
of Vanin-1 along with approximately 4Kb upstream was cloned into a lacZ 
reporter construct and used in pronuclear injections to generate transgenic 
animals. If any such elements were contained in this fragment, X-Gal 
staining would detect expression in the developing gonads. Unfortunately, 
the fragment isolated did not confer any gonad specific LacZ expression in 
three independent transgenic lines. The conclusion from this is that this 
genomic region does not contain any such elements. Additionally, the 
possibility that the construct did not insert completely intact cannot be ruled 
out.
5.7 Summary
• Vanin-1 is expressed in the Sertoli cells of the developing testis.
• Expression is observed initially immediately prior to overt cord 
formation.
• Based on the expression profile and function of the Vanin-1 gene in 
other contexts, two hypotheses concerning the gonadal role of Vanin-
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the fragment isolated did not confer any gonad specific LacZ expression in 
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genomic region does not contain any such elements. Additionally, the 
possibility that the construct did not insert completely intact cannot be ruled 
out.
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• Vanin-1 is expressed in the Sertoli cells of the developing testis.
• Expression is observed initially immediately prior to overt cord 
formation.
• Based on the expression profile and function of the Vanin-1 gene in 
other contexts, two hypotheses concerning the gonadal role of Vanin-
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1 can be immediately posited. Firstly, it may play a role in regulation 
of mesonephric cell migration into the gonad or, secondly, it may play 
a role in the regulation of Sertoli cell association with myoid cell 
precursors after migration in order to facilitate cord formation. 
However other functions cannot be ruled out. For example, given its 
expression in the supporting cell lineage, Vanin-1 could play a role in 
the development of germ cells.
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Chapter 6: Organ culture studies of Vanin-1 
function
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6.1 Introduction
Vanin-l is a GPI-anchored cell surface molecule originally thought to be 
involved in the homing of bone marrow cells to the thymus. Administration 
of anti-Vanin-1 monoclonal antibody (mAB 407) after sub-lethal irradiation 
of mice inhibits the repopulation of the thymus. It also inhibits the binding 
of pro-T cells to thymic sections. Previous chapters have shown that Vanin-1 
exhibits a sexually dimorphic expression profile in the developing gonad. 
Transcripts are only found in the male gonad and are restricted to the Sertoli 
cells of the testis cords. This expression is first observed at 12.0 dpc, 
immediately prior to overt cord formation.
As mentioned previously, the expression of the sex determining gene Sry is 
required for the supporting cell precursors in the XY gonad to commit to the 
Sertoli cell fate, and therefore to initiate sexual differentiation. However, the 
identity of signals from the Sertoli cells that function in the masculinisation 
of other somatic lineages remains unclear. In addition, how cell-cell 
communication results in the development of testicular morphology is 
poorly understood.
Studies employing in vitro culturing of explanted gonads have shown that 
the development of the characteristic architecture of the testis is dependent 
on the male-specific migration of precursor cells from the mesonephros into 
the gonad (Martineau et al., 1997). This migration is induced by the 
production of a testicular chemoattractant that is dependent on Sry activity
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(Capel et a l, 1999). Other processes required to produce the characteristic 
testicular morphology include increased vascularisation and cell 
proliferation and these are also dependent on Sertoli cell products 
(Martineau et al., 1997; Schmahl et al., 2000). Martineau et al. also 
demonstrate that migratory peritubular myoid cells surround the Sertoli 
cells within the gonad. Sertoli cells and peritubular myoid cells interact to 
from testicular cords, separated by a basement membrane.
Three key observations relating Vanin-1 to testis development can be noted:
1 The location and timing of Vanin-1 expression: it is restricted to the 
pre- Sertoli cells, immediately prior to cord formation.
2 Vanin-1 is a cell surface molecule.
3 Vanin-1 is thought to be involved in thymic homing.
Given these observations, two possible roles for Vanin-1 in male gonad
development stand out:
1 It is required for cell migration from the mesonephros into the male 
gonad.
2 It is involved in the post-migrational organisation of gonadal cells
into testis cords.
Other functions could also be attributed to Vanin-1 also, for example, 
functions relating to germ cell development. However, the association 
between the expression of Vanin-1 and testis cord formation and its
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described role in thymus development both suggest that its putative 
morphogenetic function should be investigated further.
Given the efficacy with which anti-Vanin-1 mAh 407 has previously been 
used to block Vanin-1 thymic function in vitro it was decided to test the 
consequences of blocking Vanin-1 activity in cultured embryonic gonads 
using the same antibody.
Previous studies have demonstrated that male gonads, when cultured, will 
form testis cords at the same rate as in vivo (Brennan et al., 1998; Capel et al., 
1999; Yao et al., 2003). Many established organ culture systems have also 
exploited the use of antibodies to study the effect of protein blocking, most 
notably kidney and lung organ culture studies (Davies et al., 1999; Falk et al., 
1996; Hirai et al., 1992; Schuger et al., 1991; Sorokin et al., 1992; Talts et al., 
1997). However, studying how embryonic gonads react to the presence of 
specific antibodies in culture has not been reported.
6.2 Aim of this chapter
The aim of this chapter is to study the effects of the presence of anti-Vanin-1 
monoclonal antibody (mAb 407) on the normal development of the 
embryonic male gonads when explanted into culture, in comparison to 
gonads cultured without mAb 407 or in the presence of a non-specific 
antibody.
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6.3 Strategy
• mAb 407 was used in an immunohistochemical analysis of 
cryosections of developing gonads in order to show that this antibody 
detected Vanin-1 in a similar pattern to transcripts seen in WMISH.
• Urogenital ridges (UGRs) of approximately 11.5 dpc, prior to overt 
cord formation, were dissected and sexed. Each UGR was cut in two 
and one gonad/mesonephros pair was placed in culture containing 
mAb 407, the other was placed in a control culture containing no 
antibody or containing mAb 31.9 (Figure 6.1). This antibody was 
generated in the same way as mAb 407 and was part of the same 
original screen.
• Cultures were incubated for 48 hours with one change of media. After 
this period they were scored according to how efficiently they formed 
testis cords: 0 = no cord formation; + = partial cord formation; and ++ 
= full cord formation.
• The efficiency of cord formation was also assessed by performing 
WMISH and immunohistochemistry using various cell markers found 
in the developing testis.
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Figure 6.1
F ig u r e  6 .1  O r g a n  c u lt u r e  s t r a t e g y
Figure 6.1 shows a schematic diagram describing the organ culture strategy. 
Each male UGR is cut in two, one gonad/mesonephros pair incubated in 
agar grooves in the presence of mAb 407 and the other in a control dish. 
Cultures are incubated for 48 hours during which time gonad development 
proceeds.
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6.4 Results
6.4.1 mAb 407 detects Vanin-1 in a similar pattern to
WMISH
On receipt of the anti-Vanin-1 monoclonal antibody (a kind gift from P. 
Naquet), it was tested in order to verify its ability to detect Vanin-1 on 
sections of male and female gonads, and thereby also to confirm the sexually 
dimorphic expression of Vanin-1 protein in the developing gonad. 
Cryosectioned tissue from developing male and female gonads was 
incubated with mAb 407 for 45 minutes and then with anti-mouse FITC IgG 
for a further 45 minutes. Staining was visualized under ultraviolet light. 
Expression of Vanin-1 protein reflects the expression pattern of Vanin-1 
transcripts (Figure 6.2). Protein is localised in the developing testis cords at
12.5 dpc (Figure 6.2B), and is concentrated towards the periphery of the 
testis cord at 13.5 dpc (Figure 6.2C). At 15.5 dpc Vanin-1 continues to be 
expressed in a sexually dimorphic manner, with protein found in the Sertoli 
cells of the testis cords, (Figure 6.2D). No expression is observed in the 
developing ovary (left panel Figure 6.2).
6.4.2 Expression of mAb 31.9, a non-specific 
monocionai antibody
To show that any effects on the development of male gonads in culture is not 
due to any general effect of adding extra molecules into the culture media.
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Figure 6.2 mAb 407 immunostaininq results in a similar pattern to 
WMISH analysis using Vanin-1 riboprobe
Figure 6.2 shows immunostaining results on gonads using mAb 407. No 
staining is seen in either the developing ovary or testis at 11.5 dpc (A). At
12.5 dpc mAb 407 detects protein in the developing testis cords (B). At 13.5 
dpc this staining is concentrated towards the periphery of the testis cords (T, 
arrow, magnified in box) (C). This pattern is also seen at 15.5 dpc (D). No 
significant staining is observed in the developing ovary at any stage (left 
panel), or with secondary antibody alone (data not shown).
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and to assess any effect of the addition of antibodies with a similar structure, 
mAb 31.9 was added to a subset of culture experiments.
This antibody originated in the same laboratory as mAb 407, and was 
generated as part of the same screen which isolated mAh 407 and hence was 
also a gift from P.Naquet. Binding of mAh 31.9 was investigated in 
cryosectioned embryonic male gonads at 13.5 dpc. No expression was 
detected in either the gonad or mesonephros (Figure 6.3).
6.4.3 Visual assessment of cord formation in culture
Cultures were set up according to the strategy laid out in Figure 6.1. 
Urogenital ridges were dissected at 11.0-11.25 dpc (corresponding to 17-21 
tail somites) into single wells. They were stored on ice in culture media as 
described in section 2.17 whilst the sex was determined. Male UGRs were 
kept and dissected into gonad/ mesonephros pairs. Initially, cultures were 
set up to assess the efficiency of this culture method on the development of 
testis cords. Under these conditions typically 80-85% of male UGRs formed 
testis cords (Figure 6.4A).
6.4.4 Test cultures
During test cultures, one pair was placed in culture along with mAb 407, 
and the other either with mAh 31.9 or in an antibody-free control. After 
approximately 48 hours, cultured gonads were scored for cord formation.
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The clear presence of well formed cords was scored as partial cord
formation as and "0" denotes a complete absence of cords (Figure 6.4 B, 
C,D).
6.4.5 Organ culture assays: scoring effects by visual 
inspection
Nine independent experiments were performed. In these experiments there 
was a significant effect on the ability of gonads cultured in the presence of 
mAb 407 to form testis cords in comparison to controls (Figure 6.5). 
Experiments 1-6 show a distinct trend: cords form in most cases in the 
absence of mAb 407 but there is a complete failure to do so in its presence. 
However, experiments 7-9 exhibited a less marked effect: a subset of gonads 
form testis cords in the presence of the antibody (Figure 6.6).
To determine whether this was due to failure of the antibody to penetrate 
the tissue, these gonads were frozen, sectioned and treated with secondary 
antibody (Figure 6.7). In all cases signal was observed within the testis cords, 
excluding lack of penetration as an explanation. In the case of those gonads 
that failed to form cords, secondary antibody treatment revealed presence of 
mAb 407 throughout the gonad (data not shown).
One possible explanation is that these gonads were slightly older when put 
into culture and hence cord formation had already been initiated at the start 
of the culture period.
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Figure 6.3
Figure 6.3 Binding of mAb 31.9 at 13.5 dpc
Figure 6.3 shows immunostaining results using the mAb 31.9, a non-specific 
monoclonal antibody on a gonadal section at 13.5 dpc. No expression is 
seen in either the testis (T) or mesonephros (M) of the male gonad.
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Figure 6.4 Initial cultures and cord formation: Score
Figure 6.4 (A) shows the percentages of gonads which either form testis 
cords, show a partial formation, or no cord formation after in vitro culture for 
48 hours. Typically, over 80% of male gonads when cultured under the 
conditions described in section 2.18 and 6.3 will form testis cords.
Figure 6.4 (B, C and D) show photographs taken under a light microscope of 
gonads cultured for 48 hours. When testis cords are clearly visible (arrow) 
they are scored ++ (B). Cultures are scored + when some signs of cord 
formation are apparent, but with no obvious cords forming (0). When no 
cords form cultures are scored as 0 (D).
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6.4.6 Markers used in the analysis of cultured gonads
To determine whether those gonads that had failed to form cords exhibited 
any other signs of abnormal gonadal differentiation, the expression of three 
lineage markers indicative of testicular differentiation was studied.
Sox9 is a marker of Sertoli cells (da Silva et al., 1996; Kent et al., 1996), Oct4 is 
a marker of primordial germ cells (Pesce et al., 1998), both of which are 
located in the testis cords, and SfiHSD is a marker of interstitial Leydig cells 
(Vainio et al., 1999) (Figure 6.8).
6.4.7 Marker analysis of cultured gonads
Examination of control gonads that had formed cords normally in culture 
indicated that all three markers were expressed in the appropriate region of 
the testis. However, gonads that had failed to form testis cords in culture in 
the presence of mAh 407 also gave positive signals for all three markers, but 
in all cases cells showing expression were apparently not organised into 
cord-like structures. In control cultures, Sox9 expression is located towards 
the periphery of the testis cords (Figure 6.9A), whereas in test cultures 
expression is more random (Figure 6.9B). Oct4 also exhibits normal 
expression in control cultures (Figure 6.10A) with transcripts in the centre of 
the cords.
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Figure 6.5 Effect of culturing XY gonads in the presence or absence of 
mAb 407: experiments 1-6
Figure 6.5 shows a bar chart incorporating the actual numbers of gonads 
placed in culture in the presence and absence of mAb 407. The first half of 
the graph shows results of adding the antibody. Adding mAb 407 inhibits 
testis cord formation in culture, as the majority of gonads do not form testis 
cords after 48 hours in culture. This effect is most marked in experiments 1- 
6. In contrast the second half of the graph shows the effects of culturing the 
other half of the UGR without mAb 407. Here the majority do form testis 
cords.
Chi-square was calculated for all experiments as 41.86 (df=2
P=0.00000000081), revealing a significant difference between cord forming 
ability in the presence and absence of mAb 407.
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Figure 6.6 Effect of culturing XY gonads in the presence or absence of 
mAb 407: experiments 7-9
Figure 6.6 shows a bar chart of the culture results in three further culture 
experiments. In these three experiments this effect was less marked. Cords 
formed in gonads cultured in the presence of mAb 407 as can be seen in the 
first half of the graph, though in a reduced capacity.
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Figure 6.7
F ig u r e  6 .7  D e t e c t io n  o f  m A b  4 0 7  in  c u l t u r e d  g o n a d s
Figure 6.7 shows immunostaining results of a cultured gonad which formed 
testis cords in the presence of mAb 407. Using the secondary antibody 
alone, mAB 407 was detected in this gonad and was localised to the testis 
cords (arrow).
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Figure 6.8
F ig u r e  6 .8  T h r e e  c e l l  m a r k e r s  o f  t e s t i s  d e v e l o p m e n t
The pattern of expression of various testicular cell markers by WMISH on 
male gonads at 13.5 dpc is shown. Sox9, a Sertoli cell marker, is expressed 
in the testis cords. Longitunal sections show how this staining is seen as a 
smooth edge around the periphery of the testis cords in the region of the 
Sertoli cells (A). Oct4, a primordial germ cell marker, is expressed in the 
germ cells in the centre of the cord. Longitudinal sections of this gonad 
reveal expression to be located towards the centre of the cord without the 
smooth edge seen in Sox9 stained gonads (B).3flhsd, a marker of Leydig 
cells, is found in the interstitium, between the testis cords. These cells can 
clearly be seen outside the testis cords in longitudinal sections (C).
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In test cultures, expression is again randomly distributed (Figure 6.1 OB). In 
control cultures 3^HSD-positive cells appear as lines (Figure 6.11A). In 
sections of control cultures, expressing cells are distributed randomly 
(Figure 6.11B).
These data suggest that the ability of the gonads to form differentiated 
testicular cell-types has been unaffected by the presence of the mAb 407. 
However, it can be seen that there is a loss of male pattern in treated gonads. 
The failure of cords to form is confirmed by the loss of the distinct pattern of 
expression by testicular cell markers.
6.4.8 Effects of mAb 407 on the formation of the 
basement membrane
As the testis develops, cords become organised within it. Germ cells are 
surrounded by Sertoli cells; peritubular myoid cells surround the Sertoli 
cells and are separated from them by a basal lamina. Indeed, cooperativity 
between Sertoli cells and peritubular myoid cells probably occurs in order to 
produce and deposit this basement membrane (Tung and Fritz, 1987; Tung 
et al., 1984). One key component of a basement membrane is laminin. 
Therefore, the pattern of laminin expression was examined in gonads 
cultured in the presence of mAb 407.
Initially, laminin expression was examined in 13.5 dpc gonads. A 
concentration of protein is seen at the edge of the testis cord, corresponding 
to the presence of a basal lamina (Figure 6.12A).
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Figure 6.9
F ig u r e  6 .9  E x p r e s s io n  o f  Sox9  in  c u l t u r e d  g o n a d s
Figure 6.9 shows WMISH analysis on gonads cultured in the presence and 
absence of mAb 407. Sox9 is expressed in the cords which develop in 
control cultures. Expression is observed mainly at the periphery of these 
cords (A) Transcripts are still detected in test cultures, however, expression 
is seen throughout the gonad (B).
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Figure 6.10
F ig u r e  6 .1 0  E x p r e s s io n  o f  Oct4 in  c u l t u r e d  g o n a d s
Oct4 expression analysis by WMISH on test and control gonads cultured in 
the presence or absence of mAb 407 is shown. Oct4 can be detected in the 
centre of the testis cords in control cultures (A, arrow).
This pattern of expression is lost in test cultures, with transcripts found 
throughout the length of the gonad (B).
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Figure 6.11
F ig u r e  6 .1 1  E x p r e s s io n  of 3RHSD in  c u lt u r e d  g o n a d s
3Hhsd expression analysis by WMISH on gonads cultured in the presence 
and absence of mAb 407 is shown. The area at the anterior end of the 
gonad exhibiting high levels of expression corresponds to the adrenal gland 
which is present in these cultures (white arrow). Expression in the gonad is 
also concentrated between the testis cords (black arrows) in control cultures 
(A).This pattern is lost in test gonads and positive cells are distributed 
randomly (B).
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In female gonads no such organisation of expression is seen although 
discrete zones of expression are observed (Figure 6.12B).
When gonads were cultured either in control media alone, or in the presence 
of mAh 31.9, the pattern of laminin protein localisation is similar to that 
noted in 13.5 dpc male gonads (Figure 6.13A, B). However, when gonads are 
cultured in the presence of mAb 407, this pattern is lost and the protein 
becomes localised to the periphery of the gonad (Figure 6.13C).
6.4.9 Effects of mAb 407 on migratory cell-types
From the above results two points can be concluded:
1- Anti-Vanin-1 antibody inhibits cord formation in XY gonad 
cultures.
2- Affected male gonads continue to differentiate testicular cell types 
as defined by marker gene expression but these are disorganised.
Two possibilities can account for this loss of testis cord formation in vitro:
1- Blocking of Vanin-1 by mAb 407 could affect the efficiency of 
mesonephric cell migration into the gonad, a requirement for testis 
cord formation.
2- Blocking of Vanin-1 function could be affecting the post- 
migrational organisation of gonadal cells into testis cords.
Several studies have shown that cell migration from the mesonephros is 
required for the development of testis cords.
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Figure 6.12
F ig u r e  6 .1 2  L a m in in  l o c a l i s a t io n  in  1 3 .5  d p c  g o n a d s
Immunostaining results are shown using an antibody to detect iaminin of 
cryosections of gonads at 13.5 dpc. Expression of iaminin is concentrated 
around the edge of the testis cords (white arrow, A). Some generalised 
expression is seen between the testis cords; however, the testis cord itself 
has a complete absence of signal (T). Laminin expression in the ovary is 
also in a well organised pattern (B).
T, testis cord; O, ovary.
149
r% w
B
• *
:\.-
.  Xi >. \
Figure 6.13
F ig u r e  6 .1 3  L a m in in  a n t ib o d y  s t a in in g  o f  g o n a d  c u l t u r e s
Immunostaining results are shown using an antibody to laminin on gonads 
cultured in the absence or presence of mAb 407. In gonads cultured in the 
absence of mAb 407 laminin protein expression is localised to the outside of 
the testis cord in a similar pattern to expression seen in 13.5 dpc male 
gonads (A).This can be clearly seen at a higher magnification (B). This 
expression pattern is lost in gonads cultured in the presence of mAb 407 
with expression concentrated towards the periphery of the gonad (white 
arrow).
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One cell-type which migrates.into the gonad from the mesonephros and is 
critical for cord formation is the peritubular myoid cell (PMC) (Merchant- 
Larios et al., 1993).
To date no definitive marker for peritubular myoid cells exists. Therefore, 
the expression of two potential markers of PMC's was studied in gonads 
cultured in the presence and absence of mAb 407.
6.4.9.1 p75NTR: a marker of peritubular myoid cells?
Mesenchymal cells that migrate from the mesonephros into the gonad to 
form PMCs can be identified by the presence on their surface of the p75 
neurotrophin receptor (p75NTR) (Campagnolo et al., 2001). p75NTR-positive 
cells appear to migrate from the mesonephros into the male gonad: these 
cells do not appear in the gonad unless a mesonephros is attached. 
Furthermore, p75NTR-positive cells differentiate into myoid cells in vitro 
(Campagnolo et al., 2001).
Expression of p75NTR was studied at 12.5 dpc and 13.5 dpc in male gonads 
using a polyclonal antibody. It can be seen that localisation of the protein 
was observed between the testis cords, in the area associated with the 
localisation of PMCs (Figure 6.14 A, B). PMCs are located around the edge of 
the Sertoli cells; however p75NTR does exhibit a more widespread pattern 
indicating that other interstitial cells may be positive for this marker. No
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immunofluoresence was observed in sections treated with secondary 
antibody alone (data not shown).
Gonads cultured in the presence and absence of mAb 407 were stained with 
anti-p75NTR (Figure 6.15). In control gonads (where no mAb 407 was 
added) p75NTR expression was localised around the testis cords in the 
interstitium. Staining was absent from the cords, as indicated by the 
corresponding expression of alkaline phosphatase, a marker of germ cells, in 
adjacent sections (Figure 6.15A). However, the staining pattern seen in 
cultures incubated with mAb 407 was markedly different, and was restricted 
to the very edges of the gonad, and completely absent from the centre. The 
appearance of such cord-free male gonads is reminiscent of one very large 
testis cord (Figure 6.15B).
6.4.9.2 Expression of Patched-1 in gonad cultures
Patched-l (Ptc-1) is expressed in both peritubular myoid cells (Bitgood et al., 
1996; Clark et al., 2000) and Leydig cells (Yao et al., 2002). It is the receptor of 
Desert Hedgehog, which itself is expressed in Sertoli cells. Expression of Ptc- 
1 was examined in control and test gonad cultures. In control cultures 
(Figure 6.16A), expression is found between the testis cords in the region 
where peritubular myoid cells are located; this can be clearly seen in cross 
section.
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BFigure 6.14
F ig u r e  6 .1 4  L o c a l i s a t io n  o f  p 7 5 N T R  in  1 2 .5  a n d  1 3 .5  d p c  m a le  g o n a d s
Figure 6.14 shows immunostaining of male gonad sections at 12.5 and 13.5 
dpc with an antibody to p75NTR. Expression is observed around the 
developing testis cords at 12.5 dpc (A). Expression is still confined to the 
interstitium in the male gonad at 13.5 dpc (B), but this expression is more 
widespread than the location of peritubular myoid cells.
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Figure 6.15 p75NTR staining of gonad cultures
Immunostaining using p75NTR antibody on sections of gonads cultured in 
the absence and presence of mAb 407. p75NTR was located outside 
developed cords in control cultures (A,right). Areas where staining was 
absent corresponded to cords, as demonstrated by adjacent sectioned 
stained for alkaline phosphatase. Alkaline phosphastase is a marker of germ 
cells (A and B, left). Absence of staining corresponds to the presence of 
cords (arrows right A). In gonads cultured in the presence of mAb 407, 
p75NTR is located around the edges of the gonad. No staining is observed 
in the centre of the gonad, corresponding to alkaline phosphatase positive 
cells (B, left).
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BFigure 6.16
F ig u r e  6 .1 6  E x p r e s s io n  o f  Ptc~1 in  c u l t u r e d  g o n a d s
Expression of Ptc-1 was detected in gonads cultured in the absence and 
presence of mAb 407 using WMISH. Expression in control cultures is 
concentrated around the outside of the cords, as seen in both wholemounts 
and sections of whole gonads (arrows A). Expression in gonads cultured in 
the presence of mAb 407 appears to be concentrated around the edges of 
the whole gonad. Isolated cells expressing Ptc-1 can be seen (circles) that 
may correspond to the location of Leydig cells (B).
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Inspection of wholemount expiants suggests expression throughout the 
length of the test gonad, in a similar manner to Sox9, and Oct4. However, 
sectioning of these gonads reveals this expression to be concentrated at the 
edges of the gonad, in a similar manner to the pattern of p75NTR expression. 
Isolated Ptc-1 expressing cells can be observed within the body of the gonad, 
and these may correspond to the presence of Leydig cells (Figure 6.16B).
6.4.9.5 Expression of PECAM in cultured gonads
Another cell type which migrates specifically into the male gonad from the 
mesonephros is the endothelial cell (Martineau et al., 1997). It has been 
shown that these cells contribute to the male-specific vasculature of the 
developing testis (Brennan et al., 2002), namely the prominent coelomic 
vessel and interstitial vessels.
Platelet endothelial cell adhesion molecule (PECAM) labels endothelial and 
germ cells and was therefore used here to study the effects of mAb 407 on 
endothelial cell migration into cultured gonads (Figure 6.17). Firstly, an anti- 
PECAM-1 monoclonal antibody was used to examine PECAM expression in
13.5 dpc male gonad explants (Figure 6.17A) where it detected two distinct 
types of positive cell. High levels of expression were associated with the 
endothelial cells of the coelomic vessel (black arrow in Figure 6.17A) and 
particular interstitial cells (pink arrow in Figure 6.17A) around the edge of 
testis cords. The latter presumably derive from endothelial cells of interstitial
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blood vessels. Lower levels of expression were detected in germ cells of the 
testis cords (white arrow in Figure 6.17A). These quantitatively distinct 
expression types were therefore used as indicators of the presence of 
endothelial (high) or germ cells (low) in cultured gonads. In gonads cultured 
in the absence of mAb 407, cells expressing at high levels (black arrow in 
Figure 6.17C control) and low levels (white arrow in Figure 6.17C control) 
were observed in the gonad in a pattern similar to 13.5 dpc male explants. In 
contrast, mAb 407-treated gonads showed almost exclusively low-level 
expressing cells in the gonad (white arrow in Figure 6.17C), whilst high-level 
expressing cells were confined to the edge of the gonad in the position of the 
coelomic vessel (black arrow in Figure 6.17C). These data suggest that 
endothelial cells are excluded from the main body of the gonad in mAb407- 
treated male gonads.
6.5 Discussion
When male gonads are explanted into organ culture, subsequent 
development of testis cords occurs at the same rate as development in vivo. 
Data described in this chapter suggests a role for Vanin-1 in the formation of 
testis cords. Blocking its function by the addition of a monoclonal antibody 
to Vanin-1 disrupts this process in vitro. A  clear trend can be seen in these 
experiments: addition of mAb 407 disrupts cord formation in the developing
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Figure 6.17
Figure 6.17 Expression of PECAM-1
Immunostaining results are shown using an antibody to PECAM-1 on 
sections of 13.5 dpc male gonads and gonads cultured in the absence and 
presence of mAb 407. PECAM-1 marks both endothelial and germ cells. 
Stronger staining can be seen in the interstitium of gonads at 13.5 dpc 
corresponding to endothelial cells of the coelomic vessel and interstitium (A 
black and pink arrows respectively), whereas weaker expression is seen in 
the testis cords corresponding to germ cells (A white arrow). No staining is 
seen in gonads treated with secondary antibody alone (B). In gonads 
cultured without mAb 407 endothelial (black arrow) and germ cell 
immunostaining (white arrow) can be seen in the gonad (C). In gonads 
cultured in the presence of mAb 407 the weaker germ cell staining can be 
observed in the gonad (white arrow) whereas the stronger endothelial 
staining is restricted to the edges (black arrow) (C).
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male gonad, with only occasional instances in which cords form successfully 
in the presence of antibody or fail to form in untreated controls. Previous 
studies have demonstrated similar sliding scales of success in cord formation 
in culture, depending on the precise age of the gonad (Tilmann and Capel, 
1999b).
The patterns of various testicular cell markers show a distinct alteration in 
test cultures. The two markers of cord cell types, Sox9 (a Sertoli cell marker) 
and Oct4 (a primordial germ cell marker), are expressed throughout the 
gonad and no cord-like pattern is observed. In contrast, two markers of 
migratory peritubular myoid cells, which are normally located in between 
the cords, are limited to the outer edge of the gonad, and do not migrate into 
the centre of the gonad. Additionally, analysis of the endothelial cell marker
PECAM suggests that endothelial cells are also limited to the edges of mAb 
407-treated gonads.
As mentioned earlier, two possible functions of Vanin-1 in the development 
of the testis come into focus in the context of Vanin-1's expression profile 
and protein function:
1- It could be involved in the migration of cells from the 
mesonephros into the gonad, a process required for testis cord 
formation.
2- It could be involved in the post-migrational organisation of cells 
into testis cords.
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The data presented here appear to support the first of these hypotheses. 
Male-specific cell-types that have their origin in the mesonephros are not 
found in the body of the gonad in samples that are cultured in the presence 
of mAb 407. However, it remains a possibility that such cells have been 
actively excluded after successful migration: it would be necessary to test 
cultured gonads at a variety of time-points to exclude this possibility.
A direct assay for defects in migration from the mesonephros caused by 
blocking Vanin-1 in vitro has already been performed. At a meeting in 2002, 
it was reported that anti-Vanin-1 mAb 407 can inhibit cell migration from the 
mesonephros into the male gonad (Koopman et al., 2002). In these 
unpublished experiments, mAb 407 was added to co-cultures of GFP- 
expressing mesonephroi and wild-type gonads. GFP-positive cells were 
excluded from the gonads in theses cultures, in contrast to controls. The data 
presented in this chapter can be seen to support these independent 
observations. Markers of PMCs and endothelial cells suggest that, whilst 
precursors of these cell-types migrate from the mesonephros, they tend to 
remain on the gonadal surface, beneath the coelomic epithelium, rather than 
entering the central body of the gonad.
It is worth pointing out that none of the markers used to identify these 
migratory cell-types is perfect, and some interpretation is required to 
support these conclusions.
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6.6 Summary
• When mAh 407 is added to male gonads in culture they fail to
develop testis cords, in contrast to control cultures which develop 
them at the same rate as in vivo.
• These cultures are positive for various markers of testicular 
development but no organisation of cells into testis cords has 
occurred. They develop as cord-free testes.
• Markers of migratory PMCs and endothelial cells are also present, 
although only at the surface of the gonads: cells do not seem to 
penetrate the body of the gonad.
• These data seem to suggest that some form of defective mesonephric 
cell migration is the basis of the cord-free testis development in mAh 
407-treated XY gonads.
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Chapter 7: Analysis of gonadal development 
in embryos lacking Vanin-1
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7.1 Introduction
The previous chapter demonstrated how the blocking of Vanin-1 function 
using mAb 407 disrupts testis cord formation in vitro. Results suggest that 
cords fail to develop, either by the inhibition of cell migration from the 
mesonephros into the gonad, or by the inability of cells to organise and 
associate with one another to form testis cords.
In order to determine the physiological role of Vanin-1 in vivo it is necessary 
to examine mice lacking the protein. Mice homozygous for a null allele of 
Vanin-1 ( Vanin-1 -/- mice or Vanin-1 null mice) were generated in the 
laboratory of Philippe Naquet (Pitari et al., 2000).
Briefly, the first exon containing the ATG initiation codon and 2 kb of 5' 
upstream promoter sequence was replaced by the neomycin gene, 
oppositely oriented thus preventing Vanin-1 transcription (Figure 7.1). This 
results in the generation of a 4.3kb fragment after H indlll digestion and a 
longer PGR fragment (Pitari et al., 2000).
Pitari et al. demonstrated that there was a complete absence of Vanin-1 
transcription and protein production in the kidney, where it is normally 
expressed. This was confirmed by Northern blot, RT-PCR and Western blot 
analysis. Furthermore, Vanin-1 is not expressed in the gonads of Vanin-1 -/- 
homozygotes at 13.5 dpc (Figure 7.2).
From their initial analysis they concluded that this Vanin-1 null mouse has 
no major general or lymphoid developmental defects under physiological
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conditions. However, they did conclude that these mice lack a pantetheinase 
function. Pantetheinase is a membrane-bound enzyme which catalyses the 
hydrolysis of D-pantetheine to produce cysteamine and pantothenic acid in 
vitro. Pantetheinase activity is found in many tissues, however, its biological 
role has not been studied in vivo. Pitari et al reported that Panm-jf-deficient 
mice lack pantetheinase activity in the kidney and liver. Consequently, these 
mice also lack free cysteamine, which is a powerful anti-oxidant. The 
putative function of Vanin-1 was discovered in the context of thymic 
reconstitution following sub-lethal irradiation, which generates free radicals. 
Because the null mouse has no major immune defects under normal 
condition, the importance of Vanin-1 might only be revealed under stress, 
for example, irradiation, oxidative or inflammatory stress.
As mentioned previously, cysteamine is a powerful anti-oxidant; and is a 
key regulator of essential metabolic pathways. However, the physiological 
importance of cysteamine is still not understood. One enzyme, y- 
glutamylcsteine synthase (y-GCS), catalyses the key step in glutathione 
(GSH) synthesis. This enzyme plays a role in protecting cellular components 
from toxic species.
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Figure 7.1 Generation of Vanin~1-deficient mice
A: Map of the construct used for the homologous recombination in ES cells. 
Arrows indicate the transcriptional orientation of the neomycin and HSV-tk 
genes. Double-head arrows indicated the size of the restriction fragments 
obtained by Southern blot analysis on a Hin6\\\ digest of genomic DNA from 
wild type or targeted alleles. The position of the 3' probe is underlined. The 
result of the recombination event was checked by Southern blot (B), PCR 
(C) and Northern blot on kidney RNA (D). The Vanin-1 gene deficiency was 
confirmed by the loss of the Vanin-1 protein in kidney visualized by Western 
blot (E) or immunochemistry (F). C: cortex; M: medulla; the arrow indicates a 
Vanin-1-positive cortical tubule whereas arrow-heads show Vanin-1 negative 
glomerul. From Pitari et al. (2000).
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Vanin-1 null mice lack free cysteamine and have subsequently been shown 
to exhibit an improved response to intestinal inflammation (Martin et al., 
2004). Null mice were tested for their response to acute and chronic 
infection, and in both cases Vanin-1 -/- mice controlled the inflammatory 
response better than controls. When -/- mice were subjected to intestinal 
injury they exhibited a greatly reduced number of intestinal haemorrhages 
compared to wild-types. In addition, transcripts associated with 
inflammatory cell activation were barely expressed compared to wild type 
mice. Higher GSH levels were found in Vanin-1 -/- mice compared to wild- 
types; this corresponded to an increased y-GCS synthesis in the liver and 
intestine. In vitro studies show that cysteamine down-regulates y-GCS 
activity. The investigations of Martin et al (Martin et al., 2004) give similar 
results in vivo. Undetectable pantetheinase activity and cysteamine levels in 
Vanin-1 -/- mice are associated with higher y-GCS activity in the liver; 
furthermore, administration of cysteamine reduced enzyme activity to wild- 
type amounts. One cysteamine function is to up-regulate inflammation. 
Therefore Vanin-1 can be classed as a regulator of intestinal inflammation, 
via its regulation of cysteamine release.
P.Naquet et al observed no changes in the sex ratio or fertility of the Vanin-1 
null mouse, two indicators of major defects in gonad development.
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7.2 Aim of this chapter
The first aim of this chapter is to study testis development in the Vanin-1 -/- 
mouse, by comparing morphology and gene expression in Vanm-l-deficient 
and wild-type gonads at 13.5 dpc. This stage was chosen because testis cords 
have developed a highly regular structure at this point and it is only 
approximately 30 hours after the onset of Vanin-1 expression.
Another aim of this chapter is to study the effects of in vitro culture on 
gonads explanted from the Vanin-1 null mouse, for two reasons. Firstly, 
because Vanin-1 was discovered in the context of thymic reconstitution 
following sub lethal irradiation, it can be concluded that its importance 
might be revealed under stress conditions. The general effect of the stress of 
culture was examined to see if male gonads from the null mouse could form 
testis cords under culture conditions. Secondly, in order to test the 
specificityof mAb 407, it was added to cultures of XY Vanin-1 null gonads in 
order to determine whether testis cord formation is affected. If no effect is 
seen, it can be concluded that the effect of the antibody is mediated 
specifically by its effect on Vanin-1.
Another member of the Vanin family, Vanin-3, exists in the mouse. The role 
of this molecule in possible compensation for loss of Vanin-1 activity was 
also studied.
The effect of the genetic background on testis development can be important 
(Albrecht et al., 2000) and therefore the effects of changing the background
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Figure 7.2
Figure 7.2 No Vanin~1 expression is observed in Vanin-1-/- gonads at
13.5 dpc
WMISH was performed on gonads homozygous for a null allele of Vanin-1 
and wild-type BALB/c gonads. No Vanin-1 transcripts are observed in male 
and female gonads of Vanin-1-/- mice at 13.5 dpc. Longitudinal sections 
confirmed this lack of expression (A). Wild-type (BALB/c) gonads exhibit 
expression in the testis cords. Longitudinal sectioning of these gonads 
revealed that this expression is located at the periphery of each cord, in the 
region of the Sertoli cells (B).
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of the homozygous mutants from BALB/c to C3H/HeH has been 
investigated.
7.3 Strategy
• WMISH was used to compare the expression of various testicular cell 
markers between Vanin-1 null and BALB/c mice. Vanin-1 -/- mice are 
kept as a homozygous colony on a BALB/c background, and hence a 
separate colony of wild-type mice was needed for all comparisons.
• 11.5 dpc male gonads from the Vanin-1 null were placed into culture 
in the presence and absence of mAb 407 to observe their development 
in vitro. The expression of testicular markers was examined in these 
cultures.
• The expression of Vanin-3 in wild-type and null mice was studied by 
WMISH and RT-PCR.
• The Vanin-1 null mutation was back-crossed onto the C3H/HeH 
background for 5 generations. At this stage, inter-crosses were 
performed in order to generate homozygous mutants.
7.4 Results
7.4.1 WMISH studies
Various testicular cell markers were used to compare gonads from male 
Vanin-1 -/- and BALB/c mice at 13.5 dpc. The Leydig cell markers 3flHSD 
and P450 Side Chain Cleavage enzyme ( See) (Rouiller et al., 1990) both
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exhibit a pattern i n - / -  embryonic gonads comparable to that seen in wild- 
type BALB/c mice (Figure 7.3 A, B) although expression can be seen to be 
slightly less intense in the BALB/c mice. This can also be observed in 
younger wild-type and -/-  gonads at approximately 13.0 dpc (Figure 7.4 A, 
B). This difference in intensity is likely to be due to the slight difference in 
developmental stage that exists between the Vanin-1 -/- and wild-type 
gonads.
The hedgehog receptor Patched-1 (Pfc-1), a marker of peritubular myoid 
cells (PMCs) and Leydig cells also exhibits a pattern that is essentially the 
same as that seen in BALB/c wild-type embryos, but with a slightly lower 
intensity (Figure 7.3, A, B, Figure 7.4 A, B). Longitudinal sections also reveal 
this expression pattern (Figure 7.5) at 13.5 dpc. p75NTR, another potential 
marker of PMCs, again showed expression that is slightly more intense 
compared to BALB/c gonads at 13.5 dpc (Figure 7.6).
To see if this differing expression intensity for several markers is reflected in 
other genes in the same pathway as Pfc-1, expression of Desert Hedgehog 
(Dhh) was investigated. Dhh is the ligand of Ptc-1 and is expressed in the 
Sertoli cells from 11.5dpc onwards (Bitgood et al., 1996). Dhh expression can 
be seen to be comparable in pattern and intensity between BALB/c and 
Vanin-1 -/- gonads at 13.5 dpc (Figure 7.7).
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Figure 7.3 Interstitial marker analysis in Vanin-1 -A and +/+ embryonic 
male gonads
WMISH analysis of various interstitial cell markers on Vanin-1-/- gonads and 
wild-type BALB/c gonads at 13.5 dpc are shown. 3flhsd a marker of Leydig 
cells shows a similar expression pattern to wild-type male gonads, though 
with slightly less intensity with expression confined to cells of the interstitium
(A). This is also seen with another Leydig cell marker See (B) and Re-1, a 
marker of PMCs and Leydig cells (0).
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Figure 7.4 Expression of interstitial cell markers at 13.0 dpc
WMISH analyses of interstitial cell markers on Vanin-1-/- and wild-type 
BALB/c male gonads at 13.0 dpc are shown. Expression of 3Hhsd (A), See 
(B) and Re-1 (C) at 13.0 dpc also reveals a comparable expression pattern 
which is slightly less intense in wild-type gonads.
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Figure 7.5 longitudinal sections of gonads stained for interstitial cell 
markers after WMISH
Longitudinal sections of male gonads at 13.5 dpc stained for interstitial cell 
markers are shown. Expression of 3Hhsd (A), See (B) and Re-1(C) in 
sections confirms the WMISH data. 3Hhsd and See exhibit similar expression 
patterns with transcripts located in the Leydig cells. Pte-1 expression is 
more extensive and is located in both Leydig and peritubular myoid cells.
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Figure 7.6 p75NTR expression in sections of Vanin-1 -A and BALB/c 
male gonads
Immunostaining of cryosections using an antibody to p75NTR are shown. 
Sections used were Vanin-1-/- and BALB/c gonads at 13.5 dpc. Expression 
of p75NTR between BALB/c and Vanin-1 -I- gonads is very similar. Protein is 
located in the interstitium in both mouse strains, with a slightly higher 
intensity in the Vanin-1 -I- mice.
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F ig u r e  7 .7  E x p r e s s io n  o f  Dhh in  m a le  g o n a d s  a t  1 3 .5  d p c
WMISH analysis of the Sertoli cell marker Dhh was performed on Vanin-1-/- 
and BALB/c gonads at 13.5 dpc. There is no discernable difference in 
expression of Dhh between BALB/c and Vanin-1 -/- mice. Transcripts are 
located in the testis cords of both mouse strains. Longitudinal sections (lower 
panels) reveal this expression to be found towards the periphery of the 
cords.
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Figure 7.8 Expression of Oct4 and Sox9 in male and female gonads at
13.5 dpc
WMISH analyses of two cell markers, the Sertoli cell marker Sox9 and Oct4, 
a marker of primordial germ cells are shown. Analysis was performed on 
male and female gonads at 13.5 dpc.
(A) No differences were observed in Oct4 expression. Transcripts were 
located throughout the length of the ovary in both strains of mice in a 
typically punctuate pattern, whereas in the male, expression was found 
within the testis cords.
(B) Expression of Sox9 in gonads at 13.5 dpc is located in the testis cords of 
male gonads and is absent from female gonads. This expression is the same 
in both Vanin-1-/- and BALB/c mice.
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Figure 7.9 Longitudinal sections of gonads analysed for expression of 
Oct4 and Sox9 by WMISH
Longitudinal sections of gonads analysed for expression of Oct4 and Sox9 
by WMISH are shown. These sections confirm that there are no differences 
in expression pattern or intensity between BALB/c and Vanin-1 -/- mice.
(A) Expression of Oct4 in the ovary is seen throughout its length, 
corresponding to the location of germ cells within it, with both mouse strains 
exhibiting a similar expression pattern.
(B) Expression of Oct4 in male gonads is also located in germ cells; these 
are found within the testis cords. A similar expression pattern is seen 
between these mice as revealed by longitudinal sectioning of the gonads 
after WMISH.
(C) Expression of the Sertoli cell marker Sox9 is found around the periphery 
of the testis cords in both mouse strains.
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Two other markers, Oct4 (germ cell) and Sox9 (Sertoli cell), also exhibit 
expression patterns essentially identical between these two mouse strains 
(Figure 7.8, Figure 7.9).
7.4.2 Organ culture studies
7.4.2.1 Effects of culture on cord formation
Male gonads were explanted at 11.5 dpc from Vanin-1 -/- and BALB/c 
embryos and placed into culture. To discount any variation in culture 
conditions between dishes, each dish was set up containing both strains in a 
clear pattern, for example:
BALB/c male gonads 
Vanin-1 -/- male gonads
Figure 7.10 layout of gonads placed in culture
Figure 7.10 shows a schematic diagram of an example of how gonads were 
explanted in a specific pattern to distinguish them in culture. This pattern 
was noted and cultures were incubated for 48 hours. 1.5% agar block 
cultured in DMEM/10% FCS/50pgmM ampicillin.
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Culture medium was changed after 24 hours and the culture terminated 
after 48 hours. Visual scoring was performed as described in section 6.4.4. In 
total, 17 gonads from the Vanin-1 -/- mouse and 11 BALB/c gonads were 
put into culture. Data obtained suggest that neither strain forms cords with 
the same success rate as gonads from 3H1 embryos. Typically, 
approximately 80% of 3H1 male gonads would form cords when cultured, 
whereas 5/11 (45%) BALB/c and 4/17 (23%) Vanin-1 -/- gonads fully formed 
testis cords (Figure 7.11).
Fisher's exact test was used to compare the data from the two strains (Fisher, 
1934). To test for a significant difference in their ability to form testis cords in 
vitro. Results revealed no significant difference between them (chi-square = 
2.84, df=2 exact P= 0.30). Flence, Vanin-1 -/- gonads form cords in vitro at the 
same efficiency as BALB/c gonads.
7.4.2.2 Effect of mAb 407 on cord formation
Cultures were also set up in the presence and absence of mAb407 to test its 
specificity. Dishes were assembled as described in section 7.4.2.1. In this 
case, each UGR was dissected into two and one gonad mesonephros pair 
was placed in a dish containing mAb407 and the other into a dish without, 
as described in Chapter 6. Culture medium was changed after 24 hours and 
the culture stopped after a further 24 hours with visual scoring for cord
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formation performed as before. Cultures were also preserved for WMISH 
analysis.
As expected mAb 407 was able to block cord formation in the BALB/c gonad 
explants though overall cord formation was not as successful as when 
performed using 3H1 gonads. Fisher's exact test was used to compare 
results, chi-square was calculated as 11.59 (df =2 exact P= 0.0020). However, 
no effect was observed with the Vanin-1 -/- cultures, chi-square was 
calculated as 1.89 (df=2 exact P=0.41) (Figure 7.12).
Analysis of the testicular cell marker Ptc-1 was used in order to study these 
cultured gonads further. Ptc-1 is a marker of peritubular myoid and Leydig 
cells, located in the interstitium of male gonads. Expression analysis by 
WMISH reveals a similar pattern between mAb 407-treated and untreated 
cultures of Vanin-1 -/-  gonads, with Ptc-1 transcripts detected in the 
interstitium of both (Figure 7.13A). A distinct difference is observed between 
BALB/c gonads which have been cultured in the absence and presence of 
mAb 407. No testis cords form in the presence of mAb 407; this is reflected in 
the expression of Ptc-1 which is restricted to the periphery of the gonad. In 
gonads cultured without mAb 407, Ptc-1 expression is located in the 
interstitium of the gonad (Figure 7.13B).
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7.4.3 Vanin-3 expression studies
Initial studies have demonstrated that the Vanin-1 -/- mouse exhibits no 
immune or testis defects. Another member of the Vanin gene family, Vanin- 
3, also exists in the mouse and is expressed in the adult liver (Granjeaud et 
al., 1999). Vanin-3 also encodes a pantetheinase enzyme, though unlike 
Vanin-1 it is a secreted protein. Therefore, any possible compensation for loss 
of Vanin-1 activity by Vanin-3 was investigated. For Vanin-3 to be 
compensating for this loss it must show expression in the same tissues as 
Vanin-1. Therefore, Vanin-3 expression was examined in developing gonads. 
RT-PCR was performed using primers which had been used to clone the full 
length Vanin-3 cDNA (Granjeaud et al., 1999). A transcript of approximately 
1.8kb was detected in adult liver RNA, as expected. However, no transcripts 
were detected in male gonads at 13.5 dpc in either BALB/c or Vanin-1 -/- 
animals (Figure 7.14A). These primers were also used to clone Vanin-3 to 
allow production of a riboprobe. WMISH was then performed on BALB/c 
and Vanin-1 - /- male gonads at 13.5 dpc. No expression was observed in 
either (Figure 7.14B).
7.4.4 Backcross of mutant allele to mouse strain 
C3H/HeH
To assess any effects of changing the genetic background of the Vanin-1 null 
mutation it was back-crossed onto mouse strain C3H/HeH.
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Figure 7.11
Figure 7.11 Effects of culture on cord formation of Vanin-1 -A and 
BALB/c gonads
Figure 7.11 shows a bar chart of the numbers of Vanin-1-/- and BALB/c XY 
gonads placed in culture at 11.5 dpc, and their resulting cord formation 
scores after 48 hours. 4/17 Vanin-1 -/- and 5/11 BALB/c gonads formed 
testis cords in vitro.
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Figure 7.12
Figure 7.12 Effects of mAb 407 on cord formation in Vanin-1-/- 
embryonic gonads in vitro.
Figure 7.12 shows a bar chart of the results of placing gonads at 11.5 dpc 
from Vanin-1-A and BALB/c mice in culture in the absence and presence of 
mAb407. mAb 407 had no effect on the ability of Vanin-1 -/- mice to form 
cords in vitro, whereas no cords formed in cultures of BALB/c where this 
antibody was added. Gonads were cultured for 48 hours.
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F ig u r e  7 .1 3  E x p r e s s io n  o f  Ptc-1 in  c u l t u r e d  m a le  g o n a d s
Expression of the peritubular myoid and Leydig cell marker Ptc-1 was 
analysed by WMISH in Vanin-1-/- and BALB/c gonads cultured in the 
absence and presence of mAb 407. No difference in expression pattern can 
be observed between Vanin-1 -/- gonads cultured in the presence or 
absence of mAb 407. Both strains formed testis cords. Transcripts were 
detected inbetween the cords in the region of peritubular myoid and Leydig 
cells (A).
A distinct difference is seen in BALB/c gonads cultured in the presence of 
mAb 407. Transcripts can be detected around cords formed in the absence 
of mAb 407 whereas expression is confined mainly to the edge of the gonad 
when cultured in the presence of the antibody (B).
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Figure 7.14
F ig u r e  7 .1 4  Vanin-3 e x p r e s s i o n  s t u d i e s
Expression analysis of Vanin-3 in gonads at 13.5 dpc was performed by RT- 
PCR and WMISH. RT-PCR produced a band of 1.8 kb detected as expected 
in adult liver (Arrow, A). No transcripts were observed in male gonads of 
BALB/c or Vanin-1 -/- mice at 13.5 dpc. HPRT expression was used as a 
positive control for the RT-PCR; a product of approximately 350bp was seen 
in all tissues (A). No expression of either gene was observed in blank or 
genomic controls.
WMISH analysis showed no transcripts of Vanin-3 were detected in BALB/c 
or Vanin-1 -/- male gonads at 13.5 dpc. This was confirmed by longitudinal 
sectioning of these gonads (lower panel) (B).
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The Vanin-1 null mutation was obtained in the form of a homozygous stock 
on a BALB/c background. After crossing mutant homozygotes to wild-type 
C3H/HeH, male mice heterozygous for the null allele were crossed with 
female C3H/HeH mice for another four generations. At this point less than 
5% of the genome will be BALB/c DNA derived. After the fifth generation of 
backcrossing heterozygous animals were inter-crossed to obtain 
homozygous animals along with heterozygous and wild type littermates. 
Firstly, litters were dissected at 13.5 dpc when testis cords have normally 
fully formed to observe any changes to their development. Genotyping was 
performed by PCR (Pitari et al., 2000). Three litters were obtained with 21 
embryos in total. Of these 6 were genotyped as Vanin-1 - /-  and were all 
female. As yet no males have been isolated at 13.5 dpc. Adult animals were 
also generated by such inter-crosses. In total, 23 female and 16 male inter­
cross mice were genotyped and 5 Vanin-1 -/- males were identified, with no 
obvious testicular abnormalities (see appendix D for genotyping results).
7.5 Discussion
The Vanin-1 - /-  mouse contains a targeted deletion of Vanin-1 causing a 
complete absence of protein from the animal. Initial data suggested that 
these mice were able to breed normally and that no abnormality in the sex 
ratio was observed. To study the gonadal development of the Vanin-1 -/- 
mouse a comparative study of various testicular markers was undertaken.
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No significant differences in expression patterns were observed between 
Vanin-1 -/-  mice and BALB/c controls. A slight reduction in intensity of 
signal could be seen with Ptc-1, See, SfiHSD, and p75NTR in BALB/c gonads, 
though this was probably due to a delay in the development of these gonads 
in comparison to the Vanin-1 -/- gonads.
When gonads from the Vanin-1 -/- mouse were placed in culture they 
developed testis cords as successfully as BALB/c controls. Furthermore, the 
addition of mAh 407 had no effect on the ability of Vanin-1 -/-  gonads to 
form cords in culture, indicating that the effects of mAb 407 on wild-type 
gonad formation in culture is mediated specifically by the presence of 
Vanin-1. This is also illustrated by the marker analysis performed on these 
cultured gonads.
From these results it is clear that the absence of Vanin-1 has no effect on the 
development of the gonads in vivo. One explanation for this discrepancy 
between the in vitro blocking effect of mAb 407 and the development of 
Vanin-1 -/- embryonic gonads could be that the activity of another, perhaps 
similar, molecule is compensating for the loss of Vanin-1 activity in the 
mutant gonads. The effect of adding blocking antibody to explanted gonads 
in vitro may be to reduce the impact of any such compensating mechanism. 
Two other Vanin molecules exist, namely Vanin-2 and Vanin-3. Vanin-2 
(VNN2) has been found in humans and is a GPI-anchored molecule at the 
cell surface. Fiowever, no cognate for this gene has been found in mice.
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Vanin-3 has been isolated in the liver of adult mice and therefore could be 
responsible for any functional redundancy. To test for this possibility, Vanin- 
3 expression was investigated in the developing gonads. No expression was 
observed in wild-type or Vanin-1 -/- mice which suggests that Vanin-3 is not 
acting in this manner.
Another explanation for the in vitro/in vivo discrepancy might be that the 
effect of mAb 407 is not equivalent to a simple loss-of-function mutation. 
mAb 407 may alter the activity of Vanin-1 in some way, mimicking a gain- 
of-function mutation. It might be fruitful, therefore, to learn more about the 
interaction of mAb 407 and Vanin-1.
It is well established that genetic background can affect how the loss of a 
gene is manifested phenotypically in the mouse. The Vanin-1 null mutation 
was therefore back-crossed from a BALB/c background to C3H/HeH. 
Homozygous mutant embryos were produced after five generations of back- 
crossing and gonads dissected at 13.5 dpc to observe any changes in testis 
development. Unfortunately no Vanin-1 -/- testes were isolated. Despite this, 
adult mice were generated which included Vanin-1 -/- males and these 
exhibited normal testicular development. Thus, changing the genetic 
background has no obvious effect on the development of the Vanin-1 -/- 
mouse. Currently these mice are being examined to verify that they are 
fertile.
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7.6 Summary
• Essentially no differences were observed between Vanin-1 -/ - gonads 
and BALB/c gonads at 13.5 dpc. Analysis of various testicular cell 
markers by WMISH and immunohistochemistry revealed very similar 
expression patterns.
• mAb 407 did not inhibit cord formation in Vanin-1 - /  - gonads in vitro, 
furthermore, these gonads did develop as successfully as wild-type 
gonads when no mAh 407 was added to the culture.
• No Vanin-5 expression was detected in wild-type or Vanin-1 -/- 
gonads at 13.5 dpc.
• Preliminary back-cross studies indicate that changing the genetic 
background of the Vanin-1 null mutation from BALB/c to C3H/HeH 
does not obviously alter the phenotype of these mice.
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Chapter 8: General Discussion
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8.1 Findings of this study
The starting point of this study was an expression-based screen to identify 
candidate genes involved in sexual development. This analysis was 
performed by wholemount in situ hybridisation (WMISH). Two genes, Gatal 
and Vanin-1, were chosen for further analysis.
8.1.1 Gata2
Gatal was chosen for further analysis based on its specific expression in the 
developing ovary. This expression was found to be located in the primordial 
germ cells between 11.5 dpc and 14.5 dpc. This expression pattern coincided 
with the reactivation of the silent X chromosome. Expression was then 
studied in embryos which contain only one X chromosome and hence do not 
undergo this process. Absence of Gatal expression in these embryos would 
suggest a direct link to X chromosome re-activation. However, Gatal 
expression was found to be unaltered. Nevertheless, this result does not rule 
out a potential role for Gatal in this process.
8.1.2 Vanin-1
Vanin-l was found to be expressed in the supporting cell lineage 
immediately prior to overt testis cord formation. Blocking of Vanin-1 protein 
in an in vitro organ culture system resulted in the failure of testis cords to
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form in the XY gonad. However, analysis of the Vanin-1-/- mouse revealed 
no abnormalities in the developing testis in vivo in the absence of Vanin-1.
8.2 Further analysis of GataZ
In order to determine the physiological role of Gata2 in vivo it is necessary to 
examine mice lacking the protein. Mice homozygous for a null allele of Gatal 
have been generated and die by 11.5 dpc (Tsai et al., 1994). Studies of a 
partial rescue did not report on any female abnormalities. A more definitive 
way to study the role of Gatal in ovary development would be to generate a 
cell-type-specific mutation using the Cre-Lox system. However, a limitation 
of this approach is the requirement for transgenic lines with restricted Cre 
expression in the developing ovary. Cre-expressing transgenes exist in the 
postnatal ovary, for example, Msx2Cre (Lan et al., 2003), but to date no lines 
have been produced for the specific excision of conditionally targeted genes 
in the embryonic ovary.
8.2 Further analysis of Vanin-1
As mentioned in Chapter 7, the effect of genetic background on testis 
development can be important (Albrecht et al., 2000). Preliminary studies of 
the effects of changing the background of the Vanin-1 null mutation from 
BALB/c to C3H/HeH have been performed. Heterozygote inter-cross litters 
have been generated, but these exhibit no alteration in the sex ratio or loss of
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any homozygous males. However, further analyses are still to be performed. 
For example, no homozygous male gonads have yet been isolated at 13.5 
dpc. Examination of gonads at this age would allow detection of any defects 
in the developing testis cords.
Vanin-1 is a candidate for regulation by male-specific transcription factors. 
An investigation of the Vanin-1 promoter/enhancers might prove to be an 
important step in testing this hypothesis. However, the transgenic studies 
reported here were unsuccessful in locating any enhancer elements which 
drive the gonadal expression of Vanin-1. One reason for this lack of success 
could be the failure of the /flcZ-reporter construct to function properly. 
Therefore, this study is being repeated with the addition of buffer sequences 
at the ends of the construct in order to protect against any loss of important 
construct sequences by nuclease activity.
Another approach to determining the role of Vanin-1 in gonadogenesis could 
be to look for genes which interact with Vanin-1 by using a sensitised genetic 
screen. This would involve the use of the Vanin-1 -/- mouse in an ENU (ethyl 
N-nitrosourea) mutagenesis study. This alkylating agent induces point 
mutations in premeiotic spermatogonial stem cells (Rinchik, 1991) and has 
been used in a variety of phenotype driven screens (Herron et al., 2002; 
Kasarskis et al., 1998). A sensitised screen would involve breeding ENU- 
induced mutations onto a Vanin-1 -/- background. Mutations in modifier loci 
could be identified by the appearance of a phenotype on the Vanin-1 -/-
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background. These could be mapped and the underlying mutations 
identified. Screening for such loci may result in the identification of new 
genes involved in the developmental pathway in question. In this instance 
such an approach may result in the identification of genes that compensate 
for the absence of Vanin-1 in the homozygous mutant individuals.
This study implemented the use of a Vanin-1 monoclonal antibody (mAb 
407) to block the function of this protein in vitro. As stated previously, this 
approach has been a long established technique used in different organ 
culture systems. However, this approach has not been used before to study 
the effects of inhibiting protein function in the developing gonad. 
Furthermore, it is unknown how this antibody interacts with Vanin-1. This 
study has demonstrated that the effects of mAh 407 are mediated by its 
specific interaction with Vanin-1, but the nature of this interaction is 
unknown. For example, does this antibody modify the function of Vanin-1 in 
some way, as opposed to merely ablating its function? The absence of a 
phenotype in Vanin-1 -/- mice may suggest so.
Two other methods can be employed in a similar organ culture study 
whereby the activity of Vanin-1 is ablated in a more controlled manner. 
Firstly, antisense morpholino oligonucleotides can be used in organ culture. 
Morpholinos can be designed to inhibit the translation of mRNA from a 
target gene (in this instance, Vanin-1) and are designed to be 
complementary, and therefore bind to, the mRNA AUG translational start
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site and the 22 bases 3' to that site. Translation is inhibited solely by a steric 
block mechanism. Therefore the expression of Vanin-1 can be blocked. This 
would therefore have the advantage of swiftness in assessing the role of a 
gene in gonad development combined with the known method of 
interaction with the target gene. Morphant technology has been used 
successfully in the mouse (Coonrod et al., 2001) and in rat organ culture 
(Roberts et al., 2002) where it was used to study Amh-induced cell death in 
the developing male mesonephros.
Secondly RNA interference technology (RNAi) could be used in an organ 
culture system. Specific mRNAs can be degraded by RNAi when double­
stranded RNA corresponding to that mRNA sequence is introduced to a cell. 
This RNAi can be performed by addition of small interfering RNAs (siRNA) 
exogenously in order to silence post-transcriptional gene expression. This is 
achieved by the direct cleavage of mRNA in a sequence-specific manner via 
the action of an RNA nuclease, or by blocking of translation. Studies in post­
implantation mouse embryos have utilised this technology effectively to 
knock-down specific genes (Gratsch et al., 2003). Therefore, the specific 
ablation of Vanin-1 could be achieved, again in a more specific and 
controlled manner. This RNAi strategy has been used successfully in 
mammalian organ culture systems (Davies et al., 2004). Furthermore, these 
approaches can be used to study the functions of other genes that may play a
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role in gonad development and can be used as a more rapid alternative to 
traditional generation of null mutations.
8.3 Success of this screen
8.3.1 Initial aims of this thesis: identification of new
genes using a gene-based approach
The initial aims of this thesis were to identify and analyse new genes 
involved in mouse gonad development, particularly genes from new 
functional classes. This was achieved by a gene-based approach whereby 
genes are selected for further study based on their expression profile and 
previous functional annotation. On this basis therefore, the identification of 
Gatal and Vanin-1 has fulfilled the first aim. This highlights one major 
advantage with this type of approach for finding new genes involved in any 
process or pathway, namely the swiftness and success in candidate gene 
identification.
8.3.2 Drawbacks of this method
However, the functional analysis of these two genes, especially Vanin-1 has 
proven to be more problematic. This highlights a major drawback in this 
gene-based approach, namely the difficulties in assigning a function to a 
particular gene.
One major way of assessing the physiological role of a gene is to examine 
mice lacking the protein. The generation of a tissue-specific null mutation of
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Gatal would greatly advance our understanding of the role of this gene in 
ovary development. However this would be technically demanding, as the 
generation of a transgenic line expressing Cre in the developing ovary 
would be required.
Mice homozygous for a null allele of Vanin-1 (Vanin-1 -/- mice) have been 
generated. However, these mice exhibit no obvious defects in the developing 
testis. This result is by no means a rare outcome in this type of study, and 
points to some kind of compensatory mechanism, or functional redundancy 
operating. An example of this type of mechanism can be seen when studying 
the role of the insulin-like growth factors (Igf) in early gonadogenesis (Nef et 
al., 2003). Null mutations in each family member (Jr-insulin receptor, Igflr- 
insulin-like growth factor 1, Jrr-insulin-receptor-related receptor) produced 
no defects in sexual development. However, the production of triple-gene 
null embryos caused complete male-to-female sex reversal.
Another member of the Vanin family, Vanin-3, exists in the mouse and may 
play a role in compensating for the loss of Vanin-1. Mice homozygous for a 
null mutation of Vanin-3 could be crossed to Vanin-1 - /-  mice to generate 
doubly homozygous mutant animals and any gonad phenotype 
investigated. However, in this thesis, no evidence for Vanin-3 expression in 
the developing testis has been found.
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8.4 Another gene-based mutagenesis approach for
finding and analysing new genes
This study used WMISH to generate candidate genes with a potential to 
function during gonad development. Further functional studies are then 
subsequently performed, with the generation of a nuU mutation by 
homologous recombination being the most informative. Another method of 
generating mutations in candidate genes is to screen archived DNA from 
ENU mutagenised mice (Cox and Brown, 2003; Hrabe de Angelis et al., 2000; 
Nolan et al., 2000a; Nolan et al., 2000b). One advantage of this approach is 
the potential range of alleles which can be isolated from a series of different 
point mutations. For example, new alleles of Vanin-1 may be isolated, 
including hypomorphic, gain-of-function and dominant negative mutations, 
as well as new null alleles.
Coghill et al. (Coghill et al., 2002) utilized archived DNA and frozen sperm 
from FI progeny of mutagenized males. Mice were then re-derived via IVF 
from the frozen sperm. Four genes were scanned for mutations, resulting in 
three functional changes in one gene, Connexin 26, and one null mutation. 
ENU-treated embryonic stem (ES) cells can also be screened. Replica 
libraries are frozen and DNA prepared from one of these (Munroe et al., 
2000). Clearly, this technique can also be implemented in the search for new 
mutations in genes already known to be involved in mouse gonad 
development.
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8.5 Phenotype-driven screens: an alternative
approach to finding new genes
As mentioned previously, one major drawback in the use of gene- 
based/driven screens is that once a gene has been shown to be a potential 
candidate in a given process determining its function can prove to be 
elusive. A different method to finding and analysing new genes is to screen 
progeny from ENU-mutagenised males for defects in gonad development. 
This way the function of any gene can be initially determined by the 
appearance of a phenotype, followed by the slower step of ascertaining 
which gene is responsible for the aberrant phenotype. This approach has 
proved very effective in finding new genes involved in a variety of 
developmental processes (for example, Herron et al., 2002, Nolan et al., 
2000a). Additionally, screens can be performed on a transgenic background. 
For example, transgenic lines can be used which carry the reporter gene GFP 
driven by the promoter of a known gene expressed in (pre-) Sertoli cells. 
Any change in expression pattern that might suggest a developmental 
abnormality can be rapidly visualised and studied further. Breeding 
schemes can be used to allow the identification of both dominant and 
recessive mutant alleles in such a screen. Clearly, the identification of 
recessive alleles is likely to be required to study the function of genes 
involved in gonadogenesis due to probable effects on fertility.
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8.6 Future studies
Many gaps in our knowledge of sexual development are still apparent. For 
example, the target(s) of Sry are still not known and the nature of 
interactions between Sry, Sox9, Fgf9 and Daxl remain unclear. Furthermore, 
when new genes are eventually discovered, how these fit into the sexual 
developmental pathway will need to be elucidated. Genetic blueprints by 
themselves tell us very little about the functional behaviour of cells and 
multi-cellular organisms. Most cellular functions are carried out by groups 
of molecules, creating a network within and between cells (Oltvai and 
Barabasi, 2002). Understanding these interactions will be a major challenge 
and requires the generation of many more mutant phenotypes, including 
those derived from multiple defective genomes. Development of new 
techniques, for example the use of proteomics and real-time imaging, will 
help us to gain insight into how various molecules interact with each other 
and determine how these networks control cellular behaviour during 
mammalian development.
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Appendix A: PCR primer details
Primer
Name Sequence (5 '-3  )
Annealing
temp
Product 
size  bp
Notes
T3 AATTAACCCTC ACTAAAGG G 50 - S e q
T7 GTAATACGACTCACTATAGG
GC 50
- S eq
HPRTA
CCTGCTGGATTACATTAAAGC
ACTG 56
RT-PG R
control
HPRTB
GTCAAGGGCATATCCAACAA
CAAAC 56
352 RT-PG R
control
0 C T 4 F CTCAGCCTTAAGAACATGTG 56
Vf AM 
RT-PG R
0 C T 4 R TTACTCTTGTCTACCTCCCTT 56
563 \MaM
RT-PG R
V nnFR T TGGGGAGTTTCAGGTGTCAA 56
v f/v f
RT-PG R
V nnRR T GTAAATGTATCTTATGATGG 56
500 Vf am
RT-PG R
V nn1F TTGCTGGTG TCGTTGGACTTC 68 f  ex o n
VnnR1
GTGGTTGGGTGGAGATAGGA 68
196 f  ex o n
LACZN2
F GGTTGGAGTGAGGGGAGTTA 55
Transgeni 
c typing
LACZN2
R GGGAGGGTTGTGGTTGAATG 55
418 Transgeni 
c typing
VnnSF GAGAGGGAGGTGGGTGGGAT 55 RT-PG R
VnnSR TTGGTGTGAGTTGGTTTGGG 55 1819 RT-PG R
K O neo
GGAATTGGGGAATGAGAAGA
GG 55
Null
typing
5 ’K O end GTTGTGGAATGGGAAAGTGG 55
Null
typing
3 ’KO end
ATTGATTGAGGAGTGAATGGG
TG 55
Null
typing
U b e ly F GTGTGAGTAGATGGGTGG 60
XO
typing
U b e ly R GGAATGGTGGTGAAGTGG 60
500 XO
typing
A
Appendix B: Control riboprobe details
Name Origin Accession # Vector Antisense
9 Gift
P.Koopman
BC004064 pBluescript II 
sk
BamH1/T7
Oct 4 IMAGE
consortium
AA522407 pBluescript II 
sk
BamH1/T7
3flHSD IMAGE
consortium
AI323693 pT7T3D-
Pac1
EcoR1/T3
IMAGE
consortium
BF719201 pT7T3D-
Pac1
EcoR1/T3
Dhh IMAGE
consortium
BE137145 pT7T3D-
Pac1
EcoR1/T3
See Isolated from
NIA/Oligo
screen
NM_019779 pSport Sal1/Sp6
B
Appendix C: Transgenic PCR genotvping results
Tail# Date of birth Sex Transgenic Notes
9 13/02/01 F
10 F
11 F
12 M
13 M
14 M
15 M
16 M
17 M + LacZ FOUNDER
18 06/03/01 F
19 F
20 F
21 F
22 M
23 M
24 21/03/01 F
25 F
c
26 F
27 F
28 F
29 M
30 20/07/01 F
31 F
32 F
33 F + Progeny PI 7
34 F + Progeny P I7
35 M + Progeny PI 7
36 M
37 M + Progeny PI 7
38 M + Progeny PI 7
39 30/08/01 F
40 F
41 F
42 F
43 F
44 M
45 M
46 M
D
47 M
48 M
49 M
50 M
51 24/09/01 F
52 F
53 F
54 F
55 M
56 M
57 M
58 M
59 M
60 M
61 02/10/01 F
62 F
63 F
64 F
65 F
66 F
67 F
E
68 M
69 M
70 10/10/01 F
71 F
72 F
73 F
74 F
75 M
76 M
77 M
78 M
79 M
80 M
92 21/10/02 F
93 F
94 F
95 F
96 F
97 F
98 F
99 M
100 M
101 M
102 06/02/02 F + LacZ FOUNDER
103 F
104 F
105 M
106 M +LacZ FOUNDER
107 M +LacZ FOUNDER
109 11/02/02 M
110 M
111 M
113 08/04/02 F -t-LacZ Progeny PI 02
114 F
115 M
116 M
117 M +LacZ Progeny P I02
118 F
119 F
120 F
121 F
122 M +LacZ Progeny PI 07
G
123 M
124 07/04/02 F -t-LacZ Progeny P106
125 F
126 F +LacZ Progeny P106
127 F
128 M
129 M +LacZ Progeny PI 06
130 11/04/02 F +LacZ Progeny PI 06
131 F +LacZ Progeny P I06
132 F
133 M +LacZ Progeny PI 06
H

Appendix D C3H/HeH inter cross genotvping results
Embryos were collected at 13.5 dpc. The sex was 
determined by the detection of Barr bodies in the amnion 
and genotyping was performed by PCR. A 350 bp band 
alone indicates -/- mice and a 120 bp band alone 
indicates wild type mice; mice containing both products 
are heterozygous for the mutation (B). Currently, no 
testes have been found which genotyped as -/- for 
Vanin-1 (A). Adult inter-cross mice generated from 
further matings were also genotyped and Vanin-1-/- 
males were identified (C).
LITTER GONAD SEX BY AMNION GENOTYPE
PREP PCR
ICA 1 TESTIS X +/+
ICA 2 OVARY XX +/-
ICA 3 OVARY XX -/-
ICA 4 OVARY XX -/-
ICA 5 OVARY XX +/-
ICA 6 OVARY XX +/-
ICA 7 OVARY XX +/+
IC B 1 OVARY XX -/-
ICB 2 OVARY XX -/-
ICB 3 OVARY XX +/-
ICB 4 OVARY XX +/+
ICB 5 TESTIS X +/-
ICB 6 TESTIS X +/-
ICB 7 OVARY XX +/-
ICB 8 TESTIS X +/+
ICB 9 OVARY XX -/-
ICC 1 OVARY XX +/-
ICC 2 TESTIS X +/-
ICC 3 OVARY XX -/-
ICC 4 TESTIS X +/-
ICC 5 TESTIS X +/-
120
ICA ICB ICC
Genotype PCR +/+ +/- -/-
Female 5 12 5
Male 6 5 5
B
Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
